http://jnci.oxfordjournals.org/content/89/13/917.full
<!DOCTYPE html
  PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html
      xmlns="http://www.w3.org/1999/xhtml"
      xml:lang="en"
      lang="en">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
      <title>Multidrug Resistance in Breast Cancer: a Meta-analysis of MDR1/gp170 Expression and Its Possible Functional Significance </title>
      <meta name="googlebot" content="NOODP" />
      <meta name="HW.ad-path" content="/cgi/content/full/89/13/917" />
      <meta content="/jnci/89/13/917.atom" name="HW.identifier" />
      <meta name="DC.Format" content="text/html" />
      <meta name="DC.Language" content="en" />
      <meta content="Multidrug Resistance in Breast Cancer: a Meta-analysis of MDR1/gp170 Expression and Its Possible Functional Significance"
            name="DC.Title" />
      <meta content="10.1093/jnci/89.13.917" name="DC.Identifier" />
      <meta content="1997-07-02" name="DC.Date" />
      <meta content="Oxford University Press" name="DC.Publisher" />
      <meta content="Bruce J. Trock" name="DC.Contributor" />
      <meta content="Fabio Leonessa" name="DC.Contributor" />
      <meta content="Robert Clarke" name="DC.Contributor" />
      <meta content="Journal of the National Cancer Institute"
            name="citation_journal_title" />
      <meta content="JNCI J Natl Cancer Inst" name="citation_journal_abbrev" />
      <meta content="0027-8874" name="citation_issn" />
      <meta content="1460-2105" name="citation_issn" />
      <meta name="citation_author" content="Bruce J. Trock" />
      <meta name="citation_author" content="Fabio Leonessa" />
      <meta name="citation_author" content="Robert Clarke" />
      <meta content="Multidrug Resistance in Breast Cancer: a Meta-analysis of MDR1/gp170 Expression and Its Possible Functional Significance"
            name="citation_title" />
      <meta content="07/02/1997" name="citation_date" />
      <meta content="89" name="citation_volume" />
      <meta content="13" name="citation_issue" />
      <meta content="917" name="citation_firstpage" />
      <meta content="931" name="citation_lastpage" />
      <meta content="89/13/917" name="citation_id" />
      <meta content="89/13/917" name="citation_id_from_sass_path" />
      <meta content="jnci;89/13/917" name="citation_mjid" />
      <meta content="10.1093/jnci/89.13.917" name="citation_doi" />
      <meta content="http://jnci.oxfordjournals.org/content/89/13/917.abstract"
            name="citation_abstract_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/89/13/917.full"
            name="citation_fulltext_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/89/13/917.full.pdf"
            name="citation_pdf_url" />
      <meta content="http://jnci.oxfordjournals.org/content/89/13/917"
            name="citation_public_url" />
      <meta content="9214671" name="citation_pmid" />
      <meta name="citation_section" content="Article" />
      <meta name="robots" content="noarchive,nofollow" />
      <meta name="googlebot" content="noarchive" />
      <link href="/content/89/13/906.short" rel="prev" />
      <link href="/content/89/13/932.short" rel="next" />
      <link rel="stylesheet" type="text/css" media="all" href="/shared/css/hw-global.css" />
      <link rel="stylesheet" type="text/css" media="print" href="/shared/css/hw-print.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/local/css/hw-local-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-ac.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-page-content.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/jquery.fancybox-1.3.4.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-global-colexpand.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-page-content.css" /><script type="text/javascript" id="session-d29548414e1">var callbackToken='53727EDD25FC4E5';</script><script type="text/javascript" id="session-d29548414e3">
                      var subCode='oupjournal_sub';
                    </script><script type="text/javascript">
            var gAuthTimeStamp = '2015-10-27T12:16:18.235-07:00';
            var gSessionId = 'EIDBGLG7uQK6NDzHIM2sxQ';
            var gAuthzRequired = 'false';
            var gAuthnMethods1 = 'ip';
            var gAuthnMethods2 = 'ip';
            var gAuthnIPs = '18.189.59.169';
            var gAuthnIndividuals = '';
            var gAuthnInstitutions = '10005282,10072538,10328193,100274300,10082403,05094000,10093227,153074108,10080507,21879000,10095822,10081742,10082405,10004595,10019502,10082401,07635000,10082404,06602000';
            </script><script type="text/javascript" src="/shared/js/jquery-min.js"></script><script type="text/javascript" src="/shared/js/fingerprint.js"></script><script type="text/javascript" src="/shared/js/hw-shared.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-site.js"></script><script type="text/javascript" src="/local/js/local-js-vars.js"></script><script type="text/javascript" src="/shared/js/pages/hw-content.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.easing-1.3.pack.js"></script><script type="text/javascript"
              src="/shared/js/fancybox/jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="/shared/js/util/content.jquery.addVariantLink.js"></script><script type="text/javascript" src="/shared/js/util/hw-col-expand.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-modalwin-vars.js"></script><script type="text/javascript"
              src="/publisher/js/hw-publisher-article-dynamic-elements.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-content.js"></script><script type="text/javascript" src="/shared/js/util/hw-mathjax.js"></script><script type="text/x-mathjax-config">
          MathJax.Hub.Config({
              tex2jax: {
                inlineMath: [["$","$"],["\\(","\\)"]],
                processClass: "tex2jax_process|mathjax"
              }
            });
          MathJax.Hub.Queue(function() {
            gColTempResize = true;
            fixColHeights(1);
            gColTempResize = false;
          });
       </script><script type="text/javascript"
              src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script><script type="text/javascript">
	    
	    
	    
	    var siqDOI = encodeURIComponent("10.1093/jnci/89.13.917");
	    var siqIsOpenAccess = encodeURIComponent("");
	    var siqPubDate = encodeURIComponent("19970702");

	    if (siqDOI.length == 0) {
	        siqDOI = "UNKNOWN";
	    }
	    
	    
		
		
	    if (gAuthnIndividuals.length != 0) {
		if (gAuthnInstitutions.length != 0) {
		    authnEntity = encodeURIComponent(gAuthnIndividuals
		        + ',' + gAuthnInstitutions);
		} else {
		    authnEntity = encodeURIComponent(gAuthnIndividuals);
		}
	    } else {
	        authnEntity = encodeURIComponent(gAuthnInstitutions);
	    }

	    var commonString =
		'authSessionId=' + gSessionId + String.fromCharCode(0x26)
		+ 'authzRequired=' + gAuthzRequired + String.fromCharCode(0x26)
		+ 'authentication_method=' + encodeURIComponent(gAuthnMethods2) + String.fromCharCode(0x26)
		+ 'authnIPs=' + gAuthnIPs + String.fromCharCode(0x26)
		+ 'authnInstitutions=' + authnEntity;

		
		
		
		

	    var gPageId = "pageid-content";
	    var gVariant = "full-text";

	    
		// Not completely done
		var eventType = "full-text";
		var accessType;
		if (siqIsOpenAccess == 'true') {
		    accessType = 'SOA';
		} else {
		    accessType = 'subscription';
		}
		    
		var NTPT_PGEXTRA =
		    commonString + String.fromCharCode(0x26)
		    + 'event_type=' + eventType + String.fromCharCode(0x26)
		    + 'publication_date=' + siqPubDate + String.fromCharCode(0x26)
		    + 'access_type=' + accessType + String.fromCharCode(0x26)
		    + 'doi=' + siqDOI ;
		    
		

	    // alert("NTPT_PGEXTRA is " + NTPT_PGEXTRA);
	</script><link rel="stylesheet" type="text/css" media="all" href="/resource/css/hw20.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-header.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-footer.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-sidebars.css" />
      <link type="text/css" media="all" rel="stylesheet" href="/site/resource/jnci_h20.css" />
      <link rel="stylesheet" type="text/css" href="/resource/css/print.css" media="print" /><script type="text/javascript" src="/resource/js/main.js"></script><link rel="stylesheet" type="text/css" media="all"
            href="http://oi-underbar.ifactory.com/underbar/css/pf_oiunderbar.css" />
      <link rel="stylesheet" type="text/css" media="screen"
            href="http://gab.cookie.oup.com/aws-cookie/jquery.fancybox-1.3.4_1.css" /><script type="text/javascript" src="/resource/js/oup_ad_size.js"></script></head>
   <body class="general_page journal jnci">
      <div class="hw-gen-page pagetype-content hw-pub-id-article" id="pageid-content"
           itemscope="itemscope"
           itemtype="http://schema.org/ScholarlyArticle">
         <noscript>
            <p>We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of
               cookies. You can change your cookie settings at any time. <a href="http://global.oup.com/cookiepolicy/">Find out more</a></p>
         </noscript>
         
         
         <p class="hide">
            <a href="#content">Skip Navigation</a>
            
         </p>
         
         
         <div id="secondary_nav">
            <strong id="page_logo" title="Oxford Journals"><a href="http://www.oxfordjournals.org/"><span>Oxford Journals</span></a></strong>
            
            <ul>
               <li id="nav_contact_us" title="Contact Us"><a href="http://www.oxfordjournals.org/contact_us.html"><span>Contact Us</span></a></li>
               <li id="nav_my_basket" title="My Basket"><a href="https://secure.oxfordjournals.org/basket.html"><span>My Basket</span></a></li>
               <li id="nav_my_account" title="My Account"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http://www.oxfordjournals.org/service/Register"><span>My 
                        
                        Account</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="header">
            
            <h1 id="page_title" title="JNCI J Natl Cancer Inst"><a href="/"><span>
                     JNCI J Natl Cancer Inst
                     </span></a></h1>
            
         </div>
         
         
         <div id="primary_nav">
            
            <ul>
               <li id="nav_about_this_journal" title="About This Journal">
                  <a href="http://www.oxfordjournals.org/jnci/about.html">
                     
                     <span>About This Journal</span>
                     </a>
                  
               </li>
               <li id="nav_contact_this_journal" title="Contact This Journal"><a href="/cgi/feedback/"><span>Contact This Journal</span></a></li>
               <li id="nav_subscriptions" title="Subscriptions">
                  <a href="http://www.oxfordjournals.org/jnci/access_purchase/buy_online.html">
                     
                     <span>Subscriptions</span>
                     </a>
                  
               </li>
               <li id="nav_current_issue" title="Current"><a href="/content/current"><span>View Current Issue (Volume 107 Issue 10 October 2015)</span></a></li>
               <li id="nav_archive" title="Archive"><a href="/content/by/year"><span>Archive</span></a></li>
               <li id="nav_search" title="Search"><a href="/search"><span>Search</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="user_nav">
            
            <div class="header-ac-elements">
               
               <div id="authstring">
                  
                  <ul>
                     <li class="subscr-ref">Institution:  MIT Libraries</li>
                     <li class="no-left-border">
                        <a href="/login?uri=http%3A%2F%2Fjnci.oxfordjournals.org%2Fcontent%2F89%2F13%2F917.full">
                           Sign In as Personal Subscriber
                           </a>
                        
                     </li>
                  </ul>           
                  
               </div>   
               
            </div>
            
         </div>
         
         
         <ul id="site-breadcrumbs">
            <li class="first"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http%3A%2F%2Fwww.oxfordjournals.org">Oxford Journals</a></li>
            <li><span class="breadcrumb_subjects"><a href="http://www.oxfordjournals.org/subject/medicine/"
                     class="breadcrumb_subject">Medicine &amp; Health</a></span></li>
            <li><a href="/">JNCI J Natl Cancer Inst</a></li>
            <li><a href="/content/89/13.toc">
                  <span xmlns="" class="volume-value">Volume 89</span>
                  <span xmlns="" class="issue-value"> Issue 13</span></a></li>
            <li>Pp. <span class="slug-pages">
                  917-931.
                  </span></li>
         </ul>
         
         
         
         
         <div id="oas_top" class="ad_hidden">
            <iframe id="id_advertframe_top"
                    src="/resource/htmlfiles/advert.html?p=Top&amp;u=jnci.oxfordjournals.org/content/89/13/917.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         <a name="content"></a>
         
         
         <div id="h20_page"></div>
         
         <div id="content-block">
            <div class="article fulltext-view" itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><h1 id="article-title-1" itemprop="headline">Multidrug Resistance in Breast Cancer: a Meta-analysis of MDR1/gp170 Expression and Its Possible Functional Significance</h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li class="contributor" id="contrib-1" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Bruce+J.+Trock&amp;sortspec=date&amp;submit=Submit">Bruce J. Trock</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-2" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Fabio+Leonessa&amp;sortspec=date&amp;submit=Submit">Fabio Leonessa</a></span> and 
                     </li>
                     <li class="last" id="contrib-3"><span class="name"><a class="name-search"
                              href="/search?author1=Robert+Clarke&amp;sortspec=date&amp;submit=Submit">Robert Clarke</a></span></li>
                  </ol>
                  <ol class="affiliation-list">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address>Department of Biomathematics and Biostatistics, Department of Medicine, and Lombardi Cancer Center, <span class="addr-line">Georgetown University Medical Center, Washington, DC</span></address>
                     </li>
                     <li class="aff"><a id="aff-2" name="aff-2"></a><address>Lombardi Cancer Center, <span class="addr-line">Georgetown University Medical Center, Washington, DC</span></address>
                     </li>
                     <li class="aff"><a id="aff-3" name="aff-3"></a><address>Department of Physiology and Biophysics and Lombardi Cancer Center, <span class="addr-line">Georgetown University Medical Center, Washington, DC</span></address>
                     </li>
                  </ol>
                  <ol class="corresp-list">
                     <li class="corresp" id="corresp-1"><em>Correspondence to:</em> Bruce J. Trock, Ph.D., Lombardi Cancer Center, Georgetown University Medical Center, 2233 Wisconsin Ave., NW, Suite 535,
                        Washington, DC 20007.
                     </li>
                  </ol>
                  <ul class="history-list">
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="received"
                         hwp:start="1996-11-09"><span class="received-label">Received </span>November 9, 1996.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="rev-recd"
                         hwp:start="1997-03-25"><span class="rev-recd-label">Revision received </span>March 25, 1997.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted"
                         hwp:start="1997-04-18"><span class="accepted-label">Accepted </span>April 18, 1997.
                     </li>
                  </ul>
               </div>
               <div class="section abstract" id="abstract-1" itemprop="description">
                  <div class="section-nav">
                     <div class="nav-placeholder"> </div><a href="#sec-1" title="Materials and Methods" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Abstract</h2>
                  
                  <p id="p-2"><em>Background:</em> P-glycoprotein (gp170; encoded by the MDR1 gene [also known as PGY1]) is a membrane protein capable of exporting a variety
                     of anticancer drugs from cells. MDR1/ gp170 expression has been studied in breast cancer, but the prevalence of this expression
                     and its role in breast tumor drug resistance are unclear. <em>Purpose:</em> We conducted a critical review and meta-analysis of studies examining MDR1/ gp170 expression in breast cancer to estimate
                     the likely prevalence and clinical relevance of this expression. We also explored reasons for differences in the findings
                     from individual studies. <em>Methods:</em> Published papers on MDR1/gp170 expression in breast cancer were identified by searching several literature databases and
                     reviewing the bibliographies of identified papers. Variability across the studies in the proportion of tumors expressing MDR1/gp170
                     was assessed by use of chi-squared tests of homogeneity, weighted means, and weighted linear regression. Pooled relative risks
                     (RRs) for the association between the induction of MDR1/gp170 expression and prior chemotherapy and associations between MDR1/gp170
                     expression and several clinical outcomes were estimated by use of Mantel-Haenszel methods. Heterogeneity among the pooled
                     RRs was explored by use of chisquared tests. Reported P values are two-sided. <em>Results:</em> Thirty-one studies were identified and evaluated. The proportion of breast tumors expressing MDR1/gp170 in all of the studies
                     was 41.2%, but there was substantial heterogeneity in the values across individual studies (P&lt;.0001). Regression analyses
                     demonstrated that a considerable portion of the observed heterogeneity was a consequence of the change, over time, from RNA
                     hybridization-based assays to immunohistochemistry-based assays of MDR1/gp170 expression. Measuring MDR1/gp170 expression
                     before versus after chemotherapy and use of cytotoxic drugs that are not substrates for gp170 also contributed to the heterogeneity.
                     Treatment with chemotherapeutic drugs or hormonal agents was associated with an increase in the proportion of tumors expressing
                     MDR1/gp170 (RR = 1.77; 95% confidence interval [CI] = 1.46-2.15). Patients with tumors expressing MDR1/gp170 were three times
                     more likely to fail to respond to chemotherapy than patients whose tumors were MDR1/ gp170 negative (RR = 3.21; 95% CI = 2.28-4.51);
                     this RR increased to 4.19 (95% CI = 2.71-6.47) when considering only patients whose tumor expression of MDR1/gp170 was measured
                     after chemotherapy. MDR1/gp170 expression was not associated with lymph node metastases, estrogen receptor status, tumor size,
                     tumor grade, or tumor histology. <em>Conclusions and Implications:</em> MDR1/gp170 expression in breast tumors is associated with treatment and with a poor response to chemotherapy. The data are
                     consistent with a contributory role for MDR1/gp170 in the multidrug resistance in some breast tumors.
                  </p>
                  
               </div>
               <p id="p-3">Breast cancer is often considered to be one of the more chemoresponsive solid tumors. Many structurally diverse cytotoxic
                  drugs, when administered either as single agents or in combination, can induce remissions in previously untreated breast cancer
                  patients (<em><a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a></em>). While the overall response rate can be high, the duration of response is relatively short (<em><a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a></em>), and most of the initially responsive breast tumors acquire a multidrug resistance phenotype. This phenotype is frequently
                  characterized by a cross-resistance to drugs to which the tumors have not been exposed. The development of a multidrug resistant
                  phenotype in metastatic breast cancer is primarily responsible for the failure of current treatment regimens. The precise
                  nature of this phenotype remains unclear. However, several mechanisms may be involved and include kinetic resistance (<em><a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a></em>,<em><a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a></em>), gp170 (PGP, Pglycoprotein) expression, glutathione transferases (<em><a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a></em>,<em><a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a></em>), superoxide dismutases (<em><a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a></em>), topoisomerases (<em><a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a></em>), and the multidrug resistance- associated protein (MRP) (<em><a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a></em>). These may occur independently or in combination, thereby conferring resistance in heavily treated patients exposed to structurally
                  and functionally diverse agents.
               </p>
               <p id="p-4">In experimental models, the multidrug-resistant phenotype is often accompanied by the expression of the MDR1 gene (also known
                  as PGY1) and/or its gp170 glycoprotein product (MDR1/ gp170, where MDR1 refers to the gene and its messenger RNA and gp170
                  denotes the glycoprotein gene product) (<em><a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a></em>). A 170- kd cell membrane glycoprotein, gp170 appears to work by actively effluxing substrates from cells (<em><a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a></em>). The glycoprotein possesses two adenosine triphosphate (ATP)-binding sites and exhibits significant ATPase activity (<em><a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a></em>). The drug-binding sites are close to gp170's cytosolic transmembrane domains (<em><a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a></em>), the drugs apparently being removed from within the membrane bilipid layer (<em><a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a></em>). Activation of gp170 may be regulated through phosphorylation by protein kinases, e.g., protein kinase C (<em><a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a></em>–<em><a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a></em>), and its efflux function may be affected by membrane lipid composition (<em><a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a></em>) and fluidity (<em><a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a></em>–<em><a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a></em>).
               </p>
               <p id="p-5">The multidrug-resistant phenotype conferred by gp170 is characterized by resistance to various structurally unrelated anticancer
                  agents, including the anthracyclines, epipodophyllotoxins, vinca alkaloids, and taxanes (<em><a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a></em>). The majority of the most widely used combination chemotherapy regimens for breast cancer include gp170 substrates as either
                  first-line or second-line treatments, most frequently in combination with non-gp170 substrates. For example, doxorubicin (Adriamycin)
                  and vinblastine are gp170 substrates and are among the most effective antineoplastic drugs in breast cancer (<em><a id="xref-ref-22-2" class="xref-bibr" href="#ref-22">22</a></em>). Paclitaxel (Taxol) when administered as a single agent (<em><a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a></em>) or in combination with doxorubicin also produces significant responses in breast cancer (<em><a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a></em>) and is likely to become more widely used as an agent for breast cancer treatment.
               </p>
               <p id="p-6">The role of MDR1/gp170 in human breast cancer remains unclear, partly because of an apparent lack of a consensus on whether
                  MDR1/gp170 is expressed in breast tumors. While various small studies (<em><a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a></em>–<em><a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a></em>) have readily detected MDR1/gp170 expression, one of the largest single studies published to date (<em><a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28</a></em>) and several smaller studies (<em><a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a></em>,<em><a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">30</a></em>) have failed to detect any expression of MDR1/gp170 in breast tumors. Even among those studies detecting MDR1/gp170 expression,
                  there has been no clear consensus regarding its likely functional significance.
               </p>
               <p id="p-7">Our primary goals were to clarify the prevalence and clinical relevance of MDR1/gp170 expression in breast cancer and to explore
                  the causes of heterogeneity across the studies evaluated. We have undertaken a critical review and meta-analysis of the published
                  literature describing the expression and potential function of the MDR1 gene and its gp170 product in breast cancer. Meta-analysis
                  has rarely been applied to basic science research. However, it may be useful for translational studies of molecular mechanisms
                  in cancer, since the rapid pace of basic research is associated with considerable variation in methods, reagents, and quality-control
                  measures, and such variation may obscure the clinical relevance of a given molecule.
               </p>
               <p id="p-8">The specific questions that we addressed are as follows: 1) Is MDR1/gp170 expressed in breast tumors and, if so, what is the
                  frequency of expression? 2) Is MDR1/gp170 expression associated with cytotoxic and/or hormonal treatment and, if so, what
                  is the magnitude of this association? 3) What is the potential functional relevance of MDR1/gp170 expression in breast cancer
                  with respect to response to chemotherapy and predicting prognosis? 4) For each of the above questions, if there is a significant
                  lack of agreement among studies, what factors contribute to this heterogeneity?
               </p>
               <p id="p-9">Both the validity and the most appropriate methodology for performing reviews of this type are controversial (<em><a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">31</a></em>–<em><a id="xref-ref-34-1" class="xref-bibr" href="#ref-34">34</a></em>). We have emphasized objective quantitative criteria in our evaluation and have followed explicit guidelines for the conduct
                  of metaanalyses and critical research reviews (<em><a id="xref-ref-35-1" class="xref-bibr" href="#ref-35">35</a></em>–<em><a id="xref-ref-37-1" class="xref-bibr" href="#ref-37">37</a></em>). Moreover, we considered an assessment of the sources of heterogeneity to be a goal of the analysis rather than a preliminary
                  step.
               </p>
               <p id="p-10">The treatment and exposures of interest are the systemic therapies administered to breast cancer patients. Such therapies
                  include cytotoxic chemotherapy, which we considered in two subsets, i.e., regimens including at least one known gp170 substrate
                  and regimens not including any known substrates. For example, the CAF regimen (cyclophosphamide, doxorubicin, and fluorouracil)
                  is considered to be an MDR1/gp170-related drug regimen because of the presence of doxorubicin. In contrast, the CMF regimen
                  (cyclophosphamide, methotrexate, and fluorouracil) is considered to be a non-MDR1/gp170-related drug regimen. We also have
                  included studies that utilized the antiestrogen tamoxifen (<em><a id="xref-ref-38-1" class="xref-bibr" href="#ref-38">38</a></em>,<em><a id="xref-ref-39-1" class="xref-bibr" href="#ref-39">39</a></em>), which is known to reverse gp170-mediated resistance in vitro.
               </p>
               <div class="section" id="sec-1">
                  <div class="section-nav"><a href="#abstract-1" title="Abstract" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-7" title="Results" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Materials and Methods</h2>
                  
                  <div id="sec-2" class="subsection">
                     
                     <h3>Criteria for Conducting the Review and Meta-analysis</h3>
                     
                     <p id="p-11">Formal research reviews and meta-analyses have become increasingly common for evaluating large, often diverse bodies of research
                        to resolve apparent lack of agreement among the individual studies. These often take the form of purely synthetic exercises,
                        where the individual study results are combined in a summary measure, without regard to the appropriateness of combining the
                        studies. Such analyses often also lack a careful exploration of the reasons for disagreement among studies. The latter can
                        often be as important as or more important than the summary measure, since the factors underlying disagreement may point to
                        informative patient subgroups or methodologic issues.
                     </p>
                     
                     <p>This review and meta-analysis focused not only on quantifying the prevalence of MDR1/gp170 expression and its functional relevance
                        in breast cancer, but also on exploring sources of variation or heterogeneity in results across studies. The appropriate criteria
                        for research reviews and meta-analyses have been widely discussed (<em><a id="xref-ref-37-2" class="xref-bibr" href="#ref-37">37</a></em>,<em><a id="xref-ref-40-1" class="xref-bibr" href="#ref-40">40</a></em>–<em><a id="xref-ref-42-1" class="xref-bibr" href="#ref-42">42</a></em>), most recently in this Journal (<em><a id="xref-ref-43-1" class="xref-bibr" href="#ref-43">43</a></em>). The general guidelines from these sources were adapted and applied for the conduct of this review as follows:
                        
                     </p>
                     <ol class="list-ord" id="list-1">
                        <li id="list-item-1">
                           <p id="p-13">We include a clear statement of the specific purpose(s) of the review, with reference to the population to be generalized,
                              the treatment or exposure of interest, and the major outcome(s) of interest (<em>see above</em>).
                           </p>
                        </li>
                        <li id="list-item-2">
                           <p id="p-14">We describe the sources and define the methods of citation searches.</p>
                        </li>
                        <li id="list-item-3">
                           <p id="p-15">We formulated specific guidelines, in advance, to determine which studies were to be excluded or included and detail the reasons
                              for exclusion or inclusion.
                           </p>
                        </li>
                        <li id="list-item-4">
                           <p id="p-16">We established, and subsequently applied, a consensual assessment of the validity of the methods used in the studies reviewed
                              and provide a determination of what conclusions are justified by these methods. More than one author was involved in determining
                              the assessment.
                           </p>
                        </li>
                        <li id="list-item-5">
                           <p id="p-17">We integrate results of individual studies in a quantitative, weighted fashion, with consideration of data limitations and/or
                              inconsistencies. Where significant heterogeneity is present, we attempt to determine its sources. This may be more important
                              than any summary measure.
                           </p>
                        </li>
                        <li id="list-item-6">
                           <p id="p-18">We summarize all major or relevant findings.</p>
                        </li>
                        <li id="list-item-7">
                           <p id="p-19">We identify specific directions or considerations for new research by identifying gaps in our present knowledge.</p>
                        </li>
                        <li id="list-item-8">
                           <p id="p-20">We provide suggestions for the design of future studies, particularly where this relates to eliminating confounding factors
                              and identified sources of heterogeneity.
                           </p>
                        </li>
                     </ol>
                     
                  </div>
                  
                  <div id="sec-3" class="subsection">
                     
                     <h3>Sources of Data and Methods of Citation Search</h3>
                     
                     <p id="p-21">To identify studies that evaluated MDR1/gp170 expression in human breast cancers, we performed an extensive literature search
                        of the following databases: Medline (National Library of Medicine, National Institutes of Health, Bethesda, MD), CANCERLIT
                        (National Library of Medicine), <em>Current Contents</em> (Institute for Scientific Information, Philadelphia, PA), <em>Current Advances in Cancer Research</em> (Current Awareness in Biological Sciences, Elsevier Science Inc., Tarrytown, NY), <em>Knowledge Finder</em> (Aries Systems Corp., North Andover, MA), and the <em>Science Citation Index</em> (Institute for Scientific Information). For keyword- based Boolean searches, we used 44 different keywords that were either
                        words or variations of words, e.g., spelling, punctuation, and abbreviation, which represent the multidrug resistance subject.
                        We also used the bibliography listings of relevant papers found in the above databases as leads for identifying additional
                        studies.
                     </p>
                     
                  </div>
                  
                  <div id="sec-4" class="subsection">
                     
                     <h3>Criteria for Inclusion or Exclusion</h3>
                     
                     <p id="p-22">For studies to be included, they had to describe original research involving measurement of MDR1/gp170 expression in human
                        breast cancers. Reviews were excluded. If more than one report described the same data, we used only the latest report. To
                        be included, a published report also must have enabled determination of the number of MDR1/gp170-positive and -negative tumors.
                        Since amplification is often an unreliable indicator for gene expression and the contribution of other relevant coamplified
                        genes cannot be assessed readily (<em><a id="xref-ref-44-1" class="xref-bibr" href="#ref-44">44</a></em>,<em><a id="xref-ref-45-1" class="xref-bibr" href="#ref-45">45</a></em>), studies based only on amplification of the MDR1 gene were not included. All other studies, which primarily used immunologic
                        detection of protein (western blot or immunohistochemistry) and/or RNA hybridization methods (northern blot or dot blot),
                        were included. Study eligibility was determined independently by all three investigators. When determining eligibility, the
                        investigators were not formally blinded to study results because it was often necessary to read the results to determine whether
                        the number of MDR1/gp170-positive tumors was given. However, the inclusion criteria are quite unambiguous, and it is unlikely
                        that lack of blinding induced bias (only four papers were excluded—see below).
                     </p>
                     
                     <p id="p-23">Three studies (<em><a id="xref-ref-28-2" class="xref-bibr" href="#ref-28">28</a></em>,<em><a id="xref-ref-46-1" class="xref-bibr" href="#ref-46">46</a></em>,<em><a id="xref-ref-47-1" class="xref-bibr" href="#ref-47">47</a></em>) used more than one assay method to evaluate the same group of tumor samples. These results were included in all analyses
                        of subgroups of studies that used a specific method. For example, the report by Merkel et al. (<em><a id="xref-ref-28-3" class="xref-bibr" href="#ref-28">28</a></em>) analyzed many of the same tumors by use of both western blot and RNA hybridization methods and was represented in both the
                        subgroups of western blot and RNA hybridization studies. (Data from the study by Merkel et al. that were based on gene amplification
                        were not included.) In analyses that pooled all studies, the results obtained by Merkel et al. were represented by the assay
                        method based on the largest number of tumors (western blot). The results obtained by Kim (<em><a id="xref-ref-46-2" class="xref-bibr" href="#ref-46">46</a></em>), who included the same number of tumors for each assay method, were represented by the method yielding the highest expression
                        of MDR1/gp170, i.e., immunohistochemistry. The study by Chevillard et al. (<em><a id="xref-ref-47-2" class="xref-bibr" href="#ref-47">47</a></em>) is represented here among the studies of immunohistochemistry. There were insufficient studies using the polymerase chain
                        reaction (PCR) to enable analysis of data obtained by this methodology.
                     </p>
                     
                  </div>
                  
                  <div id="sec-5" class="subsection">
                     
                     <h3>Assessment of Studies and Methods</h3>
                     
                     <p id="p-24">Studies of MDR1/gp170 expression in breast cancer are essentially translational research. Thus, methodologic considerations
                        must be coupled with the ability to derive clinical inferences from the results. With this in mind, we chose to assess the
                        methodologic rigor and the clinical relevance of the studies by applying a series of objective technical criteria. These criteria
                        were used to describe the studies, but a “quality score” was not obtained for use as a stratification factor for the meta-analysis.
                        Such quality scores are often confounded and highly subjective. Stratification or exploration of heterogeneity can be better
                        accomplished on the basis of the individual components of the quality score (<em><a id="xref-ref-33-1" class="xref-bibr" href="#ref-33">33</a></em>).
                     </p>
                     
                     <p>The criteria that we used were based on factors that we deemed a priori to be potential contributors to heterogeneity and
                        that also comprised a set of important criteria for the conduct of this type of translational research. The criteria included
                        the following:
                        
                     </p>
                     <ol class="list-ord" id="list-2">
                        <li id="list-item-9">
                           <p id="p-26">Appropriate consideration of statistical precision, i.e., adequate sample size, use of confidence intervals (CIs), or consideration
                              of sample size in interpretation of results. Twenty-five patients were considered to be the minimum adequate sample size because
                              this size would produce an upper confidence bound of less than 10% if the study found no tumors expressing MDR1/gp170.
                           </p>
                        </li>
                        <li id="list-item-10">
                           <p id="p-27">Adequate description of tumors and treatment, such that MDR1/ gp170-positive and -negative tumors could be classified according
                              to whether the assay was performed on primary or metastatic tumors (before or after chemotherapy) and according to whether
                              treatment included multidrug-resistant substrates (e.g., doxorubicin) or non-multidrug-resistant substrates (e.g., cyclophosphamide).
                           </p>
                        </li>
                        <li id="list-item-11">
                           <p id="p-28">A clear description of the criteria for MDR1/gp170 positivity, sufficient to allow comparison among studies.</p>
                        </li>
                        <li id="list-item-12">
                           <p id="p-29">A clear description of the characteristics of the patient population and criteria for accrual.</p>
                        </li>
                        <li id="list-item-13">
                           <p id="p-30">The presence of positive controls in the assay for MDR1/gp170 expression.</p>
                        </li>
                        <li id="list-item-14">
                           <p id="p-31">The presence of negative controls in the assay for MDR1/gp170 expression.</p>
                        </li>
                        <li id="list-item-15">
                           <p id="p-32">The use of more than one antibody for assessing gp170 expression (immunohistochemistry studies only) and the use of non-crossreacting
                              antibodies or confirmatory methods such as PCR.
                           </p>
                        </li>
                     </ol>
                     
                     <p id="p-33">These criteria were established in advance by all three authors, who also scored each study independently. Each criterion
                        was scored simply as (+) or (−) by each assessor.
                     </p>
                     
                  </div>
                  
                  <div id="sec-6" class="subsection">
                     
                     <h3>Statistical Methods, Integration of Individual Studies, and Assessment of Heterogeneity</h3>
                     
                     <p id="p-34">The proportion of tumors expressing MDR1/gp170 was calculated in each study and in subgroups where appropriate. A 95% CI for
                        the proportion was calculated by use of standard methods for the binomial distribution. The proportions were pooled across
                        studies as the weighted average of the proportions with the use of individual study sample sizes as weights (<em><a id="xref-ref-48-1" class="xref-bibr" href="#ref-48">48</a></em>). A chi-squared test for homogeneity (χ<sup>2</sup> homog) of the proportions was calculated by use of standard methods for 2 × C contingency tables (<em><a id="xref-ref-49-1" class="xref-bibr" href="#ref-49">49</a></em>). It should be noted, however, that the test for heterogeneity may be too sensitive when the number of studies (number of
                        columns in the contingency table) is large.
                     </p>
                     
                     <p id="p-35">To explore sources of significant heterogeneity among the studies, we examined whether the proportion of MDR1/gp170-expressing
                        tumors exhibited a linear trend with any characteristics of the individual studies. We applied a weighted regression model,
                        with the study-specific proportion as the dependent variable and weighted by the sample size. This analysis was performed
                        by use of the weighted regression option in the procedure PROC REG in SAS (Statistical Analysis Systems Institute Inc., Cary,
                        NC). Since each “observation” was an average over all patients in a study, the standard errors of the regression coefficients
                        were corrected by dividing by the square root of the residual mean square (<em><a id="xref-ref-50-1" class="xref-bibr" href="#ref-50">50</a></em>).
                     </p>
                     
                     <p id="p-36">We also examined heterogeneity by classifying studies according to potential sources of heterogeneity and recalculating the
                        weighted mean proportions and x<sup>2</sup><sub>homog</sub> within these subgroups. To compare subgroups of studies, e.g., studies in which MDR1/gp170 was measured before versus after
                        chemotherapy, we calculated the weighted mean of the proportion expressing MDR1/gp170 for each subgroup of studies. The difference
                        between means was divided by the standard deviation of the difference to give a <em>z</em>-score as described by Greenland (<em><a id="xref-ref-50-2" class="xref-bibr" href="#ref-50">50</a></em>).
                     </p>
                     
                     <p id="p-37">We examined the potential association between MDR1/gp170 expression and 1) prognostic factors, 2) prior treatment, 3) clinical
                        response to chemotherapy, and 4) in vitro doxorubicin resistance. We determined the relative risk (RR) of the particular clinical
                        outcome in MDR1/gp170-positive versus -negative tumors for each study and pooled the RRs across studies by using a Mantel-Haenszel
                        approach (<em><a id="xref-ref-51-1" class="xref-bibr" href="#ref-51">51</a></em>). Cochran-Mantel-Haenszel statistics (<em><a id="xref-ref-52-1" class="xref-bibr" href="#ref-52">52</a></em>), as implemented in the SAS subroutine PROC FREQ, were used to test the significance of the pooled RR. A similar approach
                        was used to investigate the effect of chemotherapy on MDR1/gp170 induction, but the RR compared the probability of MDR1/gp170
                        induction between patients with and without prior chemotherapy at the time of MDR1/gp170 measurement. CIs for the pooled RRs
                        and a χ<sup>2</sup><sub>homog</sub> of RRs were calculated by use of the method of Breslow and Day (<em><a id="xref-ref-51-2" class="xref-bibr" href="#ref-51">51</a></em>). These analyses were conducted by the procedure PROC FREQ in SAS. Since many studies had small cell sizes or cells with
                        zero patients, we included the continuity correction of 0.5 added to each cell for the calculation of RRs. We used pooled
                        RRs rather than odds ratios because the latter can overestimate the RR when the outcome being considered occurs in more than
                        10% of the study sample (<em><a id="xref-ref-53-1" class="xref-bibr" href="#ref-53">53</a></em>). Since the samples in these studies were sampled in a cohort fashion, there is no need to use the odds ratio because the
                        RR provides a clearer indication of the clinical impact of MDR1/gp170 expression. All P values are two-sided.
                     </p>
                     
                  </div>
                  
               </div>
               <div class="section" id="sec-7">
                  <div class="section-nav"><a href="#sec-1" title="Materials and Methods" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-12" title="Discussion" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Results</h2>
                  
                  <div id="sec-8" class="subsection">
                     
                     <h3>Results of Citation Search</h3>
                     
                     <p id="p-38">Thirty-one studies (<em><a id="xref-ref-25-2" class="xref-bibr" href="#ref-25">25</a></em>–<em><a id="xref-ref-30-2" class="xref-bibr" href="#ref-30">30</a></em>,<em><a id="xref-ref-46-3" class="xref-bibr" href="#ref-46">46</a></em>,<em><a id="xref-ref-47-3" class="xref-bibr" href="#ref-47">47</a></em>,<em><a id="xref-ref-54-1" class="xref-bibr" href="#ref-54">54</a></em>–<em><a id="xref-ref-76-1" class="xref-bibr" href="#ref-76">76</a></em>) were identified that met the criteria for inclusion in the meta-analysis. These included 21 studies (<em><a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a></em>,<em><a id="xref-ref-46-4" class="xref-bibr" href="#ref-46">46</a></em>,<em><a id="xref-ref-47-4" class="xref-bibr" href="#ref-47">47</a></em>,<em><a id="xref-ref-55-1" class="xref-bibr" href="#ref-55">55</a></em>,<em><a id="xref-ref-57-1" class="xref-bibr" href="#ref-57">57</a></em>–<em><a id="xref-ref-59-1" class="xref-bibr" href="#ref-59">59</a></em>,<em><a id="xref-ref-61-1" class="xref-bibr" href="#ref-61">61</a></em>,<em><a id="xref-ref-62-1" class="xref-bibr" href="#ref-62">62</a></em>,<em><a id="xref-ref-64-1" class="xref-bibr" href="#ref-64">64</a></em>–<em><a id="xref-ref-75-1" class="xref-bibr" href="#ref-75">75</a></em>) with MDR1/ gp170 expression based on immunohistochemistry, eight studies (<em><a id="xref-ref-57-2" class="xref-bibr" href="#ref-57">27</a></em>–<em><a id="xref-ref-29-2" class="xref-bibr" href="#ref-29">29</a></em>,<em><a id="xref-ref-46-5" class="xref-bibr" href="#ref-46">46</a></em>,<em><a id="xref-ref-54-2" class="xref-bibr" href="#ref-54">54</a></em>,<em><a id="xref-ref-56-1" class="xref-bibr" href="#ref-56">56</a></em>,<em><a id="xref-ref-60-1" class="xref-bibr" href="#ref-60">60</a></em>,<em><a id="xref-ref-63-1" class="xref-bibr" href="#ref-63">63</a></em>) based on RNA hybridization methods, three studies (<em><a id="xref-ref-25-3" class="xref-bibr" href="#ref-25">25</a></em>,<em><a id="xref-ref-28-4" class="xref-bibr" href="#ref-28">28</a></em>,<em><a id="xref-ref-30-3" class="xref-bibr" href="#ref-30">30</a></em>) based on immunoblot (western blot) methods, and two studies (<em><a id="xref-ref-47-5" class="xref-bibr" href="#ref-47">47</a></em>,<em><a id="xref-ref-76-2" class="xref-bibr" href="#ref-76">76</a></em>) based on the reverse transcription- PCR. [Three studies (<em><a id="xref-ref-28-5" class="xref-bibr" href="#ref-28">28</a></em>,<em><a id="xref-ref-46-6" class="xref-bibr" href="#ref-46">46</a></em>,<em><a id="xref-ref-47-6" class="xref-bibr" href="#ref-47">47</a></em>) used more than one method.] One additional study (<em><a id="xref-ref-77-1" class="xref-bibr" href="#ref-77">77</a></em>) was excluded from the analysis because it used only gene amplification as an indicator of MDR1/gp170 activity. Twelve studies
                        (<em><a id="xref-ref-30-4" class="xref-bibr" href="#ref-30">30</a></em>,<em><a id="xref-ref-46-7" class="xref-bibr" href="#ref-46">46</a></em>,<em><a id="xref-ref-54-3" class="xref-bibr" href="#ref-54">54</a></em>,<em><a id="xref-ref-56-2" class="xref-bibr" href="#ref-56">56</a></em>,<em><a id="xref-ref-59-2" class="xref-bibr" href="#ref-59">59</a></em>,<em><a id="xref-ref-61-2" class="xref-bibr" href="#ref-61">61</a></em>,<em><a id="xref-ref-64-2" class="xref-bibr" href="#ref-64">64</a></em>–<em><a id="xref-ref-66-1" class="xref-bibr" href="#ref-66">66</a></em>,<em><a id="xref-ref-70-1" class="xref-bibr" href="#ref-70">70</a></em>,<em><a id="xref-ref-72-1" class="xref-bibr" href="#ref-72">72</a></em>,<em><a id="xref-ref-75-2" class="xref-bibr" href="#ref-75">75</a></em>) measured MDR1/gp170 expression on tumors prior to any chemotherapy or hormonal therapy, 13 studies (<em><a id="xref-ref-25-4" class="xref-bibr" href="#ref-25">25</a></em>–<em><a id="xref-ref-28-6" class="xref-bibr" href="#ref-28">28</a></em>,<em><a id="xref-ref-47-7" class="xref-bibr" href="#ref-47">47</a></em>,<em><a id="xref-ref-55-2" class="xref-bibr" href="#ref-55">55</a></em>,<em><a id="xref-ref-57-3" class="xref-bibr" href="#ref-57">57</a></em>,<em><a id="xref-ref-62-2" class="xref-bibr" href="#ref-62">62</a></em>,<em><a id="xref-ref-63-2" class="xref-bibr" href="#ref-63">63</a></em>,<em><a id="xref-ref-67-1" class="xref-bibr" href="#ref-67">67</a></em>,<em><a id="xref-ref-73-1" class="xref-bibr" href="#ref-73">73</a></em>,<em><a id="xref-ref-74-1" class="xref-bibr" href="#ref-74">74</a></em>,<em><a id="xref-ref-76-3" class="xref-bibr" href="#ref-76">76</a></em>) included tumor measurements both before and after treatment, two studies (<em><a id="xref-ref-68-1" class="xref-bibr" href="#ref-68">68</a></em>,<em><a id="xref-ref-69-1" class="xref-bibr" href="#ref-69">69</a></em>) had only post-treatment tumor measurements, and in four studies (<em><a id="xref-ref-29-3" class="xref-bibr" href="#ref-29">29</a></em>,<em><a id="xref-ref-58-1" class="xref-bibr" href="#ref-58">58</a></em>,<em><a id="xref-ref-60-2" class="xref-bibr" href="#ref-60">60</a></em>,<em><a id="xref-ref-71-1" class="xref-bibr" href="#ref-71">71</a></em>) the authors did not indicate the timing of the assay with respect to treatment. In addition to the studies that met the
                        inclusion criteria, four published reports identified by the search were excluded for the following reasons: Only gene amplification
                        was used as an indicator of MDR1 activity (<em><a id="xref-ref-77-2" class="xref-bibr" href="#ref-77">77</a></em>), results for breast tumors could not be separated from those for all tumors (<em><a id="xref-ref-78-1" class="xref-bibr" href="#ref-78">78</a></em>), no samples from breast cancers were tested (<em><a id="xref-ref-79-1" class="xref-bibr" href="#ref-79">79</a></em>), and the report described earlier results that are included in a later report (<em><a id="xref-ref-80-1" class="xref-bibr" href="#ref-80">80</a></em>).
                     </p>
                     
                  </div>
                  
                  <div id="sec-9" class="subsection">
                     
                     <h3>Assessment of Methodologic Rigor of Studies</h3>
                     
                     <p id="p-39"><a id="xref-fig-1-1" class="xref-fig" href="#F1">Table 1</a> lists the degree to which the individual studies complied with the criteria for methodologic rigor. Only two of the criteria,
                        i.e., a definition of MDR1/gp170 positivity and the use of positive and negative controls, were met by nearly all studies.
                        For each of the other four criteria, there were many studies that did not adhere to at least one criterion. Thirty-five percent
                        of the studies had a sample size of fewer than 25 patients. None of these 11 studies (<em><a id="xref-ref-26-2" class="xref-bibr" href="#ref-26">26</a></em>,<em><a id="xref-ref-29-4" class="xref-bibr" href="#ref-29">29</a></em>,<em><a id="xref-ref-30-5" class="xref-bibr" href="#ref-30">30</a></em>,<em><a id="xref-ref-46-8" class="xref-bibr" href="#ref-46">46</a></em>,<em><a id="xref-ref-57-4" class="xref-bibr" href="#ref-57">54</a></em>,<em><a id="xref-ref-55-3" class="xref-bibr" href="#ref-55">55</a></em>,<em><a id="xref-ref-58-2" class="xref-bibr" href="#ref-58">58</a></em>,<em><a id="xref-ref-59-3" class="xref-bibr" href="#ref-59">59</a></em>,<em><a id="xref-ref-61-3" class="xref-bibr" href="#ref-61">61</a></em>,<em><a id="xref-ref-74-2" class="xref-bibr" href="#ref-74">74</a></em>,<em><a id="xref-ref-76-4" class="xref-bibr" href="#ref-76">76</a></em>) used CIs to indicate the degree of uncertainty in their data, and they did not discuss the possible influence of sample
                        size on their results. Because small samples produce relatively imprecise estimates of the prevalence of MDR1/gp170 expression
                        and its association with clinical parameters, sample size may contribute to heterogeneity. Thirty-two percent of the studies
                        did not provide a sufficient description to determine whether tumor samples came from primary or metastatic tumors or from
                        treated or untreated patients and the type of treatment(s) used, or they did not use treatments known to be gp170 substrates.
                        As a result, it is difficult to interpret the observed prevalence of MDR1/gp170 expression. Most studies did not adequately
                        describe the patient base or accrual procedure. This information is important for determining the representativeness of patients
                        in an individual study and the ability to generalize study results. It also allows the reader to determine a study's susceptibility
                        to various forms of bias (e.g., size bias, defined as bias toward larger tumors that allow multiple sampling).
                     </p>
                     
                     <div id="F1" class="fig pos-anchor odd">
                        <div class="fig-inline"><img alt="Table 1." src="917/F1.medium.gif" /></div>
                        <div class="fig-caption"><span class="fig-label"><strong>Table 1.</strong></span> 
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                     <p id="p-40">Fourteen studies (<em><a id="xref-ref-46-9" class="xref-bibr" href="#ref-46">46</a></em>,<em><a id="xref-ref-55-4" class="xref-bibr" href="#ref-55">55</a></em>,<em><a id="xref-ref-57-5" class="xref-bibr" href="#ref-57">57</a></em>,<em><a id="xref-ref-59-4" class="xref-bibr" href="#ref-59">59</a></em>,<em><a id="xref-ref-61-4" class="xref-bibr" href="#ref-61">61</a></em>,<em><a id="xref-ref-62-3" class="xref-bibr" href="#ref-62">62</a></em>,<em><a id="xref-ref-64-3" class="xref-bibr" href="#ref-64">64</a></em>,<em><a id="xref-ref-65-1" class="xref-bibr" href="#ref-65">65</a></em>,<em><a id="xref-ref-67-2" class="xref-bibr" href="#ref-67">67</a></em>–<em><a id="xref-ref-69-2" class="xref-bibr" href="#ref-69">69</a></em>,<em><a id="xref-ref-72-2" class="xref-bibr" href="#ref-72">72</a></em>,<em><a id="xref-ref-73-2" class="xref-bibr" href="#ref-73">73</a></em>,<em><a id="xref-ref-75-3" class="xref-bibr" href="#ref-75">75</a></em>) of the 21 (67%) studies based on immunohistochemical detection of gp170 and all three studies (25,28,30) using the western
                        blot technique used only one antibody (<a id="xref-fig-1-2" class="xref-fig" href="#F1">Table 1</a>), despite the commercial availability of several antibodies with nonoverlapping epitopes (<em><a id="xref-ref-81-1" class="xref-bibr" href="#ref-81">81</a></em>–<em><a id="xref-ref-84-1" class="xref-bibr" href="#ref-84">84</a></em>). Unfortunately, several of the antibodies used in isolation have well-defined cross-reactivity with proteins other than
                        gp170. For example, both JSB-1 (<em><a id="xref-ref-85-1" class="xref-bibr" href="#ref-85">85</a></em>) and C494 (<em><a id="xref-ref-86-1" class="xref-bibr" href="#ref-86">86</a></em>) cross-react with pyruvate carboxylase. The C219 monoclonal antibody recognizes MDR3, a member of the same gene family that
                        is not involved in drug resistance (<em><a id="xref-ref-87-1" class="xref-bibr" href="#ref-87">87</a></em>). This antibody also cross-reacts with the heavy chain of muscle myosin (<em><a id="xref-ref-84-2" class="xref-bibr" href="#ref-84">84</a></em>), and myofibroblasts are a major component of the desmoplastic response to breast cancer (<em><a id="xref-ref-88-1" class="xref-bibr" href="#ref-88">88</a></em>). Thus, there may be a tendency for an increased frequency of false-positive results in some singleantibody studies, where
                        the adequacy of the negative controls becomes critical for assessing the likely validity of gp170 estimates.
                     </p>
                     
                  </div>
                  
                  <div id="sec-10" class="subsection">
                     
                     <h3>Proportion of MDR1/gp170-Positive Tumors</h3>
                     
                     <p id="p-41">Panels A and B of <a id="xref-fig-2-1" class="xref-fig" href="#F2">Fig. 1</a> show the proportion of MDR1/gp170-positive tumors and the associated 95% CIs for studies with MDR1/gp170 measured before
                        or after treatment, respectively. Expression varies considerably across studies; this variation is apparent regardless of
                        whether the tumor material was assayed before or after chemotherapy. Some potential sources of heterogeneity are indicated
                        by stratifying the studies according to the type of assay method (<a id="xref-fig-2-2" class="xref-fig" href="#F2">Fig. 1, A</a>) or the type of treatment received (<a id="xref-fig-2-3" class="xref-fig" href="#F2">Fig. 1, B</a>). <a id="xref-fig-2-4" class="xref-fig" href="#F2">Fig. 1, A</a>, shows that most of the studies that found no expression of MDR1/gp170 were based on western blot or RNA hybridization methods.
                        Only one immunohistochemistry study (<a id="xref-ref-58-3" class="xref-bibr" href="#ref-58">58</a>) found no immunoreactivity (based on only eight breast tumors), but this study reported some staining of “apparently normal
                        parenchymal” cells in some specimens.
                     </p>
                     
                     <div id="F2" class="fig pos-anchor even">
                        <div class="fig-inline"><img alt="Figure" src="917/F2.medium.gif" /></div>
                     </div>
                     
                     <p id="p-42">Based on the weighted average over all 31 studies listed in Table 1, the percentage of tumors expressing MDR1/gp170 was 41.2%
                        (95% CI = 36.0%-46.5%). However, the proportions were highly variable across individual studies (P&lt;.0001). These studies were
                        performed over an 8-year period (1989-1996). To evaluate whether potential sources of heterogeneity may have changed over
                        time, we performed a weighted linear regression of the proportion of MDR1/gp170-positive tumors in each study against the
                        calendar year when the study was published. Table 2 shows a highly significant trend with time, there being a slope coefficient
                        of 0.040, with <em>z</em> = 3.52 (<em>P</em> = .0005). This trend indicates that, on average, there was an increase of about 4.0% per year in the reported detection of
                        MDR1/gp170 expression in breast tumors.
                     </p>
                     
                     <p id="p-43">There was a shift away from RNA hybridization methods toward immunohistochemical methods over this time, so we stratified
                        the studies according to whether they used RNA hybridization or immunohistochemical methods and conducted separate regressions
                        within each group of studies. (No regression was conducted for the western blot studies because there were only three such
                        studies.) Within groups of studies using either RNA hybridization or immunohistochemical methods, no trend of MDR1/gp170 expression
                        with time was evident (<a id="xref-fig-3-1" class="xref-fig" href="#F3">Table 2</a>). Thus, a significant degree of variability among the studies appears to be due to the shift over time from RNA hybridization
                        methods (primarily northern blot hybridizations) to the more sensitive immunohistochemical methodologies.
                     </p>
                     
                     <p id="p-44">We next examined heterogeneity separately within both the RNA hybridization and immunohistochemistry studies. The average
                        percentage of tumors expressing MDR1/gp170 was 27.1% (95% CI = 15.4%-38.6%) for studies using RNA hybridization methods and
                        48.5% (95% CI = 42.0%-55.0%) for immunohistochemistry studies. However, even within these subgroups, there was still significant
                        heterogeneity (<em>P</em>&lt;.0001 for both RNA hybridization and immunohistochemistry studies).
                     </p>
                     
                     <div id="F3" class="fig pos-anchor odd">
                        <div class="fig-inline"><img alt="Figure" src="917/F3.medium.gif" /></div>
                     </div>
                     
                     <p id="p-45">We further stratified these subgroups according to whether MDR1/gp170 had been measured before or after chemotherapy or hormonal
                        therapy. The difference between values before and after chemotherapy or hormonal therapy was relatively small for both immunohistochemistry
                        and RNA hybridization studies, and significant heterogeneity still existed within these subgroups (<a id="xref-fig-4-1" class="xref-fig" href="#F4">Table 3</a>). Among studies of values after chemotherapy or hormonal therapy, we compared MDR1/gp170 expression among tumors from patients
                        treated with and without drugs associated with the multidrug-resistant phenotype (data not shown). As expected, MDR1/gp170
                        expression was higher for patients treated with MDR1/gp170-related drugs, with an average of 57.2% of tumors being positive.
                        However, a sizable percentage (44.6%) of patients treated with non-MDR1/gp170-related drugs also expressed MDR1/gp170. The
                        studies of MDR1/gp170- related and non-MDR1/gp170-related drugs exhibited marginally significant heterogeneity (<em>P</em> = .052 and <em>P</em> = .054, respectively).
                     </p>
                     
                     <div id="F4" class="fig pos-anchor even">
                        <div class="fig-inline"><img alt="Figure" src="917/F4.medium.gif" /></div>
                     </div>
                     
                  </div>
                  
                  <div id="sec-11" class="subsection">
                     
                     <h3>Associations With Clinical Parameters</h3>
                     
                     <p id="p-46">It has been suggested that the expression of MDR1/gp170 is more likely to be a surrogate marker for a worse prognosis than
                        an indicator of potential response to cytotoxic chemotherapy (<em><a id="xref-ref-89-1" class="xref-bibr" href="#ref-89">89</a></em>). To address the clinical relevance of MDR1/gp170 expression, we considered the evidence linking it to various clinical parameters,
                        including induction by cytotoxic or hormonal treatment and association with 1) established prognostic attributes, 2) response
                        to chemotherapy, 3) recurrence and survival, and 4) in vitro doxorubicin resistance.
                     </p>
                     
                     <p id="p-47"><strong>Induction of MDR1/gp170 expression</strong>. The effect of chemotherapy on induction of MDR1/gp170 expression is shown in Table 4. This analysis was performed by comparing
                        the proportion of patients whose tumors expressed MDR1/gp170 before chemotherapy with that of patients whose tumors expressed
                        MDR1/gp170 after chemotherapy. We used only studies that provided both pretreatment and post-treatment data, although most
                        were not consecutive measurements on the same patients. In the 13 studies meeting this criterion (<em><a id="xref-ref-25-5" class="xref-bibr" href="#ref-25">25</a></em>–<em><a id="xref-ref-28-7" class="xref-bibr" href="#ref-28">28</a></em>,<em><a id="xref-ref-47-8" class="xref-bibr" href="#ref-47">47</a></em>,<em><a id="xref-ref-55-5" class="xref-bibr" href="#ref-55">55</a></em>, <em><a id="xref-ref-57-6" class="xref-bibr" href="#ref-57">57</a></em>,<em><a id="xref-ref-62-4" class="xref-bibr" href="#ref-62">62</a></em>,<em><a id="xref-ref-63-3" class="xref-bibr" href="#ref-63">63</a></em>,<em><a id="xref-ref-67-3" class="xref-bibr" href="#ref-67">67</a></em>,<em><a id="xref-ref-73-3" class="xref-bibr" href="#ref-73">73</a></em>,<em><a id="xref-ref-74-3" class="xref-bibr" href="#ref-74">74</a></em>,<em><a id="xref-ref-76-5" class="xref-bibr" href="#ref-76">76</a></em>), treatment with cytotoxic or hormonal agents was associated with a significant increase in the proportion of tumors expressing
                        MDR1/gp170 (RR = 1.77 [95% CI = 1.46-2.15]; <em>P</em>&lt;.0001). Unlike the analysis performed on all studies, there was only marginally significant heterogeneity in this subgroup
                        (<em>P</em> = .056). When we excluded the three studies that used drugs not commonly related to MDR1/gp170 (<em><a id="xref-ref-27-2" class="xref-bibr" href="#ref-27">27</a></em>,<em><a id="xref-ref-67-4" class="xref-bibr" href="#ref-67">67</a></em>,<em><a id="xref-ref-76-6" class="xref-bibr" href="#ref-76">76</a></em>), the effect was somewhat stronger (RR = 1.99 [95% CI = 1.56-2.54]; <em>P</em>&lt;.0001), and there was no significant heterogeneity (<em>P</em> = .19). The results were unchanged when we repeated the analyses by reclassifying as negative those tumors exhibiting weakly
                        positive expression (<em><a id="xref-ref-25-6" class="xref-bibr" href="#ref-25">25,</a></em><em><a id="xref-ref-55-6" class="xref-bibr" href="#ref-55">55</a></em>,<em><a id="xref-ref-57-7" class="xref-bibr" href="#ref-57">57</a></em>).
                     </p>
                     
                     <div id="F5" class="fig pos-anchor odd">
                        <div class="fig-inline"><img alt="Figure" src="917/F5.medium.gif" /></div>
                     </div>
                     
                     <p id="p-48"><strong>Association with prognostic attributes</strong>. Only 11 studies (<em><a id="xref-ref-54-4" class="xref-bibr" href="#ref-54">54</a></em>,<em><a id="xref-ref-57-8" class="xref-bibr" href="#ref-57">57</a></em>,<em><a id="xref-ref-60-3" class="xref-bibr" href="#ref-60">60</a></em>,<em><a id="xref-ref-61-5" class="xref-bibr" href="#ref-61">61</a></em>,<em><a id="xref-ref-63-4" class="xref-bibr" href="#ref-63">63</a></em>,<em><a id="xref-ref-65-2" class="xref-bibr" href="#ref-65">65</a></em>,<em><a id="xref-ref-69-3" class="xref-bibr" href="#ref-69">69</a></em>,<em><a id="xref-ref-70-2" class="xref-bibr" href="#ref-70">70</a></em>,<em><a id="xref-ref-73-4" class="xref-bibr" href="#ref-73">73</a></em>-–<em><a id="xref-ref-75-4" class="xref-bibr" href="#ref-75">75</a></em>) included data associating MDR1/gp170 expression with one or more known prognostic attributes, including lymph node status
                        at diagnosis, tumor size, tumor histology, tumor grade, and estrogen receptor status. We considered only attributes examined
                        in three or more studies. Table 5 shows that none of these attributes were significantly associated with MDR1/gp170 expression.
                        This result suggests that MDR1/gp170 expression is not acting as a surrogate for another prognostic factor in its ability
                        to predict outcome or response to chemotherapy.
                     </p>
                     
                     <p id="p-49"><strong>Association with response to chemotherapy.</strong> Since studies provided different levels of detail about clinical response, we considered all studies in which it was possible
                        to determine the number of patients who exhibited at least a clinical partial response, i.e., either partial response (PR)
                        or complete response (CR). These responses were defined according to widely accepted usage, where CR indicates complete disappearance
                        of the tumor, while PR indicates a greater than 50% reduction in the largest diameter of the tumor. There were nine studies
                        in which these data could be determined (<em><a id="xref-ref-47-9" class="xref-bibr" href="#ref-47">47</a></em>,<em><a id="xref-ref-57-9" class="xref-bibr" href="#ref-57">57</a></em>,<em><a id="xref-ref-61-6" class="xref-bibr" href="#ref-61">61</a></em>–<em><a id="xref-ref-64-4" class="xref-bibr" href="#ref-64">64</a></em>,<em><a id="xref-ref-68-2" class="xref-bibr" href="#ref-68">68</a></em>,<em><a id="xref-ref-69-4" class="xref-bibr" href="#ref-69">69</a></em>,<em><a id="xref-ref-74-4" class="xref-bibr" href="#ref-74">74</a></em>). An additional three studies either did not permit classification of the responses of patients into CR/PR versus less than
                        PR (<em><a id="xref-ref-46-10" class="xref-bibr" href="#ref-46">46</a></em>,<em><a id="xref-ref-67-5" class="xref-bibr" href="#ref-67">67</a></em>) or did not permit the association between MDR1/gp170 positivity versus negativity (<em><a id="xref-ref-73-5" class="xref-bibr" href="#ref-73">73</a></em>).
                     </p>
                     
                     <p id="p-50"><a id="xref-fig-7-1" class="xref-fig" href="#F7">Table 6</a> shows that patients whose tumors expressed MDR1/ gp170 were 3.21 times more likely to exhibit a worse than PR than patients
                        whose tumors did not express MDR1/gp170 (<em>P</em>&lt;.0001). There was no evidence of significant heterogeneity among these studies (<em>P</em> = .27). Excluding the single study using treatment with non-MDR1/gp170-related drugs did not significantly change the association.
                        Furthermore, the association between MDR1/gp170 expression and clinical response became stronger when the studies were restricted
                        to those in which expression was measured after any treatment (RR = 4.19 [95% CI = 2.71= 2.44-6.14]; <em>P</em>&lt;.0001) (<a id="xref-fig-7-2" class="xref-fig" href="#F7">Table 6</a>). This is consistent with the ability of MDR1/gp170- related drugs to induce MDR1/gp170 expression and the ability of this
                        induced expression to confer cross-resistance among classical substrates for gp170 but not for other drugs (<em><a id="xref-ref-10-2" class="xref-bibr" href="#ref-10">10</a></em>,<em><a id="xref-ref-90-1" class="xref-bibr" href="#ref-90">90</a></em>–<em><a id="xref-ref-92-1" class="xref-bibr" href="#ref-92">92</a></em>). When we repeated the analyses by reclassifying as negative those tumors exhibiting weak positive expression (<em><a id="xref-ref-61-7" class="xref-bibr" href="#ref-61">61</a></em>,<em><a id="xref-ref-69-5" class="xref-bibr" href="#ref-69">69</a></em>,<em><a id="xref-ref-74-5" class="xref-bibr" href="#ref-74">74</a></em>), the results were unchanged.
                     </p>
                     
                     <div id="F6" class="fig pos-anchor even">
                        <div class="fig-inline"><img alt="Figure" src="917/F6.medium.gif" /></div>
                     </div>
                     
                     <p id="p-51">An important clinical concern is whether the expression of MDR1/gp170 before initial chemotherapy will predict response. Only
                        five studies (<em><a id="xref-ref-47-10" class="xref-bibr" href="#ref-47">47</a></em>,<em><a id="xref-ref-57-10" class="xref-bibr" href="#ref-57">57</a></em>,<em><a id="xref-ref-61-8" class="xref-bibr" href="#ref-61">61</a></em>,<em><a id="xref-ref-64-5" class="xref-bibr" href="#ref-64">64</a></em>,<em><a id="xref-ref-74-6" class="xref-bibr" href="#ref-74">74</a></em>), with a total of 115 patients, measured expression before treatment in patients evaluated for response to subsequent chemotherapy.
                        When combined (χ<sup>2</sup><sub>homog</sub> = 1.98; <em>P</em> = .74), these studies indicate a suggestive, but not statistically significant, association between MDR1/gp170 expression
                        prior to treatment and a worse than partial clinical response to cytotoxic regimens containing gp170 substrates (RR = 1.47
                        [95% CI = 0.94-2.29]; χ<sup>2</sup><sub>homog</sub> = 2.91; <em>P</em> = .088).
                     </p>
                     
                     <p id="p-52"><strong>Association with recurrence and survival.</strong> Eight studies (<em><a id="xref-ref-61-9" class="xref-bibr" href="#ref-61">61</a></em>,<em><a id="xref-ref-63-5" class="xref-bibr" href="#ref-63">63</a></em>,<em><a id="xref-ref-69-6" class="xref-bibr" href="#ref-69">69</a></em>,<em><a id="xref-ref-71-2" class="xref-bibr" href="#ref-71">71</a></em>–<em><a id="xref-ref-75-5" class="xref-bibr" href="#ref-75">75</a></em>) associated MDR1/gp170 expression with either recurrence-free survival or overall survival. Unfortunately, conducting any
                        formal statistical evaluation of the combined studies was not possible because the necessary data were included in only two
                        studies that evaluated recurrence-free survival (<em><a id="xref-ref-63-6" class="xref-bibr" href="#ref-63">63</a></em>,<em><a id="xref-ref-69-7" class="xref-bibr" href="#ref-69">69</a></em>) and in three studies that evaluated overall survival (<em><a id="xref-ref-63-7" class="xref-bibr" href="#ref-63">63</a></em>,<em><a id="xref-ref-74-7" class="xref-bibr" href="#ref-74">74</a></em>,<em><a id="xref-ref-75-6" class="xref-bibr" href="#ref-75">75</a></em>). However, of the four studies that associated MDR1/ gp170 expression with recurrence-free survival, two (<em><a id="xref-ref-61-10" class="xref-bibr" href="#ref-61">61</a></em>,<em><a id="xref-ref-69-8" class="xref-bibr" href="#ref-69">69</a></em>) found reduced survival associated with expression, whereas the other two (<em><a id="xref-ref-63-8" class="xref-bibr" href="#ref-63">63</a></em>,<em><a id="xref-ref-71-3" class="xref-bibr" href="#ref-71">71</a></em>) did not. Similarly, three studies (<em><a id="xref-ref-71-4" class="xref-bibr" href="#ref-71">71</a></em>,<em><a id="xref-ref-72-3" class="xref-bibr" href="#ref-72">72</a></em>,<em><a id="xref-ref-75-7" class="xref-bibr" href="#ref-75">75</a></em>) found that expression was associated with a significant reduction in overall survival, whereas three other studies (<em><a id="xref-ref-63-9" class="xref-bibr" href="#ref-63">63</a></em>,<em><a id="xref-ref-73-6" class="xref-bibr" href="#ref-73">73</a></em>,<em><a id="xref-ref-74-8" class="xref-bibr" href="#ref-74">74</a></em>) did not. Only two studies (<em><a id="xref-ref-71-5" class="xref-bibr" href="#ref-71">71</a></em>,<em><a id="xref-ref-72-4" class="xref-bibr" href="#ref-72">72</a></em>) used multivariable analysis to control for other major prognostic factors, although both studies observed significant survival
                        decrements even in univariate analyses.
                     </p>
                     
                     <div id="F7" class="fig pos-anchor odd">
                        <div class="fig-inline"><img alt="Figure" src="917/F7.medium.gif" /></div>
                     </div>
                     
                     <p id="p-53"><strong>Association with in vitro doxorubicin resistance.</strong> Three studies (<em><a id="xref-ref-25-7" class="xref-bibr" href="#ref-25">25</a></em>,<em><a id="xref-ref-26-3" class="xref-bibr" href="#ref-26">26</a></em>,<em><a id="xref-ref-64-6" class="xref-bibr" href="#ref-64">64</a></em>), with a total of 93 patients, examined the association between MDR1/gp170 expression and resistance to doxorubicin using
                        an in vitro clonogenic assay on cells from patients' tumors. Patients whose tumors expressed MDR1/gp170 were 2.5 times more
                        likely to exhibit in vitro resistance to doxorubicin (RR = 2.50; 95% CI = 1.77-3.52) (<em>P</em>&lt;.0001). There was no evidence of significant heterogeneity in this group of studies (χ<sup>2</sup><sub>homog</sub> = 4.15 [2 degrees of freedom]; <em>P</em> = .14). These studies indicate that some breast tumor cell subpopulations express sufficient levels of MDR1/gp170 to confer
                        a functional level of in vitro drug resistance.
                     </p>
                     
                  </div>
                  
               </div>
               <div class="section" id="sec-12">
                  <div class="section-nav"><a href="#sec-7" title="Results" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-22" title="Conclusions" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Discussion</h2>
                  
                  <p id="p-54">The considerable variability across studies of MDR1/gp170 expression explains the controversy regarding the presence of this
                     expression and its relevance in breast cancer. A cursory evaluation of this literature could lead to apparently equally justifiable
                     support for quite divergent opinions. For example, it could be argued and supported by several citations either that MDR1/gp170
                     expression is rarely detected in breast cancer and has no clinical relevance or that expression is widely detected and may
                     have considerable clinical relevance. With such variability across many independent studies, a careful review and meta-analysis
                     can provide a critical and objective approach to the body of research.
                  </p>
                  
                  <div id="sec-13" class="subsection">
                     
                     <h3>Purpose and Interpretation of Meta-analyses</h3>
                     
                     <p id="p-55">In its simplest form, meta-analysis is a systematic approach to combining, in a quantitative fashion, the results of related
                        studies. The approach and its justification are conceptually similar to those used in either multicenter studies or studies
                        with a large number of potentially relevant subgroups or strata. Combining the results of individual studies is performed
                        in a manner similar to that of combining the results across strata in a single large study. However, the validity of such
                        data pooling and the generation of a summary statistic require that the studies be sufficiently alike in the association being
                        measured. Thus, both the study population and methods should be sufficiently similar that it is reasonable to consider all
                        the studies as if they had been generated as subgroups of a single large study. This is rarely the case, or there would be
                        little controversy with regard to the overall inference from the studies and there would be little need to conduct a meta-analysis
                        (<em><a id="xref-ref-33-2" class="xref-bibr" href="#ref-33">33</a></em>).
                     </p>
                     
                     <p id="p-56">As occurred with the MDR1/gp170 analyses, groups of studies typically exhibit meaningful variability, and the search for the
                        source of the variability is important. This search may also identify subgroups of studies that are sufficiently alike to
                        make data pooling appropriate. For example, this meta-analysis showed that significant heterogeneity in the proportion of
                        tumors expressing MDR1/gp170 could be attributed to differences in types of assays (immunohistochemistry based versus RNA
                        hybridization based), complicating meaningful interpretation of a summary measure of this proportion.
                     </p>
                     
                     <p id="p-57">Where subgroups of studies are chosen on a rational and predefined basis and the data from the integrated studies do not exhibit
                        significant heterogeneity, meaningful associations among variables can be identified. For example, all nine of the studies
                        that contain information on MDR1/gp170 expression and response to chemotherapy (<em><a id="xref-ref-47-11" class="xref-bibr" href="#ref-47">47</a></em>,<em><a id="xref-ref-57-11" class="xref-bibr" href="#ref-57">57</a></em>,<em><a id="xref-ref-61-11" class="xref-bibr" href="#ref-61">61</a></em>-<em><a id="xref-ref-64-7" class="xref-bibr" href="#ref-64">64</a></em>,<em><a id="xref-ref-68-3" class="xref-bibr" href="#ref-68">68</a></em>,<em><a id="xref-ref-69-9" class="xref-bibr" href="#ref-69">69</a></em>,<em><a id="xref-ref-73-7" class="xref-bibr" href="#ref-73">73</a></em>) can be validly combined and explored because there is no significant heterogeneity (<a id="xref-fig-6-1" class="xref-fig" href="#F6">Table 6</a>; χ<sup>2</sup><sub>homog</sub> = 10.0; <em>P</em> = .27).
                     </p>
                     
                     <p id="p-58">One concern in the conduct of any meta-analysis is publication bias, i.e., the tendency for studies reporting “negative” results
                        to be underrepresented in the literature. <a id="xref-fig-8-1" class="xref-fig" href="#F8">Fig. 2</a> shows a “funnel plot,” where the proportion of MDR1/gp170-positive tumors in each study is plotted against the sample size
                        (as an indicator of standard error). In the absence of publication bias, such a plot should resemble a funnel lying on its
                        side with the narrow end pointing to the right, with study results scattered around an expected “true” value and the degree
                        of scatter decreasing with sample size. Publication bias would be suggested by a lack of small “negative” studies, i.e., studies
                        with zero or low percentages of tumors expressing MDR1/gp170 (<em><a id="xref-ref-93-1" class="xref-bibr" href="#ref-93">93</a></em>). <a id="xref-fig-8-2" class="xref-fig" href="#F8">Fig. 2</a> shows no apparent bias against negative studies, since six studies (<em><a id="xref-ref-28-8" class="xref-bibr" href="#ref-28">28</a></em>-–<em><a id="xref-ref-30-6" class="xref-bibr" href="#ref-30">30</a></em>,<em><a id="xref-ref-58-4" class="xref-bibr" href="#ref-58">58</a></em>,<em><a id="xref-ref-59-5" class="xref-bibr" href="#ref-59">59</a></em>,<em><a id="xref-ref-63-10" class="xref-bibr" href="#ref-63">63</a></em>) demonstrated expression in 10% or less of tumors, and four of these studies (<em><a id="xref-ref-29-5" class="xref-bibr" href="#ref-29">29</a></em>,<em><a id="xref-ref-30-7" class="xref-bibr" href="#ref-30">30</a></em>,<em><a id="xref-ref-58-5" class="xref-bibr" href="#ref-58">58</a></em>,<em><a id="xref-ref-59-6" class="xref-bibr" href="#ref-59">59</a></em>) had 20 patients or fewer.
                     </p>
                     
                     <div id="F8" class="fig pos-anchor even">
                        <div class="fig-inline"><img alt="Fig. 2" src="917/F8.medium.gif" /></div>
                        <div class="fig-caption"><span class="fig-label"><strong>Fig. 2</strong></span> 
                           
                           <p id="p-59" class="first-child">Funnel plot evaluation of publication bias in studies of MDR1/gp170 expression and breast cancer. Data represent the proportion
                              of MDR1/gp170-positive tumors (from untreated plus treated patients) in each study, plotted against the study sample size.
                           </p>
                           
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                  </div>
                  
                  <div id="sec-14" class="subsection">
                     
                     <h3>Frequent but Heterogeneous Expression of MDR1/gp170 in Breast Cancer</h3>
                     
                     <p id="p-60">Northern and western blot hybridization techniques suffer from the possible loss of the signal by dilution from surrounding
                        MDR1/gp170-negative tissues. This result may account for the generally lower estimates of positivity in the studies using
                        these techniques when compared with immunohistochemistry. For many years, the single largest study in breast cancer provided
                        the most compelling evidence for a lack of expression and, therefore, of any functional role of MDR1/gp170 in breast cancer
                        (<em><a id="xref-ref-28-9" class="xref-bibr" href="#ref-28">28</a></em>). Merkel et al. (<em><a id="xref-ref-28-10" class="xref-bibr" href="#ref-28">28</a></em>) acknowledge that their analysis, which utilized northern, Southern, and western blotting analyses of homogenates of breast
                        tumor tissues, may be too insensitive to adequately quantitate MDR1/gp170 expression. This may be the most likely explanation
                        for the lack of detectable MDR1/gp170 expression in breast tumors in their study, since expression has been readily detected
                        in more recent studies of comparable size (<em><a id="xref-ref-65-3" class="xref-bibr" href="#ref-65">65</a></em>,<em><a id="xref-ref-71-6" class="xref-bibr" href="#ref-71">71</a></em>,<em><a id="xref-ref-73-8" class="xref-bibr" href="#ref-73">73</a></em>).
                     </p>
                     
                     <p id="p-61">As the results of our analysis indicate, the increase over time in the use of more sensitive immunohistochemistry-based assays
                        has been accompanied by an increase in the reported prevalence of MDR1/gp170 expression. An inability to detect gene expression
                        by use of earlier RNA hybridization or immunoblot assay techniques is not surprising, given the generally heterogeneous and
                        low levels of expression now apparent in many breast tumors (<em><a id="xref-ref-62-5" class="xref-bibr" href="#ref-62">62</a></em>,<em><a id="xref-ref-66-2" class="xref-bibr" href="#ref-66">66</a></em>,<em><a id="xref-ref-73-9" class="xref-bibr" href="#ref-73">73</a></em>). Immunoblotting has recently been recommended as one means to detect MDR1/gp170 expression in tumors (<em><a id="xref-ref-94-1" class="xref-bibr" href="#ref-94">94</a></em>). However, it is apparent from our study that this approach is inappropriate for analysis of the relatively low levels of
                        MDR1/gp170 expression in breast tumors.
                     </p>
                     
                     <p id="p-62">While one source of heterogeneity arises from the use of different assays for MDR1/gp170 expression, significant heterogeneity
                        remains when studies using similar assay techniques are combined. This applies to both RNA hybridization and immuWhile one
                        source of heterogeneity arises from the use of different assays for MDR1/gp170 expression, significant heterogeneity remains
                        when studies using similar assay techniques are combined. This applies to both RNA hybridization and immunohistochemical analyses.
                        There are clearly many other sources of heterogeneity (e.g., differences in patient populations resulting from patient selection
                        criteria; whether there has been prior treatment, the nature of the treatment, and whether it includes gp170 substrates; the
                        timing of sampling relative to diagnosis and treatment; the use of primary versus metastatic tumor tissue; and sampling artifacts
                        reflecting heterogeneous expression within the tissue). Additional sources of heterogeneity specific to different types of
                        assays include tissue handling and preparation, the choice of antibody(ies) or probes, general laboratory procedures for the
                        particular assay, and the choice of an immunodetection method. Differences in the criteria for scoring tumors as positive
                        or negative also contribute significantly to heterogeneity. Several workshops and individual laboratories (<em><a id="xref-ref-94-2" class="xref-bibr" href="#ref-94">94</a></em>–<em><a id="xref-ref-98-1" class="xref-bibr" href="#ref-98">98</a></em>) have described their protocols for optimal detection of MDR1/gp170. With such diversity of opinion and laboratory practice,
                        obtaining an internationally recognized standardized approach may be difficult in the short term.
                     </p>
                     
                     <p id="p-63">The significant heterogeneity across studies prevents the generation of a statistically valid summary estimate to describe
                        the overall prevalence of MDR1/gp170 expression in breast cancer. However, the weighted average over all 31 studies provides
                        a very general approximation and implies that approximately 40% of all breast tumors express detectable levels of MDR1/gp170.
                        This may be an underestimate, since it combines the typically lower positivity rates found in the less sensitive RNA hybridization
                        studies. While less than the frequency of positivity for estrogen receptor expression, which is almost 70% in all breast tumors
                        when assayed by immunohistochemistry (<em><a id="xref-ref-99-1" class="xref-bibr" href="#ref-99">99</a></em>–<em><a id="xref-ref-101-1" class="xref-bibr" href="#ref-101">101</a></em>), the frequency of gp170 positivity exceeds that of other prognostic indicators. For example, overexpression of erbB2 when
                        detected by immunohistochemistry approaches 20% in all breast cancers and 25% in invasive ductal cell carcinomas (<em><a id="xref-ref-102-1" class="xref-bibr" href="#ref-102">102</a></em>). This overexpression also may be associated with reduced sensitivity to some chemotherapeutic regimens (103). p53 mutations
                        are considered the most frequent genetic changes in breast cancer; they are found in approximately 15%-50% of breast cancers
                        (<em><a id="xref-ref-104-1" class="xref-bibr" href="#ref-104">104</a></em>,<em><a id="xref-ref-105-1" class="xref-bibr" href="#ref-105">105</a></em>), a frequency that compares with our estimate of 40% MDR1/gp170 positivity. With such a high relative frequency for detection
                        of MDR1/gp170, a definitive assessment of its functional role in breast cancer is an important goal.
                     </p>
                     
                  </div>
                  
                  <div id="sec-15" class="subsection">
                     
                     <h3>MDR1/gp170 Expression in Untreated and Treated Breast Cancers</h3>
                     
                     <p id="p-64">Many previously untreated breast cancers, 27% in the RNA hybridization studies and 46% in the immunohistochemistry studies,
                        express MDR1/gp170. These observations strongly suggest that many breast tumors already acquire MDR1/gp170 expression before
                        clinical detection. Among previously untreated breast cancer patients, 20%-55% obtain a worse than PR when they are treated
                        with cytotoxic chemotherapy. Furthermore, among those who respond to first-line chemotherapy, the median duration of response
                        is relatively short (only 5-13 months) (<em><a id="xref-ref-2-2" class="xref-bibr" href="#ref-2">2</a></em>). These observations are consistent with the likely acquired expression of low levels of MDR1/gp170 and/or other multiple
                        drug resistance mechanisms early in the biology of breast cancer progression. This acquisition may not require the selective
                        pressure imposed by chemotherapy. It also is not clear whether the expression detected after chemotherapy represents either
                        an induced expression or a selection that increases the proportion of MDR1/gp170-expressing tumor subpopulations.
                     </p>
                     
                     <p id="p-65">A few studies (<em><a id="xref-ref-58-6" class="xref-bibr" href="#ref-58">58</a></em>,<em><a id="xref-ref-66-3" class="xref-bibr" href="#ref-66">66</a></em>,<em><a id="xref-ref-106-1" class="xref-bibr" href="#ref-106">106</a></em>) have looked for MDR1/gp170 expression in the normal breast. The results of these studies suggest that expression is low,
                        absent, or predominantly stromal. Pavelic et al. (<em><a id="xref-ref-106-2" class="xref-bibr" href="#ref-106">106</a></em>), using four independent antibodies, detected MDR1/gp170 expression in normal ductal epithelia. Greater than 80% of normal
                        breast ductal epithelium stained positively with the MRK-16 anti-gp170 antibody, and staining was confined to the luminal
                        surface (<em><a id="xref-ref-79-2" class="xref-bibr" href="#ref-79">79</a></em>). These observations suggest that some MDR1/gp170-positive breast tumors may arise in those previously untreated patients
                        with tumors of intraductal origin.
                     </p>
                     
                     <p id="p-66">Selection against MDR1/gp170-related drugs in vitro frequently induces MDR1/gp170 expression (<em><a id="xref-ref-10-3" class="xref-bibr" href="#ref-10">10</a></em>). Furthermore, the meta-analysis results demonstrate that MDR1/gp170 expression is twice as likely to be detected in tumors
                        from treated versus untreated patients. This increased incidence of detectable MDR1/gp170 expression may be a direct consequence
                        of the cytotoxic drug therapy.
                     </p>
                     
                  </div>
                  
                  <div id="sec-16" class="subsection">
                     
                     <h3>Association of MDR1/gp170 Expression With a Worse Than PR</h3>
                     
                     <p id="p-67">Because of its ability to function as a drug efflux pump, gp170 confers multidrug resistance in vitro. Thus, it would be predicted
                        that the detection of its expression in breast cancer would be associated with clinical resistance. In our analysis, patients
                        with detectable levels of MDR1/gp170 were three times more likely to exhibit a less than partial clinical response to cytotoxic
                        chemotherapy. Since the incidence of MDR1/gp170 expression increases with treatment, and the response rate to second-line
                        chemotherapy is worse than that to first-line treatment, we would expect MDR1/gp170 expression measured after treatment to
                        show a stronger association with a poor clinical response. The post-treatment analysis for all drugs indicated that MDR1/gp170
                        expression in treated tumors was associated with a fourfold increase in risk for a patient having a worse than PR. These data
                        infer that the expression of MDR1/gp170 may already have been present in the tumors prior to and/or during chemotherapy. Furthermore,
                        they demonstrate a strong association between detectable MDR1/gp170 expression and a poor clinical response to cytotoxic chemotherapy.
                     </p>
                     
                     <p id="p-68">There were only limited data concerning the predictive utility of MDR1/gp170 expression measured before treatment. However,
                        in the five evaluated studies (<em><a id="xref-ref-47-12" class="xref-bibr" href="#ref-47">47</a></em>,<em><a id="xref-ref-57-12" class="xref-bibr" href="#ref-57">57</a></em>,<em><a id="xref-ref-61-12" class="xref-bibr" href="#ref-61">61</a></em>,<em><a id="xref-ref-64-8" class="xref-bibr" href="#ref-64">64</a></em>,<em><a id="xref-ref-74-9" class="xref-bibr" href="#ref-74">74</a></em>), there is a marginally significant 50% increase in the probability of an associated worse than partial clinical response.
                        While this finding suggests that de novo gp170 expression also may play a role in drug resistance, it is inconclusive. The
                        relatively small number of patients and the differences in immunohistochemistrybased assay techniques across studies may contribute
                        to the inability of these studies to demonstrate clearly, either way, the role of gp170 expression in previously untreated
                        breast cancer patients. Additional prospective, randomized, clinical trials are clearly needed to resolve this issue.
                     </p>
                     
                  </div>
                  
                  <div id="sec-17" class="subsection">
                     
                     <h3>Expression of MDR1/gp170 and Overall Survival</h3>
                     
                     <p id="p-69">The data relating MDR1/gp170 expression to recurrence-free and overall survival could not be analyzed because the required
                        data were not available in most published reports. The individual studies were essentially equally grouped in favor of and
                        against an association between expression and survival. This is not entirely unexpected, since response to therapy generally
                        is not associated with survival (107,108). Until sufficient studies are completed and the data are reported in a way that
                        can be readily accessed, any association of MDR1/gp170 expression with survival, whether positive or negative, will remain
                        unknown.
                     </p>
                     
                  </div>
                  
                  <div id="sec-18" class="subsection">
                     
                     <h3>Expression of MDR1/gp170 and Other Prognostic Attributes</h3>
                     
                     <p id="p-70">Expression of MDR1/gp170, rather than being associated with treatment, may merely reflect a more aggressive phenotype (<em><a id="xref-ref-89-2" class="xref-bibr" href="#ref-89">89</a></em>). Individual studies have found an association between the detectable expression of MDR1/gp170 in breast tumors and a poor
                        prognosis (<em><a id="xref-ref-61-13" class="xref-bibr" href="#ref-61">61</a></em>), poor survival (<em><a id="xref-ref-61-14" class="xref-bibr" href="#ref-61">61</a></em>,<em><a id="xref-ref-69-10" class="xref-bibr" href="#ref-69">69</a></em>), lymph node metastasis (<em><a id="xref-ref-109-1" class="xref-bibr" href="#ref-109">109</a></em>), and low progesterone receptor expression (<em><a id="xref-ref-54-5" class="xref-bibr" href="#ref-54">54</a></em>). Among all the studies that have examined associations with other prognostic attributes, however, there is little evidence
                        to support the contention that MDR1/gp170 expression is merely a surrogate for other indicators of an aggressive phenotype.
                        We found no association of MDR1/gp170 with either positive lymph nodes, tumor size, grade, histology, or estrogen receptor
                        expression. However, relatively few studies examined such associations. The most commonly evaluated markers, lymph node status
                        and tumor size, were examined in nine studies (<em><a id="xref-ref-54-6" class="xref-bibr" href="#ref-54">54</a></em>,<em><a id="xref-ref-57-13" class="xref-bibr" href="#ref-57">57</a></em>,<em><a id="xref-ref-60-4" class="xref-bibr" href="#ref-60">60</a></em>,<em><a id="xref-ref-61-15" class="xref-bibr" href="#ref-61">61</a></em>,<em><a id="xref-ref-63-11" class="xref-bibr" href="#ref-63">63</a></em>,<em><a id="xref-ref-69-11" class="xref-bibr" href="#ref-69">69</a></em>,<em><a id="xref-ref-70-3" class="xref-bibr" href="#ref-70">70</a></em>,<em><a id="xref-ref-74-10" class="xref-bibr" href="#ref-74">74</a></em>,<em><a id="xref-ref-75-8" class="xref-bibr" href="#ref-75">75</a></em>) and seven studies (<em><a id="xref-ref-54-7" class="xref-bibr" href="#ref-54">54</a></em>,<em><a id="xref-ref-60-5" class="xref-bibr" href="#ref-60">60</a></em>,<em><a id="xref-ref-61-16" class="xref-bibr" href="#ref-61">61</a></em>, <em><a id="xref-ref-63-12" class="xref-bibr" href="#ref-63">63</a></em>,<em><a id="xref-ref-70-4" class="xref-bibr" href="#ref-70">70</a></em>,<em><a id="xref-ref-74-11" class="xref-bibr" href="#ref-74">74</a></em>,<em><a id="xref-ref-75-9" class="xref-bibr" href="#ref-75">75</a></em>), respectively.
                     </p>
                     
                  </div>
                  
                  <div id="sec-19" class="subsection">
                     
                     <h3>Establishing the Functional Relevance of MDR1/gp170 Expression—Considerations and Future Directions</h3>
                     
                     <p id="p-71">The meta-analysis data clearly indicate that MDR1/gp170 is expressed in a significant proportion of breast tumors. A direct
                        examination of the clinical relevance of MDR1/gp170 expression is clearly the next most important step. The precise delineation
                        of this role is likely to be difficult and complex. Clinical studies have almost exclusively assessed MDR1/gp170 expression
                        either before or after therapy, but not during treatment. In experimental models, MDR1/gp170 expression is frequently induced
                        by exposure to a substrate (<em><a id="xref-ref-110-1" class="xref-bibr" href="#ref-110">110</a></em>), and expression becomes constitutive only after repeated or prolonged in vitro exposure. Thus, in some tumors, expression
                        may be detectable only during either therapy or the later cycles of therapy. The level of expression before or after treatment
                        may underestimate the level induced during treatment and may produce a false-negative impression with regard to the role of
                        MDR1/gp170.
                     </p>
                     
                     <p id="p-72">Studies that have begun to address gp170 function in patients have used response to a combination chemotherapy regimen as
                        their end point. This may be a suboptimal approach. Determining the individual contribution of each drug to the response in
                        a specific tumor is currently impossible. For example, when a regimen is used in which each drug is effective as a single
                        agent, e.g., CAF, what proportion of the response, or lack thereof, will be due to the gp170 substrate? Furthermore, doxorubicin
                        is the major or sole gp170 substrate in chemotherapy regimens used in most studies. However, doxorubicin is subject to several
                        drug resistance mechanisms unrelated to gp170, including an altered expression of manganese superoxide dismutase (<em><a id="xref-ref-7-2" class="xref-bibr" href="#ref-7">7</a></em>) and increased activities of glutathione transferase and topoisomerase II (<em><a id="xref-ref-111-1" class="xref-bibr" href="#ref-111">111</a></em>,<em><a id="xref-ref-112-1" class="xref-bibr" href="#ref-112">112</a></em>). Thus, when using doxorubicin as the gp170 substrate, lack of a clinical response can be attributed only cautiously to gp170.
                        This is also a concern for the present meta-analysis and suggests that patients previously treated with a non-MDR1/ gp170-related
                        regimen should be excluded from future studies, since this treatment may induce cross-resistance mechanisms to some MDR1/gp170-related
                        drugs.
                     </p>
                     
                  </div>
                  
                  <div id="sec-20" class="subsection">
                     
                     <h3>Suggestions for Design of Future Clinical Trials</h3>
                     
                     <p>We wish to raise several issues for consideration, since these issues are likely to have contributed to the significant heterogeneity
                        apparent in previously published studies. We hope that these suggestions will provide some degree of consistency within, if
                        not among, future studies. Several groups (94,95) have recently attempted to derive specific guidelines for the assessment
                        of MDR1/gp170 positivity. Our analysis of the sources of heterogeneity among published studies supports some suggestions raised
                        in these reports and raises the following additional issues for consideration:
                        
                     </p>
                     <ol class="list-ord" id="list-3">
                        <li id="list-item-16">
                           <p id="p-74">In general, well-designed prospective studies with adequate statistical power are preferable to retrospective studies. Thus,
                              MDR1/gp170 expression should be measured before the commencement of cytotoxic chemotherapy. If a neoadjuvant design is adopted,
                              investigators should consider the feasibility of also measuring MDR1/gp170 expression in biopsy specimens obtained during
                              chemotherapy. Any tissue removed, or accessible either after treatment or upon relapse, also should be examined for MDR1/gp170
                              expression.
                           </p>
                        </li>
                        <li id="list-item-17">
                           <p id="p-75">Where possible, the study population should comprise patients not previously treated with any systemic therapies. These patients
                              may have fewer other endogenous cross-resistance mechanisms present, e.g., altered topoisomerase or glutathione transferase
                              expression, or at least express other mechanisms at relatively low levels.
                           </p>
                        </li>
                        <li id="list-item-18">
                           <p id="p-76">Measuring gp170 expression may be preferable to measuring MDR1 expression, since immunohistochemistry is more sensitive and
                              can discriminate between stromal and tumor cell expression.
                           </p>
                        </li>
                        <li id="list-item-19">
                           <p id="p-77">Where immunohistochemistry is adopted, there should be a clear definition of positivity and negativity of expression compared
                              with well-defined positive and negative controls. Since some anti-gp170 antibodies cross-react with epitopes on proteins other
                              than gp170 (<em><a id="xref-ref-58-7" class="xref-bibr" href="#ref-58">58</a></em>,<em><a id="xref-ref-84-3" class="xref-bibr" href="#ref-84">84</a></em>,<em><a id="xref-ref-87-2" class="xref-bibr" href="#ref-87">87</a></em>), more than one antibody with nonoverlapping cross-reactivities should be considered. Samples should be screened and scored
                              in a blinded fashion by more than one pathologist using criteria established before the analysis. Experimental criteria discussed
                              in detail by others (94-98) also should be considered.
                           </p>
                        </li>
                        <li id="list-item-20">
                           <p id="p-78">When the data are presented, the methods of accruing patients (samples), characteristics of the study population, and the
                              treatments (exposures) should be described in detail. Data should be presented so that MDR1/gp170 positivity can be described
                              among the following patient subgroups: those whose tumors are assayed before or after treatment, those whose tumors are treated
                              with MDR1/gp170-related or non-MDR1/gp170-related substrates, and those whose tumors are primary or metastatic.
                           </p>
                        </li>
                        <li id="list-item-21">
                           <p id="p-79"></p>
                        </li>
                     </ol>
                     <p>
                        
                     </p>
                     
                     <p id="p-80">MDR1/gp170 expression might be associated with the induction of other drug resistance mechanisms. It is possible that exposure
                        to cytotoxic drugs induces a cellular stress response that co-induces several stress and detoxification mechanisms. This response
                        could include increased expression of the heat shock proteins (<em><a id="xref-ref-113-1" class="xref-bibr" href="#ref-113">113</a></em>), glutathione transferases (<em><a id="xref-ref-5-2" class="xref-bibr" href="#ref-5">5</a></em>), and superoxide dismutases (<em><a id="xref-ref-7-3" class="xref-bibr" href="#ref-7">7</a></em>). The activity of some DNA repair processes, including the activity of the topoisomerases, also may be altered (<em><a id="xref-ref-8-2" class="xref-bibr" href="#ref-8">8</a></em>). Since each subpopulation of cells within a tumor may express a different pattern of these various resistance mechanisms,
                        future studies should determine whether MDR1/gp170 expression either is a general marker for drug resistance or arises independently
                        of other resistance mechanisms. A recent study (<em><a id="xref-ref-114-1" class="xref-bibr" href="#ref-114">114</a></em>) suggests that combining assessments of MDR1/gp170 with those of MRP provides a more accurate predictor of clinical drug
                        resistance in patients with acute myeloid leukemia.
                     </p>
                     
                     <p id="p-81">Studies with agents that can reverse gp170 function provide another approach to determining the functional relevance of expression.
                        However, this approach is likely to be complicated by several additional factors. While there is no clear consensus on how
                        best to detect MDR1/gp170, several studies with reversing agents (<em><a id="xref-ref-115-1" class="xref-bibr" href="#ref-115">115</a></em>–<em><a id="xref-ref-118-1" class="xref-bibr" href="#ref-118">118</a></em>) have been performed on breast cancer patient populations in whom the MDR1/gp170 status is either unknown or not reported.
                        Antibodies and complementary DNA probes have been available for several years, and such study designs are discouraged.
                     </p>
                     
                     <p id="p-82">One “intrapatient” study design has been suggested that might alleviate some of these concerns and is worthy of consideration
                        (<em><a id="xref-ref-119-1" class="xref-bibr" href="#ref-119">119</a></em>). Previously untreated breast cancer patients with comparable disease status could receive a single MDR1/gp170- related substrate
                        regimen until relapse. These patients are then screened for MDR1/gp170 expression in accessible lesions, and patients with
                        MDR1/gp170-positive tumors are assigned to subsequent groups where the same drug is administered with the reversing agent.
                        The pharmacokinetics of the cytotoxic agent would be established in each patient, both when the drug is administered alone
                        and subsequently when the drug is given with the reversing agent. This will enable each patient essentially to act as his
                        or her own control and reduce the effects of interpatient variation (<em><a id="xref-ref-119-2" class="xref-bibr" href="#ref-119">119</a></em>). To control for unrelated effects on clinical response and pharmacokinetics, selecting patients with broadly comparable
                        performance status may be necessary. Patients should be evaluated for MDR1/gp170 expression before any systemic therapy is
                        initiated.
                     </p>
                     
                  </div>
                  
                  <div id="sec-21" class="subsection">
                     
                     <h3>Implications of This Analysis for Future Translational Research Studies</h3>
                     
                     <p id="p-83">The studies reviewed in this analysis varied substantially with respect to the level of information presented in the published
                        reports. Because of the nature of translational research, it is vital that researchers provide the information necessary to
                        readily understand the clinical implications of a particular study. Results should be presented in a way that allows differences
                        in the critical subgroups to be discerned, particularly when the activity of the molecule is thought to vary with clinical
                        attributes, e.g., expression levels in patients before and after treatment. A clear description of the patient population
                        and method of accrual also is important. Tumor samples assayed in a particular study will rarely come from randomized clinical
                        trials, so it is important to consider the selection factors, implicit or explicit, that influence the study sample's composition.
                        Tumor specimens accrued to tumor banks or to individual studies generally represent a number of clinical and institutional
                        factors, including tumor size, referral patterns, tissue-handling procedures, procurement policies, consent procedures, other
                        protocols competing for tissue, and recruitment into clinical trials. All these factors can influence the biologic characteristics
                        of patients or specimens comprising a particular study.
                     </p>
                     
                  </div>
                  
               </div>
               <div class="section" id="sec-22">
                  <div class="section-nav"><a href="#sec-12" title="Discussion" class="prev-section-link"><span>Previous Section</span></a><a href="#fn-group-1" title="Footnotes" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Conclusions</h2>
                  
                  <p id="p-84">The data from our meta-analysis indicate that many breast tumors express detectable levels of MDR1/gp170. There is considerable
                     heterogeneity across studies of MDR1/gp170 expression, resulting partly from the different techniques and end points utilized.
                     The incidence of expression is higher in patients who have received cytotoxic chemotherapy and in those who either will have
                     or have had a worse than partial clinical response to chemotherapy. While the functional relevance of this expression remains
                     to be established, these data are strongly supportive of a likely role for MDR1/gp170 in conferring clinical resistance to
                     gp170 substrates in a significant proportion of breast tumors. We found no evidence to support the assumption that MDR1/gp170
                     expression has no role in breast cancer.
                  </p>
                  
                  <p id="p-85">While the precise role of MDR1/gp170 in breast cancer remains to be established definitively, it seems likely that, in tumors
                     where expression is detectable, this expression contributes to the multidrug-resistant phenotype. However, it seems equally
                     likely that multidrug resistance in breast cancer is a multifactorial phenomenon and may include MRP and the altered expression
                     of superoxide dismutases, glutathione transferases, heat shock proteins, and other resistance genes. The precise contribution
                     of each potential multidrug resistance mechanism is unclear, and it is likely that more than one mechanism can operate within
                     the same tumor cell subpopulation and/or within different subpopulations of the same tumor. If correct, then the establishment
                     of a role for any of these other resistance mechanisms will become as complex and controversial as is the study of MDR1/gp170.
                  </p>
                  
                  <p id="p-86">The potential complexity that applies to the study of drug resistance in breast cancer likely also applies to other solid
                     tumors. Clearly, the design of future clinical trials to establish the functional relevance of drug resistance mechanisms
                     will require careful and detailed consideration of the patient population, the drugs used to induce response, and the potential
                     contribution of other drug resistance mechanisms.
                  </p>
                  
                  <p id="p-87">One purpose of meta-analyses is to identify potential directions for future studies and, if possible, to provide suggestions
                     for incorporation into improved study designs. In this respect, the issues we have raised regarding study design are provided
                     in the hope that they will both raise awareness and generate some discussion of the complexities and difficulties associated
                     with establishing the role of MDR1/gp170 and other drug resistance mechanisms.
                  </p>
                  
               </div>
               <div class="section fn-group" id="fn-group-1">
                  <div class="section-nav"><a href="#sec-22" title="Conclusions" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="References" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Footnotes</h2>
                  <ul>
                     <li class="fn-supported-by" id="fn-1">
                        
                        <p id="p-1">Supported in part by Public Health Service grants P30CA51008 and P50CA58185 (R. Clarke and B. J. Trock) from the National
                           Cancer Institute, National Institutes of Health, Department of Health and Human Services; and in part by grant RP950649 (R.
                           Clarke) from the Department of the Army, U.S. Army Medical Research and Materiel Command.
                        </p>
                        
                     </li>
                  </ul>
               </div>
               <ul class="copyright-statement">
                  <li class="fn" id="copyright-statement-1">© Oxford University Press</li>
               </ul>
               <div class="section ref-list" id="ref-list-1">
                  <div class="section-nav"><a href="#fn-group-1" title="Footnotes" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder"> </div>
                  </div>
                  <h2>References</h2>
                  <ol class="cit-list ref-use-labels">
                     <li><span class="ref-label">(1)</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference (1) in text"
                           id="ref-1">↵</a>
                        
                        
                        <div class="cit ref-cit ref-book" id="cit-89.13.917.1">
                           <div class="cit-metadata">
                              <ol class="cit-ed-list duplicate">
                                 <li><span class="cit-ed"><span class="cit-name-surname">Powles</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-ed"><span class="cit-name-surname">Smith</span>  <span class="cit-name-given-names">IE</span></span></li>
                              </ol>
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Henderson</span>  <span class="cit-name-given-names">IC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shapiro</span>  <span class="cit-name-given-names">CI</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Adjuvant chemotherapy: an overview</span>. In: 
                                 <span class="cit-ed"><span class="cit-name-surname">Powles</span>  <span class="cit-name-given-names">T</span></span>, 
                                 <span class="cit-ed"><span class="cit-name-surname">Smith</span>  <span class="cit-name-given-names">IE</span></span>
                                 , editors. <span class="cit-source">Medical management of breast cancer</span>. <span class="cit-publ-loc">London</span>: <span class="cit-publ-name">Dunitz</span>; <span class="cit-pub-date">1991</span>. p. <span class="cit-fpage">197</span>-<span class="cit-lpage">215</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Adjuvant%20chemotherapy%3A%20an%20overview&amp;author=IC%20Henderson&amp;author=CI%20Shapiro&amp;publication_year=1991&amp;citation_inbook_title=Medical%20management%20of%20breast%20cancer">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(2)</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference (2) in text"
                           id="ref-2">↵</a>
                        
                        
                        <div class="cit ref-cit ref-book" id="cit-89.13.917.2">
                           <div class="cit-metadata">
                              <ol class="cit-ed-list duplicate">
                                 <li><span class="cit-ed"><span class="cit-name-surname">DeVita</span>  <span class="cit-name-given-names">VT</span>  <span class="cit-name-suffix">Jr</span></span>, 
                                 </li>
                                 <li><span class="cit-ed"><span class="cit-name-surname">Hellman</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-ed"><span class="cit-name-surname">Rosenberg</span>  <span class="cit-name-given-names">SA</span></span></li>
                              </ol>
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Harris</span>  <span class="cit-name-given-names">JR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Morrow</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bonadonna</span>  <span class="cit-name-given-names">G</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Cancer of the breast</span>. In: 
                                 <span class="cit-ed"><span class="cit-name-surname">DeVita</span>  <span class="cit-name-given-names">VT</span>  <span class="cit-name-suffix">Jr</span></span>, 
                                 <span class="cit-ed"><span class="cit-name-surname">Hellman</span>  <span class="cit-name-given-names">S</span></span>, 
                                 <span class="cit-ed"><span class="cit-name-surname">Rosenberg</span>  <span class="cit-name-given-names">SA</span></span>
                                 , editors. <span class="cit-source">Cancer: principles and practice of oncology</span>. <span class="cit-publ-loc">Philadelphia</span>: <span class="cit-publ-name">Lippincott</span>; <span class="cit-pub-date">1993</span>. p. <span class="cit-fpage">1264</span>-<span class="cit-lpage">332</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Cancer%20of%20the%20breast&amp;author=JR%20Harris&amp;author=M%20Morrow&amp;author=G%20Bonadonna&amp;publication_year=1993&amp;citation_inbook_title=Cancer%3A%20principles%20and%20practice%20of%20oncology">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(3)</span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference (3) in text"
                           id="ref-3">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.3">
                           <div class="cit-metadata">
                              <ol class="cit-ed-list duplicate">
                                 <li><span class="cit-ed"><span class="cit-name-surname">Tsuruo</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-ed"><span class="cit-name-surname">Ogawa</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-ed"><span class="cit-name-surname">Carter</span>  <span class="cit-name-given-names">SK</span></span></li>
                              </ol>
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Clarke</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dickson</span>  <span class="cit-name-given-names">RB</span></span></li>
                              </ol><cite>; 
                                 <span class="cit-ed"><span class="cit-name-surname">Tsuruo</span>  <span class="cit-name-given-names">T</span></span>, 
                                 <span class="cit-ed"><span class="cit-name-surname">Ogawa</span>  <span class="cit-name-given-names">M</span></span>, 
                                 <span class="cit-ed"><span class="cit-name-surname">Carter</span>  <span class="cit-name-given-names">SK</span></span>
                                 , editors. <span class="cit-article-title">The interactions among steroid hormones, antiestrogens, biological response modifiers and cytotoxic drugs in breast cancer</span>. <abbr class="cit-jnl-abbrev">Drug resistance as a biochemical target in cancer chemotherapy</abbr> <span class="cit-publ-loc">New York</span>: <span class="cit-publ-name">Academic Press</span>; <span class="cit-pub-date">1991</span>:<span class="cit-fpage">223</span>-<span class="cit-lpage">53</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=The%20interactions%20among%20steroid%20hormones%2C%20antiestrogens%2C%20biological%20response%20modifiers%20and%20cytotoxic%20drugs%20in%20breast%20cancer&amp;author=R%20Clarke&amp;author=RB%20Dickson&amp;publication_year=1991&amp;journal=Drug%20resistance%20as%20a%20biochemical%20target%20in%20cancer%20chemotherapy&amp;pages=223-53">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(4)</span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference (4) in text"
                           id="ref-4">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.4">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Clarke</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lippman</span>  <span class="cit-name-given-names">ME</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dickson</span>  <span class="cit-name-given-names">RB</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Mechanism of hormone and cytotoxic drug interactions in the development and treatment of breast cancer</span>. <abbr class="cit-jnl-abbrev">Prog Clin Biol Res</abbr> <span class="cit-pub-date">1989</span>;<span class="cit-vol">322</span>:<span class="cit-fpage">243</span>-<span class="cit-lpage">78</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=A1990BP95A00017&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Mechanism%20of%20hormone%20and%20cytotoxic%20drug%20interactions%20in%20the%20development%20and%20treatment%20of%20breast%20cancer&amp;author=R%20Clarke&amp;author=ME%20Lippman&amp;author=RB%20Dickson&amp;publication_year=1989&amp;journal=Prog%20Clin%20Biol%20Res&amp;volume=322&amp;pages=243-78">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(5)</span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference (5) in text"
                           id="ref-5">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.5">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Morrow</span>  <span class="cit-name-given-names">CS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chiu</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cowan</span>  <span class="cit-name-given-names">KH</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Posttranscriptional control of glutathione S-transferase pi gene expression in human breast cancer cells</span>. <abbr class="cit-jnl-abbrev">J Biol Chem</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">267</span>:<span class="cit-fpage">10544</span>-<span class="cit-lpage">50</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=267/15/10544"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(6)</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference (6) in text"
                           id="ref-6">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.6">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Molina</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Oesterreich</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zhou</span>  <span class="cit-name-given-names">JL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tandon</span>  <span class="cit-name-given-names">AK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Clark</span>  <span class="cit-name-given-names">GM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Allred</span>  <span class="cit-name-given-names">DC</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Glutathione transferase GST pi in breast tumors evaluated by three techniques</span>. <abbr class="cit-jnl-abbrev">Dis Markers</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">11</span>:<span class="cit-fpage">71</span>-<span class="cit-lpage">82</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=8261735&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1993MB24400002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Glutathione%20transferase%20GST%20pi%20in%20breast%20tumors%20evaluated%20by%20three%20techniques&amp;author=R%20Molina&amp;author=S%20Oesterreich&amp;author=JL%20Zhou&amp;author=AK%20Tandon&amp;author=GM%20Clark&amp;author=DC%20Allred&amp;publication_year=1993&amp;journal=Dis%20Markers&amp;volume=11&amp;pages=71-82">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(7)</span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference (7) in text"
                           id="ref-7">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.7">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zyad</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Benard</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tursz</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Clarke</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chouaib</span>  <span class="cit-name-given-names">S</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Resistance to TNF-α and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">54</span>:<span class="cit-fpage">825</span>-<span class="cit-lpage">31</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=54/3/825"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(8)</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference (8) in text"
                           id="ref-8">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.8"
                             data-doi="10.1007/BF01606432">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tuccari</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rizzo</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Giuffre</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Barresi</span>  <span class="cit-name-given-names">G</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: correlation with clinico-pathological
                                    features</span>. <abbr class="cit-jnl-abbrev">Virchows Arch A Pathol Anat Histopathol</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">423</span>:<span class="cit-fpage">51</span>-<span class="cit-lpage">5</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/BF01606432&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=8212534&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1993LU94800008&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Immunocytochemical%20detection%20of%20DNA%20topoisomerase%20type%20II%20in%20primary%20breast%20carcinomas%3A%20correlation%20with%20clinico-pathological%20features&amp;author=G%20Tuccari&amp;author=A%20Rizzo&amp;author=G%20Giuffre&amp;author=G%20Barresi&amp;publication_year=1993&amp;journal=Virchows%20Arch%20A%20Pathol%20Anat%20Histopathol&amp;volume=423&amp;pages=51-5">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(9)</span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference (9) in text"
                           id="ref-9">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.9">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schneider</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Horton</span>  <span class="cit-name-given-names">JK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yang</span>  <span class="cit-name-given-names">CH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nakagawa</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cowan</span>  <span class="cit-name-given-names">KH</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast
                                    carcinoma MCF7 cell line selected for etoposide resistance</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">54</span>:<span class="cit-fpage">152</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=54/1/152"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(10)</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference (10) in text"
                           id="ref-10">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.10"
                             data-doi="10.1210/mend-2-10-886">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vickers</span>  <span class="cit-name-given-names">PJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dickson</span>  <span class="cit-name-given-names">RB</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shoemaker</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cowan</span>  <span class="cit-name-given-names">KH</span></span></li>
                              </ol><cite>. <span class="cit-article-title">A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent
                                    tumor growth in vivo</span>. <abbr class="cit-jnl-abbrev">Mol Endocrinol</abbr> <span class="cit-pub-date">1988</span>;<span class="cit-vol">2</span>:<span class="cit-fpage">886</span>-<span class="cit-lpage">92</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1210/mend-2-10-886&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=3185565&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1988Q131900002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=A%20multidrug-resistant%20MCF-7%20human%20breast%20cancer%20cell%20line%20which%20exhibits%20cross-resistance%20to%20antiestrogens%20and%20hormone-independent%20tumor%20growth%20in%20vivo&amp;author=PJ%20Vickers&amp;author=RB%20Dickson&amp;author=R%20Shoemaker&amp;author=KH%20Cowan&amp;publication_year=1988&amp;journal=Mol%20Endocrinol&amp;volume=2&amp;pages=886-92">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(11)</span><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference (11) in text"
                           id="ref-11">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.11">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Juliano</span>  <span class="cit-name-given-names">RL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ling</span>  <span class="cit-name-given-names">V</span></span></li>
                              </ol><cite>. <span class="cit-article-title">A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants</span>. <abbr class="cit-jnl-abbrev">Biochim Biophys Acta</abbr> <span class="cit-pub-date">1976</span>;<span class="cit-vol">455</span>:<span class="cit-fpage">152</span>-<span class="cit-lpage">62</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=990323&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1976CL76800012&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=A%20surface%20glycoprotein%20modulating%20drug%20permeability%20in%20Chinese%20hamster%20ovary%20cell%20mutants&amp;author=RL%20Juliano&amp;author=V%20Ling&amp;publication_year=1976&amp;journal=Biochim%20Biophys%20Acta&amp;volume=455&amp;pages=152-62">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(12)</span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference (12) in text"
                           id="ref-12">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.12"
                             data-doi="10.1073/pnas.89.18.8472">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ambudkar</span>  <span class="cit-name-given-names">SV</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lelong</span>  <span class="cit-name-given-names">IH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zhang</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cardarelli</span>  <span class="cit-name-given-names">CO</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gottesman</span>  <span class="cit-name-given-names">MM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pastan</span>  <span class="cit-name-given-names">I</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Partial purification and reconstitution of the human multidrugresistance pump: characterization of the drug-stimulatable ATP
                                    hydrolysis</span>. <abbr class="cit-jnl-abbrev">Proc Natl Acad Sci U S A</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">89</span>:<span class="cit-fpage">8472</span>-<span class="cit-lpage">6</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=89/18/8472"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(13)</span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference (13) in text"
                           id="ref-13">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.13">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bruggemann</span>  <span class="cit-name-given-names">EP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Currier</span>  <span class="cit-name-given-names">SJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gottesman</span>  <span class="cit-name-given-names">MM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pastan</span>  <span class="cit-name-given-names">I</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Characterization of the azidopine and vinblastine binding site of P-glycoprotein</span>. <abbr class="cit-jnl-abbrev">J Biol Chem</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">267</span>:<span class="cit-fpage">21020</span>-<span class="cit-lpage">6</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=267/29/21020"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(14)</span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference (14) in text"
                           id="ref-14">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.14">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Raviv</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pollard</span>  <span class="cit-name-given-names">HB</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bruggemann</span>  <span class="cit-name-given-names">EP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pastan</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gottesman</span>  <span class="cit-name-given-names">MM</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Photosensitized labeling of a functional multidrug transporter in living drugresistant tumor cells</span>. <abbr class="cit-jnl-abbrev">J Biol Chem</abbr> <span class="cit-pub-date">1990</span>;<span class="cit-vol">265</span>:<span class="cit-fpage">3975</span>-<span class="cit-lpage">80</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=265/7/3975"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(15)</span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference (15) in text"
                           id="ref-15">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.15">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hamada</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hagiwara</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nakajima</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tsuruo</span>  <span class="cit-name-given-names">T</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: effects of verapamil,
                                    trifluoperazine and phorbol esters</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1987</span>;<span class="cit-vol">47</span>:<span class="cit-fpage">2860</span>-<span class="cit-lpage">5</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=47/11/2860"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(16)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.16">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chambers</span>  <span class="cit-name-given-names">TC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zheng</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kuo</span>  <span class="cit-name-given-names">JF</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein
                                    phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells</span>. <abbr class="cit-jnl-abbrev">Mol Pharmacol</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">41</span>:<span class="cit-fpage">1008</span>-<span class="cit-lpage">15</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=molpharm&amp;resid=41/6/1008"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(17)</span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference (17) in text"
                           id="ref-17">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.17">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yu</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ahmad</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Aquino</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fairchild</span>  <span class="cit-name-given-names">CR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Trepel</span>  <span class="cit-name-given-names">JB</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ohno</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein</span>. <abbr class="cit-jnl-abbrev">Cancer Commun</abbr> <span class="cit-pub-date">1991</span>;<span class="cit-vol">3</span>:<span class="cit-fpage">181</span>-<span class="cit-lpage">9</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1675575&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1991FV44000003&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Transfection%20with%20protein%20kinase%20C%20alpha%20confers%20increased%20multidrug%20resistance%20to%20MCF-7%20cells%20expressing%20P-glycoprotein&amp;author=G%20Yu&amp;author=S%20Ahmad&amp;author=A%20Aquino&amp;author=CR%20Fairchild&amp;author=JB%20Trepel&amp;author=S%20Ohno&amp;publication_year=1991&amp;journal=Cancer%20Commun&amp;volume=3&amp;pages=181-9">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(18)</span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference (18) in text"
                           id="ref-18">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.18"
                             data-doi="10.1021/bi00483a017">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Escriba</span>  <span class="cit-name-given-names">PV</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ferrer-Montiel</span>  <span class="cit-name-given-names">AV</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ferragut</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gonzalez-Ros</span>  <span class="cit-name-given-names">JM</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells: implications in drug-resistance
                                    phenomena</span>. <abbr class="cit-jnl-abbrev">Biochemistry</abbr> <span class="cit-pub-date">1990</span>;<span class="cit-vol">29</span>:<span class="cit-fpage">7275</span>-<span class="cit-lpage">82</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1021/bi00483a017&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=2207106&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1990DT68000017&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Role%20of%20membrane%20lipids%20in%20the%20interaction%20of%20daunomycin%20with%20plasma%20membranes%20from%20tumor%20cells%3A%20implications%20in%20drug-resistance%20phenomena&amp;author=PV%20Escriba&amp;author=AV%20Ferrer-Montiel&amp;author=JA%20Ferragut&amp;author=JM%20Gonzalez-Ros&amp;publication_year=1990&amp;journal=Biochemistry&amp;volume=29&amp;pages=7275-82">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(19)</span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference (19) in text"
                           id="ref-19">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.19"
                             data-doi="10.1093/jnci/82.21.1702">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Clarke</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">van den Berg</span>  <span class="cit-name-given-names">HW</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Murphy</span>  <span class="cit-name-given-names">RF</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17b-estradiol</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">1990</span>;<span class="cit-vol">82</span>:<span class="cit-fpage">1702</span>-<span class="cit-lpage">5</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=82/21/1702"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(20)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.20">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sinicrope</span>  <span class="cit-name-given-names">FA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dudeja</span>  <span class="cit-name-given-names">PK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bissonnette</span>  <span class="cit-name-given-names">BM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Safa</span>  <span class="cit-name-given-names">AR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Brasitus</span>  <span class="cit-name-given-names">TA</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles</span>. <abbr class="cit-jnl-abbrev">J Biol Chem</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">267</span>:<span class="cit-fpage">24995</span>-<span class="cit-lpage">5002</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=267/35/24995"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(21)</span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference (21) in text"
                           id="ref-21">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.21">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Woodcock</span>  <span class="cit-name-given-names">DM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Linsenmeyer</span>  <span class="cit-name-given-names">ME</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chojnowski</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kriegler</span>  <span class="cit-name-given-names">AB</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nink</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Webster</span>  <span class="cit-name-given-names">LK</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Reversal of multidrug resistance by surfactants</span>. <abbr class="cit-jnl-abbrev">Br J Cancer</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">66</span>:<span class="cit-fpage">62</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1637678&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1992JE59200011&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Reversal%20of%20multidrug%20resistance%20by%20surfactants&amp;author=DM%20Woodcock&amp;author=ME%20Linsenmeyer&amp;author=G%20Chojnowski&amp;author=AB%20Kriegler&amp;author=V%20Nink&amp;author=LK%20Webster&amp;publication_year=1992&amp;journal=Br%20J%20Cancer&amp;volume=66&amp;pages=62-8">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(22)</span><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference (22) in text"
                           id="ref-22">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.22">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gottesman</span>  <span class="cit-name-given-names">MM</span></span></li>
                              </ol><cite>. <span class="cit-article-title">How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">53</span>:<span class="cit-fpage">747</span>-<span class="cit-lpage">54</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=PDF&amp;journalCode=canres&amp;resid=53/4/747"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(23)</span><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference (23) in text"
                           id="ref-23">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.23"
                             data-doi="10.1093/jnci/83.24.1797-a">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Holmes</span>  <span class="cit-name-given-names">FA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Walters</span>  <span class="cit-name-given-names">RS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Theriault</span>  <span class="cit-name-given-names">RL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Forman</span>  <span class="cit-name-given-names">AD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Newton</span>  <span class="cit-name-given-names">LK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Raber</span>  <span class="cit-name-given-names">MN</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">1991</span>;<span class="cit-vol">83</span>:<span class="cit-fpage">1797</span>-<span class="cit-lpage">805</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=83/24/1797-a"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(24)</span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference (24) in text"
                           id="ref-24">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.24">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fisherman</span>  <span class="cit-name-given-names">JS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cowan</span>  <span class="cit-name-given-names">KH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Noone</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Denicoff</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Berg</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Poplack</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with
                                    metastatic breast cancer</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">1996</span>;<span class="cit-vol">14</span>:<span class="cit-fpage">774</span>-<span class="cit-lpage">82</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=14/3/774"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(25)</span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference (25) in text"
                           id="ref-25">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.25"
                             data-doi="10.1016/0277-5379(91)90476-T">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sanfilippo</span>  <span class="cit-name-given-names">O</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ronchi</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">De Marco</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Di Fronzo</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Silvestrini</span>  <span class="cit-name-given-names">R</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine</span>. <abbr class="cit-jnl-abbrev">Eur J Cancer</abbr> <span class="cit-pub-date">1991</span>;<span class="cit-vol">27</span>:<span class="cit-fpage">155</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0277-5379(91)90476-T&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=1673852&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1991FD47000015&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Expression%20of%20P-glycoprotein%20in%20breast%20cancer%20tissue%20and%20in%20vitro%20resistance%20to%20doxorubicin%20and%20vincristine&amp;author=O%20Sanfilippo&amp;author=E%20Ronchi&amp;author=C%20De%20Marco&amp;author=G%20Di%20Fronzo&amp;author=R%20Silvestrini&amp;publication_year=1991&amp;journal=Eur%20J%20Cancer&amp;volume=27&amp;pages=155-8">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(26)</span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference (26) in text"
                           id="ref-26">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.26"
                             data-doi="10.1093/jnci/81.9.696">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Salmon</span>  <span class="cit-name-given-names">SE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Grogan</span>  <span class="cit-name-given-names">TM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Miller</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Scheper</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dalton</span>  <span class="cit-name-given-names">WS</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">1989</span>;<span class="cit-vol">81</span>:<span class="cit-fpage">696</span>-<span class="cit-lpage">701</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=81/9/696"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(27)</span><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference (27) in text"
                           id="ref-27">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.27"
                             data-doi="10.1093/jnci/81.2.116">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Goldstein</span>  <span class="cit-name-given-names">LJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Galski</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fojo</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Willingham</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lai</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gazdar</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Expression of a multidrug resistance gene in human cancers</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">1989</span>;<span class="cit-vol">81</span>:<span class="cit-fpage">116</span>-<span class="cit-lpage">24</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=81/2/116"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(28)</span><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference (28) in text"
                           id="ref-28">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.28">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Merkel</span>  <span class="cit-name-given-names">DE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fuqua</span>  <span class="cit-name-given-names">SA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tandon</span>  <span class="cit-name-given-names">AK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hill</span>  <span class="cit-name-given-names">SM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Buzdar</span>  <span class="cit-name-given-names">AU</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">McGuire</span>  <span class="cit-name-given-names">WL</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Electrophoretic analysis of 248 clinical breast cancer specimens for Pglycoprotein overexpression or gene amplification</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">1989</span>;<span class="cit-vol">7</span>:<span class="cit-fpage">1129</span>-<span class="cit-lpage">36</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=7/8/1129"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(29)</span><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference (29) in text"
                           id="ref-29">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.29">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Moscow</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fairchild</span>  <span class="cit-name-given-names">CR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Madden</span>  <span class="cit-name-given-names">MJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ransom</span>  <span class="cit-name-given-names">DT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wieand</span>  <span class="cit-name-given-names">HS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">O'Brien</span>  <span class="cit-name-given-names">EE</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1989</span>;<span class="cit-vol">49</span>:<span class="cit-fpage">1422</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=49/6/1422"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(30)</span><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference (30) in text"
                           id="ref-30">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.30">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ronchi</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sanfilippo</span>  <span class="cit-name-given-names">O</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Di Fronzo</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bani</span>  <span class="cit-name-given-names">MR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Della Torre</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Catania</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Detection of the 170 kDa P-glycoprotein in neoplastic and normal tissues</span>. <abbr class="cit-jnl-abbrev">Tumori</abbr> <span class="cit-pub-date">1989</span>;<span class="cit-vol">75</span>:<span class="cit-fpage">542</span>-<span class="cit-lpage">6</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=2575816&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1989CL53300005&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Detection%20of%20the%20170%20kDa%20P-glycoprotein%20in%20neoplastic%20and%20normal%20tissues&amp;author=E%20Ronchi&amp;author=O%20Sanfilippo&amp;author=G%20Di%20Fronzo&amp;author=MR%20Bani&amp;author=G%20Della%20Torre&amp;author=S%20Catania&amp;publication_year=1989&amp;journal=Tumori&amp;volume=75&amp;pages=542-6">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(31)</span><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference (31) in text"
                           id="ref-31">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.31">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shapiro</span>  <span class="cit-name-given-names">S</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Meta-analysis/Shmeta-analysis</span>. <abbr class="cit-jnl-abbrev">Am J Epidemiol</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">140</span>:<span class="cit-fpage">771</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=amjepid&amp;resid=140/9/771"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(32)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.32">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Petitti</span>  <span class="cit-name-given-names">DB</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Of babies and bathwater</span>. <abbr class="cit-jnl-abbrev">Am J Epidemiol</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">140</span>:<span class="cit-fpage">779</span>-<span class="cit-lpage">82.</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=PDF&amp;journalCode=amjepid&amp;resid=140/9/779"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(33)</span><a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference (33) in text"
                           id="ref-33">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.33">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Greenland</span>  <span class="cit-name-given-names">S</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Invited commentary: a critical look at some popular metaanalytic methods</span>. <abbr class="cit-jnl-abbrev">Am J Epidemiol</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">140</span>:<span class="cit-fpage">290</span>-<span class="cit-lpage">6</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=amjepid&amp;resid=140/3/290"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(34)</span><a class="rev-xref-ref" href="#xref-ref-34-1" title="View reference (34) in text"
                           id="ref-34">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.34">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Greenland</span>  <span class="cit-name-given-names">S</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Can meta-analysis be salvaged?</span> <abbr class="cit-jnl-abbrev">Am J Epidemiol</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">140</span>:<span class="cit-fpage">783</span>-<span class="cit-lpage">7</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=PDF&amp;journalCode=amjepid&amp;resid=140/9/783"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(35)</span><a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference (35) in text"
                           id="ref-35">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.35"
                             data-doi="10.7326/0003-4819-106-3-485">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mulrow</span>  <span class="cit-name-given-names">CD</span></span></li>
                              </ol><cite>. <span class="cit-article-title">The medical review article: state of the science</span>. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr> <span class="cit-pub-date">1987</span>;<span class="cit-vol">106</span>:<span class="cit-fpage">485</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.7326/0003-4819-106-3-485&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=3813259&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1987G363900061&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=The%20medical%20review%20article%3A%20state%20of%20the%20science&amp;author=CD%20Mulrow&amp;publication_year=1987&amp;journal=Ann%20Intern%20Med&amp;volume=106&amp;pages=485-8">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(36)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.36">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Oxman</span>  <span class="cit-name-given-names">AD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Guyatt</span>  <span class="cit-name-given-names">GH</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Guidelines for reading literature reviews</span>. <abbr class="cit-jnl-abbrev">Can Med Assoc J</abbr> <span class="cit-pub-date">1988</span>;<span class="cit-vol">183</span>:<span class="cit-fpage">697</span>-<span class="cit-lpage">703</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Guidelines%20for%20reading%20literature%20reviews&amp;author=AD%20Oxman&amp;author=GH%20Guyatt&amp;publication_year=1988&amp;journal=Can%20Med%20Assoc%20J&amp;volume=183&amp;pages=697-703">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(37)</span><a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference (37) in text"
                           id="ref-37">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.37"
                             data-doi="10.1136/jech.47.3.169">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Milne</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chambers</span>  <span class="cit-name-given-names">L</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Assessing the scientific quality of review articles</span>. <abbr class="cit-jnl-abbrev">J Epidemiol Community Health</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">47</span>:<span class="cit-fpage">169</span>-<span class="cit-lpage">70</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=PDF&amp;journalCode=jech&amp;resid=47/3/169"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(38)</span><a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference (38) in text"
                           id="ref-38">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.38">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Leonessa</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jacobson</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Boyle</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lippman</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">McGarvey</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Clarke</span>  <span class="cit-name-given-names">R</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, M(r)
                                    170,000 glycoprotein (gp170) binding studies</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">54</span>:<span class="cit-fpage">441</span>-<span class="cit-lpage">7</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=54/2/441"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(39)</span><a class="rev-xref-ref" href="#xref-ref-39-1" title="View reference (39) in text"
                           id="ref-39">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.39">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ramu</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Glaubiger</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fuks</span>  <span class="cit-name-given-names">Z</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1984</span>;<span class="cit-vol">44</span>:<span class="cit-fpage">4392</span>-<span class="cit-lpage">5</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=44/10/4392"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(40)</span><a class="rev-xref-ref" href="#xref-ref-40-1" title="View reference (40) in text"
                           id="ref-40">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.40">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dickersin</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Berlin</span>  <span class="cit-name-given-names">JA</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Meta-analysis: state-of-the-science</span>. <abbr class="cit-jnl-abbrev">Epidemiol Rev</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">14</span>:<span class="cit-fpage">154</span>-<span class="cit-lpage">76</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=PDF&amp;journalCode=epirev&amp;resid=14/1/154"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(41)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.41"
                             data-doi="10.1002/sim.4780100618">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chalmers</span>  <span class="cit-name-given-names">TC</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Problems induced by meta-analyses</span>. <abbr class="cit-jnl-abbrev">Stat Med</abbr> <span class="cit-pub-date">1991</span>;<span class="cit-vol">10</span>:<span class="cit-fpage">971</span>-<span class="cit-lpage">80</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/sim.4780100618&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=1876787&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1991FP88700016&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Problems%20induced%20by%20meta-analyses&amp;author=TC%20Chalmers&amp;publication_year=1991&amp;journal=Stat%20Med&amp;volume=10&amp;pages=971-80">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(42)</span><a class="rev-xref-ref" href="#xref-ref-42-1" title="View reference (42) in text"
                           id="ref-42">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.42"
                             data-doi="10.1016/0895-4356(88)90053-4">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gerbarg</span>  <span class="cit-name-given-names">ZB</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Horwitz</span>  <span class="cit-name-given-names">RI</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Resolving conflicting clinical trials: guidelines for meta-analysis</span>. <abbr class="cit-jnl-abbrev">J Clin Epidemiol</abbr> <span class="cit-pub-date">1988</span>;<span class="cit-vol">41</span>:<span class="cit-fpage">503</span>-<span class="cit-lpage">9</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0895-4356(88)90053-4&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=3367182&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1988N334600012&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Resolving%20conflicting%20clinical%20trials%3A%20guidelines%20for%20meta-analysis&amp;author=ZB%20Gerbarg&amp;author=RI%20Horwitz&amp;publication_year=1988&amp;journal=J%20Clin%20Epidemiol&amp;volume=41&amp;pages=503-9">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(43)</span><a class="rev-xref-ref" href="#xref-ref-43-1" title="View reference (43) in text"
                           id="ref-43">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.43"
                             data-doi="10.1093/jnci/89.1.6">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Weed</span>  <span class="cit-name-given-names">DL</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Methodologic guidelines for review papers</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">1997</span>;<span class="cit-vol">89</span>:<span class="cit-fpage">6</span>-<span class="cit-lpage">7</span>. <span class="cit-comment">[editorial]</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=FULL&amp;journalCode=jnci&amp;resid=89/1/6"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(44)</span><a class="rev-xref-ref" href="#xref-ref-44-1" title="View reference (44) in text"
                           id="ref-44">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.44">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Theillet</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Le Roy</span>  <span class="cit-name-given-names">X</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">De Lapeyriere</span>  <span class="cit-name-given-names">O</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Grosgeorges</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Adnane</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Raynaud</span>  <span class="cit-name-given-names">SD</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas</span>. <abbr class="cit-jnl-abbrev">Oncogene</abbr> <span class="cit-pub-date">1989</span>;<span class="cit-vol">4</span>:<span class="cit-fpage">915</span>-<span class="cit-lpage">22</span>. <span class="cit-comment">[published erratum appears in Oncogene 1989;4:1537]</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=2474139&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1989AE58400015&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Amplification%20of%20FGF-related%20genes%20in%20human%20tumors%3A%20possible%20involvement%20of%20HST%20in%20breast%20carcinomas&amp;author=C%20Theillet&amp;author=X%20Le%20Roy&amp;author=O%20De%20Lapeyriere&amp;author=J%20Grosgeorges&amp;author=J%20Adnane&amp;author=SD%20Raynaud&amp;publication_year=1989&amp;journal=Oncogene&amp;volume=4&amp;pages=915-22">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(45)</span><a class="rev-xref-ref" href="#xref-ref-45-1" title="View reference (45) in text"
                           id="ref-45">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.45">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Smith</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Houlbrook</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Greenall</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Carmichael</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Harris</span>  <span class="cit-name-given-names">AL</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Topoisomerase II alpha co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: relationship
                                    to m-AMSA and mitoxantrone sensitivity</span>. <abbr class="cit-jnl-abbrev">Oncogene</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">8</span>:<span class="cit-fpage">933</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=8096076&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1993KT22000015&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Topoisomerase%20II%20alpha%20co-amplification%20with%20erbB2%20in%20human%20primary%20breast%20cancer%20and%20breast%20cancer%20cell%20lines%3A%20relationship%20to%20m-AMSA%20and%20mitoxantrone%20sensitivity&amp;author=K%20Smith&amp;author=S%20Houlbrook&amp;author=M%20Greenall&amp;author=J%20Carmichael&amp;author=AL%20Harris&amp;publication_year=1993&amp;journal=Oncogene&amp;volume=8&amp;pages=933-8">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(46)</span><a class="rev-xref-ref" href="#xref-ref-46-1" title="View reference (46) in text"
                           id="ref-46">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.46">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kim</span>  <span class="cit-name-given-names">R</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Expression of the multidrug resistance gene in human tumors</span>. <abbr class="cit-jnl-abbrev">Hiroshima J Med Sci</abbr> <span class="cit-pub-date">1990</span>;<span class="cit-vol">39</span>:<span class="cit-fpage">71</span>-<span class="cit-lpage">7</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1980915&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Expression%20of%20the%20multidrug%20resistance%20gene%20in%20human%20tumors&amp;author=R%20Kim&amp;publication_year=1990&amp;journal=Hiroshima%20J%20Med%20Sci&amp;volume=39&amp;pages=71-7">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(47)</span><a class="rev-xref-ref" href="#xref-ref-47-1" title="View reference (47) in text"
                           id="ref-47">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.47"
                             data-doi="10.1002/(SICI)1097-0142(19960115)77:2&lt;292::AID-CNCR11&gt;3.0.CO;2-X">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chevillard</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pouillart</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Beldjord</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Asselain</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Beuzeboc</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Magdelenat</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast
                                    cancer response to neoadjuvant chemotherapy</span>. <abbr class="cit-jnl-abbrev">Cancer</abbr> <span class="cit-pub-date">1996</span>;<span class="cit-vol">77</span>:<span class="cit-fpage">292</span>-<span class="cit-lpage">300</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/(SICI)1097-0142(19960115)77:2%3C292::AID-CNCR11%3E3.0.CO;2-X&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=8625237&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1996TR25600011&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Sequential%20assessment%20of%20multidrug%20resistance%20phenotype%20and%20measurement%20of%20S-phase%20fraction%20as%20predictive%20markers%20of%20breast%20cancer%20response%20to%20neoadjuvant%20chemotherapy&amp;author=S%20Chevillard&amp;author=P%20Pouillart&amp;author=C%20Beldjord&amp;author=B%20Asselain&amp;author=P%20Beuzeboc&amp;author=H%20Magdelenat&amp;publication_year=1996&amp;journal=Cancer&amp;volume=77&amp;pages=292-300">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(48)</span><a class="rev-xref-ref" href="#xref-ref-48-1" title="View reference (48) in text"
                           id="ref-48">↵</a>
                        
                        
                        <div class="cit ref-cit ref-book" id="cit-89.13.917.48">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fleiss</span>  <span class="cit-name-given-names">JL</span></span></li>
                              </ol><cite>. <span class="cit-source">Statistical methods for rates and proportions</span>. <span class="cit-publ-loc">New York</span>: <span class="cit-publ-name">John Wiley &amp; Sons</span>; <span class="cit-pub-date">1981</span>. p. <span class="cit-fpage">33</span>-<span class="cit-lpage">46</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Statistical%20methods%20for%20rates%20and%20proportions&amp;author=JL%20Fleiss&amp;publication_year=1981">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(49)</span><a class="rev-xref-ref" href="#xref-ref-49-1" title="View reference (49) in text"
                           id="ref-49">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.49">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Snedecor</span>  <span class="cit-name-given-names">GW</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cochran</span>  <span class="cit-name-given-names">WG</span></span></li>
                              </ol><cite>. <abbr class="cit-jnl-abbrev">Statistical methods</abbr> <span class="cit-publ-loc">Ames (IA)</span>: <span class="cit-publ-name">Iowa State University Press</span>; <span class="cit-pub-date">1976</span>:<span class="cit-fpage">213</span>-<span class="cit-lpage">53</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?author=GW%20Snedecor&amp;author=WG%20Cochran&amp;publication_year=1976&amp;journal=Statistical%20methods&amp;pages=213-53">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(50)</span><a class="rev-xref-ref" href="#xref-ref-50-1" title="View reference (50) in text"
                           id="ref-50">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.50">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Greenland</span>  <span class="cit-name-given-names">S</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Quantitative methods in the review of epidemiologic literature</span>. <abbr class="cit-jnl-abbrev">Epidemiol Rev</abbr> <span class="cit-pub-date">1987</span>;<span class="cit-vol">9</span>:<span class="cit-fpage">1</span>-<span class="cit-lpage">30</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=PDF&amp;journalCode=epirev&amp;resid=9/1/1"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(51)</span><a class="rev-xref-ref" href="#xref-ref-51-1" title="View reference (51) in text"
                           id="ref-51">↵</a>
                        
                        
                        <div class="cit ref-cit ref-book" id="cit-89.13.917.51">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Breslow</span>  <span class="cit-name-given-names">NE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Day</span>  <span class="cit-name-given-names">NE</span></span></li>
                              </ol><cite>. <span class="cit-source">Statistical methods in cancer research Volume II—the design and analysis of cohort studies</span>. <span class="cit-publ-loc">Lyon</span>: <span class="cit-publ-name">IARC</span>; <span class="cit-pub-date">1987</span>. p. <span class="cit-fpage">109</span>-<span class="cit-lpage">12</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Statistical%20methods%20in%20cancer%20research%20Volume%20II%E2%80%94the%20design%20and%20analysis%20of%20cohort%20studies&amp;author=NE%20Breslow&amp;author=NE%20Day&amp;publication_year=1987">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(52)</span><a class="rev-xref-ref" href="#xref-ref-52-1" title="View reference (52) in text"
                           id="ref-52">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.52"
                             data-doi="10.2307/1402373">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Landis</span>  <span class="cit-name-given-names">RJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Heyman</span>  <span class="cit-name-given-names">ER</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Koch</span>  <span class="cit-name-given-names">GG</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Average partial association in threeway contingency tables: a review and discussion of alternative tests</span>. <abbr class="cit-jnl-abbrev">Int Stat Rev</abbr> <span class="cit-pub-date">1978</span>;<span class="cit-vol">46</span>:<span class="cit-fpage">237</span>-<span class="cit-lpage">54</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.2307/1402373&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=A1978GH11000001&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Average%20partial%20association%20in%20threeway%20contingency%20tables%3A%20a%20review%20and%20discussion%20of%20alternative%20tests&amp;author=RJ%20Landis&amp;author=ER%20Heyman&amp;author=GG%20Koch&amp;publication_year=1978&amp;journal=Int%20Stat%20Rev&amp;volume=46&amp;pages=237-54">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(53)</span><a class="rev-xref-ref" href="#xref-ref-53-1" title="View reference (53) in text"
                           id="ref-53">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.53">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kleinbaum</span>  <span class="cit-name-given-names">DG</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kupper</span>  <span class="cit-name-given-names">LL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Morgenstern</span>  <span class="cit-name-given-names">H</span></span></li>
                              </ol><cite>. <abbr class="cit-jnl-abbrev">Epidemiologic research</abbr> <span class="cit-publ-loc">New York</span>: <span class="cit-publ-name">Van Nostrand Reinhold Co.</span>; <span class="cit-pub-date">1982</span>:<span class="cit-fpage">143</span>-<span class="cit-lpage">7</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?author=DG%20Kleinbaum&amp;author=LL%20Kupper&amp;author=H%20Morgenstern&amp;publication_year=1982&amp;journal=Epidemiologic%20research&amp;pages=143-7">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(54)</span><a class="rev-xref-ref" href="#xref-ref-54-1" title="View reference (54) in text"
                           id="ref-54">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.54">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kacinski</span>  <span class="cit-name-given-names">BM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yee</span>  <span class="cit-name-given-names">LD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Carter</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Li</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kuo</span>  <span class="cit-name-given-names">MT</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Human breast carcinoma cell levels of MDR-1 (P-glycoprotein) transcripts correlate in vivo inversely and reciprocally with
                                    tumor progesterone receptor content</span>. <abbr class="cit-jnl-abbrev">Cancer Commun</abbr> <span class="cit-pub-date">1989</span>;<span class="cit-vol">1</span>:<span class="cit-fpage">1</span>-<span class="cit-lpage">6</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=2576982&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Human%20breast%20carcinoma%20cell%20levels%20of%20MDR-1%20%28P-glycoprotein%29%20transcripts%20correlate%20in%20vivo%20inversely%20and%20reciprocally%20with%20tumor%20progesterone%20receptor%20content&amp;author=BM%20Kacinski&amp;author=LD%20Yee&amp;author=D%20Carter&amp;author=D%20Li&amp;author=MT%20Kuo&amp;publication_year=1989&amp;journal=Cancer%20Commun&amp;volume=1&amp;pages=1-6">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(55)</span><a class="rev-xref-ref" href="#xref-ref-55-1" title="View reference (55) in text"
                           id="ref-55">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.55">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schneider</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bak</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Efferth</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaufmann</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mattern</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Volm</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Pglycoprotein expression in treated and untreated human breast cancer</span>. <abbr class="cit-jnl-abbrev">Br J Cancer</abbr> <span class="cit-pub-date">1989</span>;<span class="cit-vol">60</span>:<span class="cit-fpage">815</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=2574987&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1989CD41400003&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Pglycoprotein%20expression%20in%20treated%20and%20untreated%20human%20breast%20cancer&amp;author=J%20Schneider&amp;author=M%20Bak&amp;author=T%20Efferth&amp;author=M%20Kaufmann&amp;author=J%20Mattern&amp;author=M%20Volm&amp;publication_year=1989&amp;journal=Br%20J%20Cancer&amp;volume=60&amp;pages=815-8">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(56)</span><a class="rev-xref-ref" href="#xref-ref-56-1" title="View reference (56) in text"
                           id="ref-56">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.56">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Keith</span>  <span class="cit-name-given-names">WN</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Stallard</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Brown</span>  <span class="cit-name-given-names">R</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Expression of mdr1 and gst-p in human breast tumours: comparison to in vitro chemosensitivity</span>. <abbr class="cit-jnl-abbrev">Br J Cancer</abbr> <span class="cit-pub-date">1990</span>;<span class="cit-vol">61</span>:<span class="cit-fpage">712</span>-<span class="cit-lpage">6</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1970934&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1990DC88400016&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Expression%20of%20mdr1%20and%20gst-p%20in%20human%20breast%20tumours%3A%20comparison%20to%20in%20vitro%20chemosensitivity&amp;author=WN%20Keith&amp;author=S%20Stallard&amp;author=R%20Brown&amp;publication_year=1990&amp;journal=Br%20J%20Cancer&amp;volume=61&amp;pages=712-6">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(57)</span><a class="rev-xref-ref" href="#xref-ref-57-1" title="View reference (57) in text"
                           id="ref-57">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.57"
                             data-doi="10.1016/0046-8177(90)90046-8">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ro</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sahin</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ro</span>  <span class="cit-name-given-names">JY</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fritsche</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hortobagyi</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Blick</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast
                                    cancer</span>. <abbr class="cit-jnl-abbrev">Hum Pathol</abbr> <span class="cit-pub-date">1990</span>;<span class="cit-vol">21</span>:<span class="cit-fpage">787</span>-<span class="cit-lpage">91</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0046-8177(90)90046-8&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=1974874&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1990DU67900002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Immunohistochemical%20analysis%20of%20P-glycoprotein%20expression%20correlated%20with%20chemotherapy%20resistance%20in%20locally%20advanced%20breast%20cancer&amp;author=J%20Ro&amp;author=A%20Sahin&amp;author=JY%20Ro&amp;author=H%20Fritsche&amp;author=G%20Hortobagyi&amp;author=M%20Blick&amp;publication_year=1990&amp;journal=Hum%20Pathol&amp;volume=21&amp;pages=787-91">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(58)</span><a class="rev-xref-ref" href="#xref-ref-58-1" title="View reference (58) in text"
                           id="ref-58">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.58"
                             data-doi="10.1177/38.9.1974900">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cordon-Cardo</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">O'Brien</span>  <span class="cit-name-given-names">JP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Boccia</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Casals</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bertino</span>  <span class="cit-name-given-names">JR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Melamed</span>  <span class="cit-name-given-names">MR</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues</span>. <abbr class="cit-jnl-abbrev">J Histochem Cytochem</abbr> <span class="cit-pub-date">1990</span>;<span class="cit-vol">38</span>:<span class="cit-fpage">1277</span>-<span class="cit-lpage">87</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=spjhc&amp;resid=38/9/1277"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(59)</span><a class="rev-xref-ref" href="#xref-ref-59-1" title="View reference (59) in text"
                           id="ref-59">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.59">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sugawara</span>  <span class="cit-name-given-names">I</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Expression and functions of P-glycoprotein (mdr1 gene product) in normal and malignant tissues</span>. <abbr class="cit-jnl-abbrev">Acta Pathol Jpn</abbr> <span class="cit-pub-date">1990</span>;<span class="cit-vol">40</span>:<span class="cit-fpage">545</span>-<span class="cit-lpage">53</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1978461&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Expression%20and%20functions%20of%20P-glycoprotein%20%28mdr1%20gene%20product%29%20in%20normal%20and%20malignant%20tissues&amp;author=I%20Sugawara&amp;publication_year=1990&amp;journal=Acta%20Pathol%20Jpn&amp;volume=40&amp;pages=545-53">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(60)</span><a class="rev-xref-ref" href="#xref-ref-60-1" title="View reference (60) in text"
                           id="ref-60">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.60">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wallner</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Depisch</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hopfner</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Haider</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Spona</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ludwig</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">MDR1 gene expression and prognostic factors in primary breast carcinomas</span>. <abbr class="cit-jnl-abbrev">Eur J Cancer</abbr> <span class="cit-pub-date">1991</span>;<span class="cit-vol">27</span>:<span class="cit-fpage">1352</span>-<span class="cit-lpage">5</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1835847&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1991GP16900006&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=MDR1%20gene%20expression%20and%20prognostic%20factors%20in%20primary%20breast%20carcinomas&amp;author=J%20Wallner&amp;author=D%20Depisch&amp;author=M%20Hopfner&amp;author=K%20Haider&amp;author=J%20Spona&amp;author=H%20Ludwig&amp;publication_year=1991&amp;journal=Eur%20J%20Cancer&amp;volume=27&amp;pages=1352-5">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(61)</span><a class="rev-xref-ref" href="#xref-ref-61-1" title="View reference (61) in text"
                           id="ref-61">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.61"
                             data-doi="10.1093/jnci/83.2.111">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Verrelle</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Meissonnier</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fonck</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Feillel</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dionet</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kwiatkowski</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">1991</span>;<span class="cit-vol">83</span>:<span class="cit-fpage">111</span>-<span class="cit-lpage">6</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=83/2/111"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(62)</span><a class="rev-xref-ref" href="#xref-ref-62-1" title="View reference (62) in text"
                           id="ref-62">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.62">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Koh</span>  <span class="cit-name-given-names">EH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chung</span>  <span class="cit-name-given-names">HC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lee</span>  <span class="cit-name-given-names">KB</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lim</span>  <span class="cit-name-given-names">HY</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kim</span>  <span class="cit-name-given-names">JH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Roh</span>  <span class="cit-name-given-names">JK</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">The value of immunohistochemical detection of P-glycoprotein in breast cancer before and after induction chemotherapy</span>. <abbr class="cit-jnl-abbrev">Yonsei Med J</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">33</span>:<span class="cit-fpage">137</span>-<span class="cit-lpage">42</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1357834&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=The%20value%20of%20immunohistochemical%20detection%20of%20P-glycoprotein%20in%20breast%20cancer%20before%20and%20after%20induction%20chemotherapy&amp;author=EH%20Koh&amp;author=HC%20Chung&amp;author=KB%20Lee&amp;author=HY%20Lim&amp;author=JH%20Kim&amp;author=JK%20Roh&amp;publication_year=1992&amp;journal=Yonsei%20Med%20J&amp;volume=33&amp;pages=137-42">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(63)</span><a class="rev-xref-ref" href="#xref-ref-63-1" title="View reference (63) in text"
                           id="ref-63">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.63"
                             data-doi="10.1007/BF00665804">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hennequin</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Delvincourt</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pourny</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jardillier</span>  <span class="cit-name-given-names">JC</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Expression of mdr1 gene in human breast primary tumors and metastases</span>. <abbr class="cit-jnl-abbrev">Breast Cancer Res Treat</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">26</span>:<span class="cit-fpage">267</span>-<span class="cit-lpage">74</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/BF00665804&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=8251651&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1993MB09200007&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Expression%20of%20mdr1%20gene%20in%20human%20breast%20primary%20tumors%20and%20metastases&amp;author=E%20Hennequin&amp;author=C%20Delvincourt&amp;author=C%20Pourny&amp;author=JC%20Jardillier&amp;publication_year=1993&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=26&amp;pages=267-74">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(64)</span><a class="rev-xref-ref" href="#xref-ref-64-1" title="View reference (64) in text"
                           id="ref-64">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.64"
                             data-doi="10.1016/0959-8049(94)90132-5">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Veneroni</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zaffaroni</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Daidone</span>  <span class="cit-name-given-names">MG</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Benini</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Villa</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Silvestrini</span>  <span class="cit-name-given-names">R</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers</span>. <abbr class="cit-jnl-abbrev">Eur J Cancer</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">30A</span>:<span class="cit-fpage">1002</span>-<span class="cit-lpage">7</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0959-8049(94)90132-5&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Expression%20of%20P-glycoprotein%20and%20in%20vitro%20or%20in%20vivo%20resistance%20to%20doxorubicin%20and%20cisplatin%20in%20breast%20and%20ovarian%20cancers&amp;author=S%20Veneroni&amp;author=N%20Zaffaroni&amp;author=MG%20Daidone&amp;author=E%20Benini&amp;author=R%20Villa&amp;author=R%20Silvestrini&amp;publication_year=1994&amp;journal=Eur%20J%20Cancer&amp;volume=30A&amp;pages=1002-7">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(65)</span><a class="rev-xref-ref" href="#xref-ref-65-1" title="View reference (65) in text"
                           id="ref-65">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.65"
                             data-doi="10.1093/jnci/86.20.1539">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Charpin</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vielh</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Duffaud</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Devictor</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Andrac</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lavaut</span>  <span class="cit-name-given-names">MN</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and
                                    to immunohistochemical prognostic indicators</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">86</span>:<span class="cit-fpage">1539</span>-<span class="cit-lpage">45</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=86/20/1539"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(66)</span><a class="rev-xref-ref" href="#xref-ref-66-1" title="View reference (66) in text"
                           id="ref-66">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.66">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wishart</span>  <span class="cit-name-given-names">GC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Plumb</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Going</span>  <span class="cit-name-given-names">JJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">McNicol</span>  <span class="cit-name-given-names">AM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">McArdle</span>  <span class="cit-name-given-names">CS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tsuruo</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">P-glycoprotin expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies</span>. <abbr class="cit-jnl-abbrev">Br J Cancer</abbr> <span class="cit-pub-date">1990</span>;<span class="cit-vol">62</span>:<span class="cit-fpage">758</span>-<span class="cit-lpage">61</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1978783&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1990EE83000012&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=P-glycoprotin%20expression%20in%20primary%20breast%20cancer%20detected%20by%20immunocytochemistry%20with%20two%20monoclonal%20antibodies&amp;author=GC%20Wishart&amp;author=JA%20Plumb&amp;author=JJ%20Going&amp;author=AM%20McNicol&amp;author=CS%20McArdle&amp;author=T%20Tsuruo&amp;publication_year=1990&amp;journal=Br%20J%20Cancer&amp;volume=62&amp;pages=758-61">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(67)</span><a class="rev-xref-ref" href="#xref-ref-67-1" title="View reference (67) in text"
                           id="ref-67">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.67"
                             data-doi="10.1016/S0140-6736(94)90169-4">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Keen</span>  <span class="cit-name-given-names">JC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Miller</span>  <span class="cit-name-given-names">EP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bellamy</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dixon</span>  <span class="cit-name-given-names">JM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Miller</span>  <span class="cit-name-given-names">WR</span></span></li>
                              </ol><cite>. <span class="cit-article-title">P-glycoprotein and resistance to tamoxifen</span>. <abbr class="cit-jnl-abbrev">Lancet</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">343</span>:<span class="cit-fpage">1047</span>-<span class="cit-lpage">8</span>. <span class="cit-comment">[letter]</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0140-6736(94)90169-4&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7909083&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1994NG68200057&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=P-glycoprotein%20and%20resistance%20to%20tamoxifen&amp;author=JC%20Keen&amp;author=EP%20Miller&amp;author=C%20Bellamy&amp;author=JM%20Dixon&amp;author=WR%20Miller&amp;publication_year=1994&amp;journal=Lancet&amp;volume=343&amp;pages=1047-8">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(68)</span><a class="rev-xref-ref" href="#xref-ref-68-1" title="View reference (68) in text"
                           id="ref-68">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.68">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dixon</span>  <span class="cit-name-given-names">AR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bell</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ellis</span>  <span class="cit-name-given-names">IO</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Elston</span>  <span class="cit-name-given-names">CW</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Blamey</span>  <span class="cit-name-given-names">RW</span></span></li>
                              </ol><cite>. <span class="cit-article-title">P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy</span>. <abbr class="cit-jnl-abbrev">Br J Cancer</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">66</span>:<span class="cit-fpage">53</span>-<span class="cit-lpage">41</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=P-glycoprotein%20expression%20in%20locally%20advanced%20breast%20cancer%20treated%20by%20neoadjuvant%20chemotherapy&amp;author=AR%20Dixon&amp;author=J%20Bell&amp;author=IO%20Ellis&amp;author=CW%20Elston&amp;author=RW%20Blamey&amp;publication_year=1992&amp;journal=Br%20J%20Cancer&amp;volume=66&amp;pages=53-41">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(69)</span><a class="rev-xref-ref" href="#xref-ref-69-1" title="View reference (69) in text"
                           id="ref-69">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.69">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Botti</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chiappetta</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">D'Aiuto</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">de Angelis</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">De Matteis</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Montella</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">PCNA/cyclin and P-glycoprotein as prognostic factors in locally advanced breast cancer. An immunohistochemical, retrospective
                                    study</span>. <abbr class="cit-jnl-abbrev">Tumori</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">79</span>:<span class="cit-fpage">214</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=7901927&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1993MA79100012&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=PCNA%2Fcyclin%20and%20P-glycoprotein%20as%20prognostic%20factors%20in%20locally%20advanced%20breast%20cancer.%20An%20immunohistochemical%2C%20retrospective%20study&amp;author=G%20Botti&amp;author=G%20Chiappetta&amp;author=G%20D%27Aiuto&amp;author=E%20de%20Angelis&amp;author=A%20De%20Matteis&amp;author=M%20Montella&amp;publication_year=1993&amp;journal=Tumori&amp;volume=79&amp;pages=214-8">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(70)</span><a class="rev-xref-ref" href="#xref-ref-70-1" title="View reference (70) in text"
                           id="ref-70">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.70"
                             data-doi="10.1093/jnci/86.11.850">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schneider</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rubio</span>  <span class="cit-name-given-names">MP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Barbazan</span>  <span class="cit-name-given-names">MJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rodriguez-Escudero</span>  <span class="cit-name-given-names">FJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Seizinger</span>  <span class="cit-name-given-names">BR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Castresana</span>  <span class="cit-name-given-names">JS</span></span></li>
                              </ol><cite>. <span class="cit-article-title">P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">86</span>:<span class="cit-fpage">850</span>-<span class="cit-lpage">5</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=86/11/850"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(71)</span><a class="rev-xref-ref" href="#xref-ref-71-1" title="View reference (71) in text"
                           id="ref-71">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.71">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Linn</span>  <span class="cit-name-given-names">SC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Giaccone</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">van Diest</span>  <span class="cit-name-given-names">PJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Blokhuis</span>  <span class="cit-name-given-names">WM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">van der Valk</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">van Kalken</span>  <span class="cit-name-given-names">CK</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Prognostic relevance of P-glycoprotein expression in breast cancer</span>. <abbr class="cit-jnl-abbrev">Ann Oncol</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">6</span>:<span class="cit-fpage">679</span>-<span class="cit-lpage">85</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=6/7/679"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(72)</span><a class="rev-xref-ref" href="#xref-ref-72-1" title="View reference (72) in text"
                           id="ref-72">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.72">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Luowen</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chunyi</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Benyao</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yi</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fei</span>  <span class="cit-name-given-names">G</span></span></li>
                              </ol><cite>. <span class="cit-article-title">P-glycoprotein expression in primary breast cancer</span>. <abbr class="cit-jnl-abbrev">Chin Med Sci J</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">12</span>:<span class="cit-fpage">12</span>-<span class="cit-lpage">5</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=P-glycoprotein%20expression%20in%20primary%20breast%20cancer&amp;author=H%20Luowen&amp;author=H%20Chunyi&amp;author=L%20Benyao&amp;author=W%20Yi&amp;author=G%20Fei&amp;publication_year=1995&amp;journal=Chin%20Med%20Sci%20J&amp;volume=12&amp;pages=12-5">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(73)</span><a class="rev-xref-ref" href="#xref-ref-73-1" title="View reference (73) in text"
                           id="ref-73">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.73"
                             data-doi="10.1007/BF00690186">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Seymour</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bezwoda</span>  <span class="cit-name-given-names">WR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dansey</span>  <span class="cit-name-given-names">RD</span></span></li>
                              </ol><cite>. <span class="cit-article-title">P-glycoprotein immunostaining correlates with ER and with high Ki67 expression but fails to predict anthracycline resistance
                                    in patients with advanced breast cancer</span>. <abbr class="cit-jnl-abbrev">Breast Cancer Res Treat</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">36</span>:<span class="cit-fpage">61</span>-<span class="cit-lpage">9</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/BF00690186&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7579508&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1995RJ18900008&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=P-glycoprotein%20immunostaining%20correlates%20with%20ER%20and%20with%20high%20Ki67%20expression%20but%20fails%20to%20predict%20anthracycline%20resistance%20in%20patients%20with%20advanced%20breast%20cancer&amp;author=L%20Seymour&amp;author=WR%20Bezwoda&amp;author=RD%20Dansey&amp;publication_year=1995&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=36&amp;pages=61-9">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(74)</span><a class="rev-xref-ref" href="#xref-ref-74-1" title="View reference (74) in text"
                           id="ref-74">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.74">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Decker</span>  <span class="cit-name-given-names">DA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Morris</span>  <span class="cit-name-given-names">LW</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Levine</span>  <span class="cit-name-given-names">AJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pettinga</span>  <span class="cit-name-given-names">JE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Grudzien</span>  <span class="cit-name-given-names">JL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Farkas</span>  <span class="cit-name-given-names">DH</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Immunohistochemical analysis of P-glycoprotein expression in breast cancer: clinical correlations</span>. <abbr class="cit-jnl-abbrev">Ann Clin Lab Sci</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">25</span>:<span class="cit-fpage">52</span>-<span class="cit-lpage">9</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=acls&amp;resid=25/1/52"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(75)</span><a class="rev-xref-ref" href="#xref-ref-75-1" title="View reference (75) in text"
                           id="ref-75">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.75">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schneider</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Romero</span>  <span class="cit-name-given-names">H</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Correlation of P-glycoprotein overexpression and cellular prognostic factors in formalin-fixed, paraffin-embedded tumor samples
                                    from breast cancer patients</span>. <abbr class="cit-jnl-abbrev">Anticancer Res</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">15</span>:<span class="cit-fpage">1117</span>-<span class="cit-lpage">21</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=7645934&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1995RP34800078&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Correlation%20of%20P-glycoprotein%20overexpression%20and%20cellular%20prognostic%20factors%20in%20formalin-fixed%2C%20paraffin-embedded%20tumor%20samples%20from%20breast%20cancer%20patients&amp;author=J%20Schneider&amp;author=H%20Romero&amp;publication_year=1995&amp;journal=Anticancer%20Res&amp;volume=15&amp;pages=1117-21">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(76)</span><a class="rev-xref-ref" href="#xref-ref-76-1" title="View reference (76) in text"
                           id="ref-76">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.76"
                             data-doi="10.1016/0959-8049(95)00552-8">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">O'Driscoll</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kennedy</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">McDermott</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kelehan</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Clynes</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Multiple drug resistance-related messenger RNA expression in archival formalinfixed paraffin-embedded human breast tumour
                                    tissue</span>. <abbr class="cit-jnl-abbrev">Eur J Cancer</abbr> <span class="cit-pub-date">1996</span>;<span class="cit-vol">32A</span>:<span class="cit-fpage">128</span>-<span class="cit-lpage">33</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0959-8049(95)00552-8&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Multiple%20drug%20resistance-related%20messenger%20RNA%20expression%20in%20archival%20formalinfixed%20paraffin-embedded%20human%20breast%20tumour%20tissue&amp;author=L%20O%27Driscoll&amp;author=S%20Kennedy&amp;author=E%20McDermott&amp;author=P%20Kelehan&amp;author=M%20Clynes&amp;publication_year=1996&amp;journal=Eur%20J%20Cancer&amp;volume=32A&amp;pages=128-33">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(77)</span><a class="rev-xref-ref" href="#xref-ref-77-1" title="View reference (77) in text"
                           id="ref-77">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.77"
                             data-doi="10.1002/ijc.2910510503">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lonn</span>  <span class="cit-name-given-names">U</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lonn</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nylen</span>  <span class="cit-name-given-names">U</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Stenkvist</span>  <span class="cit-name-given-names">B</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Appearance and detection of multiple copies of the mdr-1 gene in clinical samples of mammary carcinoma</span>. <abbr class="cit-jnl-abbrev">Int J Cancer</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">51</span>:<span class="cit-fpage">682</span>-<span class="cit-lpage">6</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/ijc.2910510503&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=1612774&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1992JD22500002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Appearance%20and%20detection%20of%20multiple%20copies%20of%20the%20mdr-1%20gene%20in%20clinical%20samples%20of%20mammary%20carcinoma&amp;author=U%20Lonn&amp;author=S%20Lonn&amp;author=U%20Nylen&amp;author=B%20Stenkvist&amp;publication_year=1992&amp;journal=Int%20J%20Cancer&amp;volume=51&amp;pages=682-6">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(78)</span><a class="rev-xref-ref" href="#xref-ref-78-1" title="View reference (78) in text"
                           id="ref-78">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.78">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kim</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hirabayashi</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nishiyama</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Saeki</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Toge</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Okada</span>  <span class="cit-name-given-names">K</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Expression of MDR1, GST-p and topoisomerase II as an indicator of clinical response to adriamycin</span>. <abbr class="cit-jnl-abbrev">Anticancer Res</abbr> <span class="cit-pub-date">1991</span>;<span class="cit-vol">11</span>:<span class="cit-fpage">429</span>-<span class="cit-lpage">31</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1850221&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1991FF99600066&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Expression%20of%20MDR1%2C%20GST-p%20and%20topoisomerase%20II%20as%20an%20indicator%20of%20clinical%20response%20to%20adriamycin&amp;author=R%20Kim&amp;author=N%20Hirabayashi&amp;author=M%20Nishiyama&amp;author=S%20Saeki&amp;author=T%20Toge&amp;author=K%20Okada&amp;publication_year=1991&amp;journal=Anticancer%20Res&amp;volume=11&amp;pages=429-31">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(79)</span><a class="rev-xref-ref" href="#xref-ref-79-1" title="View reference (79) in text"
                           id="ref-79">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.79"
                             data-doi="10.1097/00019606-199506000-00010">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Scala</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Saeki</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lynch</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Salomon</span>  <span class="cit-name-given-names">DS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Merino</span>  <span class="cit-name-given-names">MJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bates</span>  <span class="cit-name-given-names">SE</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Coexpression of TGF a, epidermal growth factor receptor, and P-glycoprotein in normal and benign breast tissues</span>. <abbr class="cit-jnl-abbrev">Diagn Mol Pathol</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">4</span>:<span class="cit-fpage">136</span>-<span class="cit-lpage">42</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1097/00019606-199506000-00010&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7551294&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1995QY36600010&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Coexpression%20of%20TGF%20a%2C%20epidermal%20growth%20factor%20receptor%2C%20and%20P-glycoprotein%20in%20normal%20and%20benign%20breast%20tissues&amp;author=S%20Scala&amp;author=T%20Saeki&amp;author=A%20Lynch&amp;author=DS%20Salomon&amp;author=MJ%20Merino&amp;author=SE%20Bates&amp;publication_year=1995&amp;journal=Diagn%20Mol%20Pathol&amp;volume=4&amp;pages=136-42">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(80)</span><a class="rev-xref-ref" href="#xref-ref-80-1" title="View reference (80) in text"
                           id="ref-80">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.80">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sugawara</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kataoka</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Morishita</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hamada</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tsuruo</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Itoyama</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1988</span>;<span class="cit-vol">48</span>:<span class="cit-fpage">1926</span>-<span class="cit-lpage">9</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=48/7/1926"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(81)</span><a class="rev-xref-ref" href="#xref-ref-81-1" title="View reference (81) in text"
                           id="ref-81">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.81">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">van der Heyden</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gheuens</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">DeBruijn</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Van Oosterom</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Maes</span>  <span class="cit-name-given-names">R</span></span></li>
                              </ol><cite>. <span class="cit-article-title">P-glycoprotein: clinical significance and methods of analysis</span>. <abbr class="cit-jnl-abbrev">Crit Rev Clin Lab Sci</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">32</span>:<span class="cit-fpage">221</span>-<span class="cit-lpage">64</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=7495497&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1995RG24700001&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=P-glycoprotein%3A%20clinical%20significance%20and%20methods%20of%20analysis&amp;author=S%20van%20der%20Heyden&amp;author=E%20Gheuens&amp;author=E%20DeBruijn&amp;author=A%20Van%20Oosterom&amp;author=R%20Maes&amp;publication_year=1995&amp;journal=Crit%20Rev%20Clin%20Lab%20Sci&amp;volume=32&amp;pages=221-64">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(82)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.82"
                             data-doi="10.1159/000217831">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bittl</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nap</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jager</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lathan</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lang</span>  <span class="cit-name-given-names">N</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Immunohistochemical detection of P-glycoprotein in normal and malignant tissues: a comparative study of three monoclonal antibodies,
                                    JSB-1, C 219 and 265/F4, against different epitopes using frozen and paraffin tissue sections</span>. <abbr class="cit-jnl-abbrev">Tumour Biol</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">14</span>:<span class="cit-fpage">155</span>-<span class="cit-lpage">66</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1159/000217831&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7692586&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Immunohistochemical%20detection%20of%20P-glycoprotein%20in%20normal%20and%20malignant%20tissues%3A%20a%20comparative%20study%20of%20three%20monoclonal%20antibodies%2C%20JSB-1%2C%20C%20219%20and%20265%2FF4%2C%20against%20different%20epitopes%20using%20frozen%20and%20paraffin%20tissue%20sections&amp;author=A%20Bittl&amp;author=M%20Nap&amp;author=W%20Jager&amp;author=B%20Lathan&amp;author=N%20Lang&amp;publication_year=1993&amp;journal=Tumour%20Biol&amp;volume=14&amp;pages=155-66">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(83)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.83"
                             data-doi="10.1073/pnas.87.1.152">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Georges</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bradley</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gariepy</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ling</span>  <span class="cit-name-given-names">V</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies</span>. <abbr class="cit-jnl-abbrev">Proc Natl Acad Sci U S A</abbr> <span class="cit-pub-date">1990</span>;<span class="cit-vol">87</span>:<span class="cit-fpage">152</span>-<span class="cit-lpage">6</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=87/1/152"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(84)</span><a class="rev-xref-ref" href="#xref-ref-84-1" title="View reference (84) in text"
                           id="ref-84">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.84"
                             data-doi="10.1177/37.2.2463300">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Thiebaut</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tsuruo</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hamada</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gottesman</span>  <span class="cit-name-given-names">MM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pastan</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Willingham</span>  <span class="cit-name-given-names">MC</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence
                                    for localization in brain capillaries and crossreactivity of one antibody with a muscle protein</span>. <abbr class="cit-jnl-abbrev">J Histochem Cytochem</abbr> <span class="cit-pub-date">1989</span>;<span class="cit-vol">37</span>:<span class="cit-fpage">159</span>-<span class="cit-lpage">64</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=spjhc&amp;resid=37/2/159"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(85)</span><a class="rev-xref-ref" href="#xref-ref-85-1" title="View reference (85) in text"
                           id="ref-85">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.85"
                             data-doi="10.1177/43.12.8537634">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rao</span>  <span class="cit-name-given-names">VV</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Anthony</span>  <span class="cit-name-given-names">DC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Piwnica-Worms</span>  <span class="cit-name-given-names">D</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Multidrug resistance Pglycoprotein monoclonal antibody JSB-1 crossreacts with pyruvate carboxylase</span>. <abbr class="cit-jnl-abbrev">J Histochem Cytochem</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">43</span>:<span class="cit-fpage">1187</span>-<span class="cit-lpage">92</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=spjhc&amp;resid=43/12/1187"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(86)</span><a class="rev-xref-ref" href="#xref-ref-86-1" title="View reference (86) in text"
                           id="ref-86">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.86">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rao</span>  <span class="cit-name-given-names">VV</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Anthony</span>  <span class="cit-name-given-names">DC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Piwnica-Worms</span>  <span class="cit-name-given-names">D</span></span></li>
                              </ol><cite>. <span class="cit-article-title">MDR1 gene-specific monoclonal antibody C494 cross-reacts with pyruvate carboxylase</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">54</span>:<span class="cit-fpage">1536</span>-<span class="cit-lpage">41</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=54/6/1536"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(87)</span><a class="rev-xref-ref" href="#xref-ref-87-1" title="View reference (87) in text"
                           id="ref-87">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.87">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schinkel</span>  <span class="cit-name-given-names">AH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Roelofs</span>  <span class="cit-name-given-names">EM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Borst</span>  <span class="cit-name-given-names">P</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1991</span>;<span class="cit-vol">51</span>:<span class="cit-fpage">2628</span>-<span class="cit-lpage">35</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=51/10/2628"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(88)</span><a class="rev-xref-ref" href="#xref-ref-88-1" title="View reference (88) in text"
                           id="ref-88">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.88"
                             data-doi="10.1016/1040-8428(92)90062-U">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Clarke</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dickson</span>  <span class="cit-name-given-names">RB</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lippman</span>  <span class="cit-name-given-names">ME</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions</span>. <abbr class="cit-jnl-abbrev">Crit Rev Oncol Hematol</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">12</span>:<span class="cit-fpage">1</span>-<span class="cit-lpage">23</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/1040-8428(92)90062-U&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=1540336&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1992HD20400001&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Hormonal%20aspects%20of%20breast%20cancer.%20Growth%20factors%2C%20drugs%20and%20stromal%20interactions&amp;author=R%20Clarke&amp;author=RB%20Dickson&amp;author=ME%20Lippman&amp;publication_year=1992&amp;journal=Crit%20Rev%20Oncol%20Hematol&amp;volume=12&amp;pages=1-23">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(89)</span><a class="rev-xref-ref" href="#xref-ref-89-1" title="View reference (89) in text"
                           id="ref-89">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.89">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaye</span>  <span class="cit-name-given-names">SB</span></span></li>
                              </ol><cite>. <span class="cit-article-title">P-glycoprotein (P-gp) and drug resistance—time for reappraisal?</span> <abbr class="cit-jnl-abbrev">Br J Cancer</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">67</span>:<span class="cit-fpage">641</span>-<span class="cit-lpage">3</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=8097103&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1993KV24700002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=P-glycoprotein%20%28P-gp%29%20and%20drug%20resistance%E2%80%94time%20for%20reappraisal%3F&amp;author=SB%20Kaye&amp;publication_year=1993&amp;journal=Br%20J%20Cancer&amp;volume=67&amp;pages=641-3">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(90)</span><a class="rev-xref-ref" href="#xref-ref-90-1" title="View reference (90) in text"
                           id="ref-90">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.90"
                             data-doi="10.1073/pnas.85.12.4486">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pastan</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gottesman</span>  <span class="cit-name-given-names">MM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ueda</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lovelace</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rutherford</span>  <span class="cit-name-given-names">AV</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Willingham</span>  <span class="cit-name-given-names">MC</span></span></li>
                              </ol><cite>. <span class="cit-article-title">A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells</span>. <abbr class="cit-jnl-abbrev">Proc Natl Acad Sci U S A</abbr> <span class="cit-pub-date">1988</span>;<span class="cit-vol">85</span>:<span class="cit-fpage">4486</span>-<span class="cit-lpage">90</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=85/12/4486"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(91)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.91"
                             data-doi="10.1093/jnci/84.19.1506">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Clarke</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Currier</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaplan</span>  <span class="cit-name-given-names">O</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lovelace</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Boulay</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gottesman</span>  <span class="cit-name-given-names">MM</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">1992</span>;<span class="cit-vol">84</span>:<span class="cit-fpage">1506</span>-<span class="cit-lpage">12</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=84/19/1506"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(92)</span><a class="rev-xref-ref" href="#xref-ref-92-1" title="View reference (92) in text"
                           id="ref-92">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.92">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Leonessa</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Green</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Licht</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wright</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wingate-Legette</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lippman</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer</span>. <abbr class="cit-jnl-abbrev">Br J Cancer</abbr> <span class="cit-pub-date">1996</span>;<span class="cit-vol">73</span>:<span class="cit-fpage">154</span>-<span class="cit-lpage">61</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=8546900&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1996TP07800005&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=MDA435%2FLCC6%20and%20MDA435%2FLCC6MDR1%3A%20ascites%20models%20of%20human%20breast%20cancer&amp;author=F%20Leonessa&amp;author=D%20Green&amp;author=T%20Licht&amp;author=A%20Wright&amp;author=K%20Wingate-Legette&amp;author=J%20Lippman&amp;publication_year=1996&amp;journal=Br%20J%20Cancer&amp;volume=73&amp;pages=154-61">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(93)</span><a class="rev-xref-ref" href="#xref-ref-93-1" title="View reference (93) in text"
                           id="ref-93">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.93">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Light</span>  <span class="cit-name-given-names">RJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pillemer</span>  <span class="cit-name-given-names">DB</span></span></li>
                              </ol><cite>. <abbr class="cit-jnl-abbrev">Summing up: the science of reviewing research</abbr> <span class="cit-publ-loc">Cambridge (MA)</span>: <span class="cit-publ-name">Harvard University Press</span>; <span class="cit-pub-date">1984</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?author=RJ%20Light&amp;author=DB%20Pillemer&amp;publication_year=1984&amp;journal=Summing%20up%3A%20the%20science%20of%20reviewing%20research">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(94)</span><a class="rev-xref-ref" href="#xref-ref-94-1" title="View reference (94) in text"
                           id="ref-94">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.94">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Beck</span>  <span class="cit-name-given-names">WT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Grogan</span>  <span class="cit-name-given-names">TM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Willman</span>  <span class="cit-name-given-names">CL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cordon-Cardo</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Parham</span>  <span class="cit-name-given-names">DM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kuttesch</span>  <span class="cit-name-given-names">JF</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1996</span>;<span class="cit-vol">56</span>:<span class="cit-fpage">3010</span>-<span class="cit-lpage">20</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=56/13/3010"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(95)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.95"
                             data-doi="10.1016/0145-2126(94)00137-Y">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hamblin</span>  <span class="cit-name-given-names">TJ</span></span></li>
                              </ol><cite>. <span class="cit-article-title">1st international conference on reversal of multidrug resistance in cancer</span>. <abbr class="cit-jnl-abbrev">Leuk Res</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">19</span>:<span class="cit-fpage">427</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0145-2126(94)00137-Y&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7596156&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1995RD72500009&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=1st%20international%20conference%20on%20reversal%20of%20multidrug%20resistance%20in%20cancer&amp;author=TJ%20Hamblin&amp;publication_year=1995&amp;journal=Leuk%20Res&amp;volume=19&amp;pages=427-8">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(96)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.96"
                             data-doi="10.1016/0959-8049(96)00045-7">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Broxterman</span>  <span class="cit-name-given-names">HJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lankelma</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pinedo</span>  <span class="cit-name-given-names">HM</span></span></li>
                              </ol><cite>. <span class="cit-article-title">How to probe clinical tumour samples for P-glycoprotein and multidrug resistance-associated protein</span>. <abbr class="cit-jnl-abbrev">Eur J Cancer</abbr> <span class="cit-pub-date">1996</span>;<span class="cit-vol">32A</span>:<span class="cit-fpage">1024</span>-<span class="cit-lpage">33</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0959-8049(96)00045-7&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=How%20to%20probe%20clinical%20tumour%20samples%20for%20P-glycoprotein%20and%20multidrug%20resistance-associated%20protein&amp;author=HJ%20Broxterman&amp;author=J%20Lankelma&amp;author=HM%20Pinedo&amp;publication_year=1996&amp;journal=Eur%20J%20Cancer&amp;volume=32A&amp;pages=1024-33">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(97)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.97">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fuqua</span>  <span class="cit-name-given-names">SA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fitzgerald</span>  <span class="cit-name-given-names">SD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">McGuire</span>  <span class="cit-name-given-names">WL</span></span></li>
                              </ol><cite>. <span class="cit-article-title">A simple polymerase chain reaction method for detecting and cloning of low-abundance transcripts</span>. <abbr class="cit-jnl-abbrev">Biotechniques</abbr> <span class="cit-pub-date">1990</span>;<span class="cit-vol">9</span>:<span class="cit-fpage">206</span>-<span class="cit-lpage">11</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1698071&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1990DW28900013&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=A%20simple%20polymerase%20chain%20reaction%20method%20for%20detecting%20and%20cloning%20of%20low-abundance%20transcripts&amp;author=SA%20Fuqua&amp;author=SD%20Fitzgerald&amp;author=WL%20McGuire&amp;publication_year=1990&amp;journal=Biotechniques&amp;volume=9&amp;pages=206-11">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(98)</span><a class="rev-xref-ref" href="#xref-ref-98-1" title="View reference (98) in text"
                           id="ref-98">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.98">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Grogan</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dalton</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rybski</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Spier</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Meltzer</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Richter</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies</span>. <abbr class="cit-jnl-abbrev">Lab Invest</abbr> <span class="cit-pub-date">1990</span>;<span class="cit-vol">63</span>:<span class="cit-fpage">815</span>-<span class="cit-lpage">24</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1979362&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1990EP75900012&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Optimization%20of%20immunocytochemical%20P-glycoprotein%20assessment%20in%20multidrug-resistant%20plasma%20cell%20myeloma%20using%20three%20antibodies&amp;author=T%20Grogan&amp;author=W%20Dalton&amp;author=J%20Rybski&amp;author=C%20Spier&amp;author=P%20Meltzer&amp;author=L%20Richter&amp;publication_year=1990&amp;journal=Lab%20Invest&amp;volume=63&amp;pages=815-24">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(99)</span><a class="rev-xref-ref" href="#xref-ref-99-1" title="View reference (99) in text"
                           id="ref-99">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.99">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kamby</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Andersen</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ejlertsen</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Birkler</span>  <span class="cit-name-given-names">NE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rytter</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zedeler</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Histological grade and steroid receptor content of primary breast cancer—impact on prognosis and possible modes of action</span>. <abbr class="cit-jnl-abbrev">Br J Cancer</abbr> <span class="cit-pub-date">1988</span>;<span class="cit-vol">58</span>:<span class="cit-fpage">480</span>-<span class="cit-lpage">6</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=3207602&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1988R014000016&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Histological%20grade%20and%20steroid%20receptor%20content%20of%20primary%20breast%20cancer%E2%80%94impact%20on%20prognosis%20and%20possible%20modes%20of%20action&amp;author=C%20Kamby&amp;author=J%20Andersen&amp;author=B%20Ejlertsen&amp;author=NE%20Birkler&amp;author=L%20Rytter&amp;author=K%20Zedeler&amp;publication_year=1988&amp;journal=Br%20J%20Cancer&amp;volume=58&amp;pages=480-6">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(100)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.100">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Andersen</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Thorpe</span>  <span class="cit-name-given-names">SM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">King</span>  <span class="cit-name-given-names">WJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rose</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Christensen</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rasmussen</span>  <span class="cit-name-given-names">BB</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that
                                    of steroidbinding assay</span>. <abbr class="cit-jnl-abbrev">Eur J Cancer</abbr> <span class="cit-pub-date">1990</span>;<span class="cit-vol">26</span>:<span class="cit-fpage">442</span>-<span class="cit-lpage">9</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1694085&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1990DH95000009&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=The%20prognostic%20value%20of%20immunohistochemical%20estrogen%20receptor%20analysis%20in%20paraffin-embedded%20and%20frozen%20sections%20versus%20that%20of%20steroidbinding%20assay&amp;author=J%20Andersen&amp;author=SM%20Thorpe&amp;author=WJ%20King&amp;author=C%20Rose&amp;author=I%20Christensen&amp;author=BB%20Rasmussen&amp;publication_year=1990&amp;journal=Eur%20J%20Cancer&amp;volume=26&amp;pages=442-9">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(101)</span><a class="rev-xref-ref" href="#xref-ref-101-1"
                           title="View reference (101) in text"
                           id="ref-101">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.101">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Foekens</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Portengen</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">van Putten</span>  <span class="cit-name-given-names">WL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Peters</span>  <span class="cit-name-given-names">HA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Krijnen</span>  <span class="cit-name-given-names">HL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Alexieva-Figusch</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1989</span>;<span class="cit-vol">49</span>:<span class="cit-fpage">5823</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=49/21/5823"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(102)</span><a class="rev-xref-ref" href="#xref-ref-102-1"
                           title="View reference (102) in text"
                           id="ref-102">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.102">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">De Potter</span>  <span class="cit-name-given-names">CR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schelfhout</span>  <span class="cit-name-given-names">AM</span></span></li>
                              </ol><cite>. <span class="cit-article-title">The neu-protein and breast cancer</span>. <abbr class="cit-jnl-abbrev">Virchows Arch</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">426</span>:<span class="cit-fpage">107</span>-<span class="cit-lpage">15</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=7757280&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1995QZ11100002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=The%20neu-protein%20and%20breast%20cancer&amp;author=CR%20De%20Potter&amp;author=AM%20Schelfhout&amp;publication_year=1995&amp;journal=Virchows%20Arch&amp;volume=426&amp;pages=107-15">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(103)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.103"
                             data-doi="10.1056/NEJM199405053301802">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Muss</span>  <span class="cit-name-given-names">HB</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Thor</span>  <span class="cit-name-given-names">AD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Berry</span>  <span class="cit-name-given-names">DA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kute</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Liu</span>  <span class="cit-name-given-names">ET</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Koerner</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer</span>. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">330</span>:<span class="cit-fpage">1260</span>-<span class="cit-lpage">6</span>. <span class="cit-comment">[published erratum appears in N Engl J Med 1994;331:211]</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1056/NEJM199405053301802&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7908410&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1994NJ51200002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=c-erbB-2%20expression%20and%20response%20to%20adjuvant%20therapy%20in%20women%20with%20node-positive%20early%20breast%20cancer&amp;author=HB%20Muss&amp;author=AD%20Thor&amp;author=DA%20Berry&amp;author=T%20Kute&amp;author=ET%20Liu&amp;author=F%20Koerner&amp;publication_year=1994&amp;journal=N%20Engl%20J%20Med&amp;volume=330&amp;pages=1260-6">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(104)</span><a class="rev-xref-ref" href="#xref-ref-104-1"
                           title="View reference (104) in text"
                           id="ref-104">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.104">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Greenblatt</span>  <span class="cit-name-given-names">MS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bennett</span>  <span class="cit-name-given-names">WP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hollstein</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Harris</span>  <span class="cit-name-given-names">CC</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">54</span>:<span class="cit-fpage">4855</span>-<span class="cit-lpage">78</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=PDF&amp;journalCode=canres&amp;resid=54/18/4855"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(105)</span><a class="rev-xref-ref" href="#xref-ref-105-1"
                           title="View reference (105) in text"
                           id="ref-105">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.105"
                             data-doi="10.1007/BF00683196">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Elledge</span>  <span class="cit-name-given-names">RM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fuqua</span>  <span class="cit-name-given-names">SA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Clark</span>  <span class="cit-name-given-names">GM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pujol</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Allred</span>  <span class="cit-name-given-names">DC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">William</span>  <span class="cit-name-given-names">L</span></span></li>
                              </ol><cite>. <span class="cit-article-title">McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancer</span>. <abbr class="cit-jnl-abbrev">Breast Cancer Res Treat</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">27</span>:<span class="cit-fpage">95</span>-<span class="cit-lpage">102</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/BF00683196&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=8260732&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1993MB09300009&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=McGuire%20Memorial%20Symposium.%20The%20role%20and%20prognostic%20significance%20of%20p53%20gene%20alterations%20in%20breast%20cancer&amp;author=RM%20Elledge&amp;author=SA%20Fuqua&amp;author=GM%20Clark&amp;author=P%20Pujol&amp;author=DC%20Allred&amp;author=L%20William&amp;publication_year=1993&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=27&amp;pages=95-102">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(106)</span><a class="rev-xref-ref" href="#xref-ref-106-1"
                           title="View reference (106) in text"
                           id="ref-106">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.106"
                             data-doi="10.1001/archotol.1993.01880190049010">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pavelic</span>  <span class="cit-name-given-names">ZP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Reising</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pavelic</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kelley</span>  <span class="cit-name-given-names">DJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Stambrook</span>  <span class="cit-name-given-names">PJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gluckman</span>  <span class="cit-name-given-names">JL</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Detection of p-glycoprotein with four monoclonal antibodies in normal and tumor tissues</span>. <abbr class="cit-jnl-abbrev">Arch Otolaryngol Head Neck Surg</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">119</span>:<span class="cit-fpage">753</span>-<span class="cit-lpage">7</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1001/archotol.1993.01880190049010&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=8100425&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1993LL82600008&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Detection%20of%20p-glycoprotein%20with%20four%20monoclonal%20antibodies%20in%20normal%20and%20tumor%20tissues&amp;author=ZP%20Pavelic&amp;author=J%20Reising&amp;author=L%20Pavelic&amp;author=DJ%20Kelley&amp;author=PJ%20Stambrook&amp;author=JL%20Gluckman&amp;publication_year=1993&amp;journal=Arch%20Otolaryngol%20Head%20Neck%20Surg&amp;volume=119&amp;pages=753-7">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(107)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.107">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Paterson</span>  <span class="cit-name-given-names">AH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cyr</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Szafran</span>  <span class="cit-name-given-names">O</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lees</span>  <span class="cit-name-given-names">AW</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hanson</span>  <span class="cit-name-given-names">J</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Response to treatment and its influence on survival in metastatic breast cancer</span>. <abbr class="cit-jnl-abbrev">Am J Clin Oncol</abbr> <span class="cit-pub-date">1985</span>;<span class="cit-vol">8</span>:<span class="cit-fpage">283</span>-<span class="cit-lpage">92</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=3909799&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1985ATS2500002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Response%20to%20treatment%20and%20its%20influence%20on%20survival%20in%20metastatic%20breast%20cancer&amp;author=AH%20Paterson&amp;author=M%20Cyr&amp;author=O%20Szafran&amp;author=AW%20Lees&amp;author=J%20Hanson&amp;publication_year=1985&amp;journal=Am%20J%20Clin%20Oncol&amp;volume=8&amp;pages=283-92">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(108)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.108">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cheblowski</span>  <span class="cit-name-given-names">RT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Irwin</span>  <span class="cit-name-given-names">LE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pugh</span>  <span class="cit-name-given-names">RP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sadoff</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hesteroff</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wiener</span>  <span class="cit-name-given-names">JM</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Survival of patients with metastatic breast cancer treated with either combination chemotherapy or sequential chemotherapy</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1979</span>;<span class="cit-vol">39</span>:<span class="cit-fpage">4503</span>-<span class="cit-lpage">6</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=39/11/4503"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(109)</span><a class="rev-xref-ref" href="#xref-ref-109-1"
                           title="View reference (109) in text"
                           id="ref-109">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.109"
                             data-doi="10.3109/02841869409083947">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">De La Torre</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Larsson</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nygren</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lindgren</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bergh</span>  <span class="cit-name-given-names">J</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Expression of the multidrug-resistance gene product in untreated human breast cancer and its relationship to prognostic markers</span>. <abbr class="cit-jnl-abbrev">Acta Oncol</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">33</span>:<span class="cit-fpage">773</span>-<span class="cit-lpage">7</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.3109/02841869409083947&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7993645&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1994PY11300007&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Expression%20of%20the%20multidrug-resistance%20gene%20product%20in%20untreated%20human%20breast%20cancer%20and%20its%20relationship%20to%20prognostic%20markers&amp;author=M%20De%20La%20Torre&amp;author=R%20Larsson&amp;author=P%20Nygren&amp;author=A%20Lindgren&amp;author=J%20Bergh&amp;publication_year=1994&amp;journal=Acta%20Oncol&amp;volume=33&amp;pages=773-7">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(110)</span><a class="rev-xref-ref" href="#xref-ref-110-1"
                           title="View reference (110) in text"
                           id="ref-110">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.110">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Herzog</span>  <span class="cit-name-given-names">CE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tsokos</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bates</span>  <span class="cit-name-given-names">SE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fojo</span>  <span class="cit-name-given-names">AT</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists</span>. <abbr class="cit-jnl-abbrev">J Biol Chem</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">268</span>:<span class="cit-fpage">2946</span>-<span class="cit-lpage">52</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=268/4/2946"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(111)</span><a class="rev-xref-ref" href="#xref-ref-111-1"
                           title="View reference (111) in text"
                           id="ref-111">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.111">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Batist</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tulple</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sinha</span>  <span class="cit-name-given-names">BK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Katki</span>  <span class="cit-name-given-names">AG</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Myers</span>  <span class="cit-name-given-names">CE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cowan</span>  <span class="cit-name-given-names">KH</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Overexpression of a novel anionic glutathione transferase in multidrugresistant human breast cancer cells</span>. <abbr class="cit-jnl-abbrev">J Biol Chem</abbr> <span class="cit-pub-date">1986</span>;<span class="cit-vol">261</span>:<span class="cit-fpage">15544</span>-<span class="cit-lpage">9</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=261/33/15544"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(112)</span><a class="rev-xref-ref" href="#xref-ref-112-1"
                           title="View reference (112) in text"
                           id="ref-112">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.112">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sinha</span>  <span class="cit-name-given-names">BK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mimnaugh</span>  <span class="cit-name-given-names">EG</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rajagopalan</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Myers</span>  <span class="cit-name-given-names">CE</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase
                                    in adriamycin resistance</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1989</span>;<span class="cit-vol">49</span>:<span class="cit-fpage">3844</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=49/14/3844"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(113)</span><a class="rev-xref-ref" href="#xref-ref-113-1"
                           title="View reference (113) in text"
                           id="ref-113">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.113"
                             data-doi="10.1007/BF00666207">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fuqua</span>  <span class="cit-name-given-names">SA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Oesterreich</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hilsenbeck</span>  <span class="cit-name-given-names">SG</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Von Hoff</span>  <span class="cit-name-given-names">DD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Eckardt</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Osborne</span>  <span class="cit-name-given-names">CK</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Heat shock proteins and drug resistance</span>. <abbr class="cit-jnl-abbrev">Breast Cancer Res Treat</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">32</span>:<span class="cit-fpage">67</span>-<span class="cit-lpage">71</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/BF00666207&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7819588&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1994PL18100008&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Heat%20shock%20proteins%20and%20drug%20resistance&amp;author=SA%20Fuqua&amp;author=S%20Oesterreich&amp;author=SG%20Hilsenbeck&amp;author=DD%20Von%20Hoff&amp;author=J%20Eckardt&amp;author=CK%20Osborne&amp;publication_year=1994&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=32&amp;pages=67-71">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(1`14)</span><a class="rev-xref-ref" href="#xref-ref-114-1"
                           title="View reference (1`14) in text"
                           id="ref-114">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.114">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schuurhuis</span>  <span class="cit-name-given-names">GJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Broxterman</span>  <span class="cit-name-given-names">HJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ossenkopple</span>  <span class="cit-name-given-names">GJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Baak</span>  <span class="cit-name-given-names">JP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Eekman</span>  <span class="cit-name-given-names">CA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kuiper</span>  <span class="cit-name-given-names">CM</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Functional multidrug resistance phenotype associated with combined overexpression of pgp/MDR1 and MRP together with 1-b-arabinofuranosylcytosine
                                    sensitivity may predict clinical response in acute myeloid leukemia</span>. <abbr class="cit-jnl-abbrev">Clin Cancer Res</abbr> <span class="cit-pub-date">1995</span>;<span class="cit-vol">1</span>:<span class="cit-fpage">81</span>-<span class="cit-lpage">93</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=clincanres&amp;resid=1/1/81"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(115)</span><a class="rev-xref-ref" href="#xref-ref-115-1"
                           title="View reference (115) in text"
                           id="ref-115">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.115">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Demicheli</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jirillo</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bonciarelli</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lonardi</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Balli</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bandello</span>  <span class="cit-name-given-names">A</span></span></li>
                              </ol><cite>. <span class="cit-article-title">48Epidoxorubicin plus verapamil in anthracycline-refractory cancer patients</span>. <abbr class="cit-jnl-abbrev">Tumori</abbr> <span class="cit-pub-date">1989</span>;<span class="cit-vol">75</span>:<span class="cit-fpage">245</span>-<span class="cit-lpage">7</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=2773076&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1989AH36900010&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=48Epidoxorubicin%20plus%20verapamil%20in%20anthracycline-refractory%20cancer%20patients&amp;author=R%20Demicheli&amp;author=A%20Jirillo&amp;author=G%20Bonciarelli&amp;author=F%20Lonardi&amp;author=M%20Balli&amp;author=A%20Bandello&amp;publication_year=1989&amp;journal=Tumori&amp;volume=75&amp;pages=245-7">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(116)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.116">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wishart</span>  <span class="cit-name-given-names">GC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bissett</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Paul</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jodrell</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Harnett</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Habeshaw</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized
                                    trial</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">12</span>:<span class="cit-fpage">1771</span>-<span class="cit-lpage">7</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=12/9/1771"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(117)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.117">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mross</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bohn</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Edler</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jonat</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Queisser</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Heidemann</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>; <span class="cit-auth cit-collab">Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society</span>. <span class="cit-article-title">Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An
                                    AIO clinical trial</span>. <abbr class="cit-jnl-abbrev">Ann Oncol</abbr> <span class="cit-pub-date">1993</span>;<span class="cit-vol">4</span>:<span class="cit-fpage">45</span>-<span class="cit-lpage">50</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=4/1/45"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(118)</span><a class="rev-xref-ref" href="#xref-ref-118-1"
                           title="View reference (118) in text"
                           id="ref-118">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.118">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Miller</span>  <span class="cit-name-given-names">RL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bukowski</span>  <span class="cit-name-given-names">RM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Budd</span>  <span class="cit-name-given-names">GT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Purvis</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Weick</span>  <span class="cit-name-given-names">JK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shepard</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Clinical modulation of doxorubicin resistance by the calmodulininhibitor, trifluoperazine: a phase I/II trial</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">1988</span>;<span class="cit-vol">6</span>:<span class="cit-fpage">880</span>-<span class="cit-lpage">8</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=6/5/880"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(119)</span><a class="rev-xref-ref" href="#xref-ref-119-1"
                           title="View reference (119) in text"
                           id="ref-119">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-89.13.917.119">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mross</span>  <span class="cit-name-given-names">K</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Multidrug-resistance modulation in metastatic breast cancer patients</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">1996</span>;<span class="cit-vol">13</span>:<span class="cit-fpage">303</span>-<span class="cit-lpage">4</span>. <span class="cit-comment">[letter]</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=A1995QA32500044&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Multidrug-resistance%20modulation%20in%20metastatic%20breast%20cancer%20patients&amp;author=K%20Mross&amp;publication_year=1996&amp;journal=J%20Clin%20Oncol&amp;volume=13&amp;pages=303-4">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(120)</span>
                        
                        
                        <div class="cit ref-cit ref-book no-rev-xref" id="cit-89.13.917.120">
                           <div class="cit-metadata">
                              <ol class="cit-ed-list">
                                 <li><span class="cit-ed"><span class="cit-name-surname">Beahrs</span>  <span class="cit-name-given-names">O</span></span>, 
                                 </li>
                                 <li><span class="cit-ed"><span class="cit-name-surname">Henson</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-ed"><span class="cit-name-surname">Hutter</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-ed"><span class="cit-name-surname">Myers</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>, editors. <span class="cit-source">Manual for staging of cancer</span>. <span class="cit-edition">3rd ed</span>. <span class="cit-publ-loc">Philadelphia</span>: <span class="cit-publ-name">Lippincott</span>; <span class="cit-pub-date">1988</span>. <span class="cit-article-title">Staging for carcinoma of the breast</span>; p. <span class="cit-fpage">145</span>-<span class="cit-lpage">50</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Staging%20for%20carcinoma%20of%20the%20breast&amp;author=O%20Beahrs&amp;author=D%20Henson&amp;author=R%20Hutter&amp;author=M%20Myers&amp;publication_year=1988&amp;citation_inbook_title=Manual%20for%20staging%20of%20cancer">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(121)</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-89.13.917.121"
                             data-doi="10.1038/bjc.1957.43">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bloom</span>  <span class="cit-name-given-names">HJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Richardson</span>  <span class="cit-name-given-names">WW</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Histologic grading and prognosis in breast cancer</span>. <abbr class="cit-jnl-abbrev">Br J Cancer</abbr> <span class="cit-pub-date">1957</span>;<span class="cit-vol">11</span>:<span class="cit-fpage">359</span>-<span class="cit-lpage">77</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/bjc.1957.43&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=13499785&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1957WN18100004&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Histologic%20grading%20and%20prognosis%20in%20breast%20cancer&amp;author=HJ%20Bloom&amp;author=WW%20Richardson&amp;publication_year=1957&amp;journal=Br%20J%20Cancer&amp;volume=11&amp;pages=359-77">Google Scholar</a></div>
                        </div>
                        
                     </li>
                  </ol>
               </div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span></div>
         <div id="col-2">
            
            <div class="article-nav sidebar-nav">
               <a href="/content/89/13/906.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="/content/89/13/932.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="/content/89/13.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              <cite>
                                 <abbr title="JNCI Journal of the National Cancer Institute" class="slug-jnl-abbrev">
                                    <nlm:abbrev-journal-title xmlns:nlm="http://schema.highwire.org/NLM/Journal" abbrev-type="publisher">JNCI J Natl Cancer Inst</nlm:abbrev-journal-title></abbr><span class="slug-pub-date" itemprop="datePublished">
                                    (1997) 
                                    </span>
                                 
                                 <span class="slug-vol">
                                    89
                                    </span><span class="slug-issue">
                                    (13):
                                    </span><span class="slug-pages">
                                    917-931.
                                    </span>
                                 <span class="slug-doi-wrapper">
                                    
                                    doi:
                                    
                                    <span title="10.1093/jnci/89.13.917" class="slug-doi">10.1093/jnci/89.13.917</span>
                                    </span>
                                 </cite>
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li class="abstract-view-link primary"><a href="/content/89/13/917.abstract" rel="view-abstract">Abstract</a><span class="free">Free</span></li>
                        <li class="notice full-text-view-link"><span class="variant-indicator">» <span>Full Text (HTML)</span></span><span class="free">Free</span></li>
                        <li class="notice full-text-pdf-view-link"><a href="/content/89/13/917.full.pdf+html" rel="view-full-text.pdf">Full Text (PDF)</a><span class="free">Free</span></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><span>Classifications</span></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search"
                                    href="/search?tocsectionid=Articles&amp;sortspec=date&amp;submit=Submit">Article</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><span>Services</span></h4>
                     <ol>
                        <li class="usage-stats-link icon-link"><a href="/articleusage?gca=jnci;89/13/917" rel="nofollow">Article metrics</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=jnci%3B89%2F13%2F917&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/89/13/917.full">Alert me when cited</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=89/13/917&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/89/13/917.full">Alert me if corrected</a></li>
                        <li class="similar-link"><a href="/search?qbe=jnci%3B89.13.917&amp;citation=Trock%20et%20al.%2089%20%2813%29:%20917&amp;submit=yes">Find similar articles</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=jnci%3B89%2F13%2F917&amp;link_type=ISI_RELATEDRECORDS"
                              id="cb-isi-similar-articles"
                              class="similar-link">Similar articles in Web of Science</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=9214671&amp;link_type=MED_NBRS" class="similar-link">Similar articles in PubMed</a></li>
                        <li class="folder-link icon-link"><a href="/cgi/folders?action=addtofolder&amp;wherefrom=JOURNALS&amp;wrapped_id=jnci%3B89%2F13%2F917">Add to my archive</a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="/citmgr?gca=jnci%3B89%2F13%2F917">Download citation</a></li>
                        <li><a class="request-permissions"
                              href="https://s100.copyright.com/AppDispatchServlet?publisherName=oup&amp;publication=jnci&amp;title=Multidrug%20Resistance%20in%20Breast%20Cancer%3A%20a%20Meta-analysis%20of%20MDR1%2Fgp170%20Expression%20and%20Its%20Possible%20Functional%20Significance%3A%20&amp;publicationDate=07%2F02%2F1997&amp;author=Bruce%20J.%20Trock%2C%20Fabio%20Leonessa%2C%20Robert%20Clarke&amp;copyright=Oxford%20University%20Press&amp;contentID=10.1093%2Fjnci%2F89.13.917&amp;volumeNum=89&amp;issueNum=13&amp;startPage=917&amp;endPage=931&amp;orderBeanReset=true"
                              target="_blank">Request Permissions</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-cit">
                     <h4 class="cb-section-header"><span>Citing Articles</span></h4>
                     <ol>
                        <li class="hw-citing-link"><a href="/content/89/13/917.full?cited-by=yes&amp;legid=jnci;89/13/917#cited-by"
                              id="cb-hw-citing-articles">Load citing article information</a></li>
                        <li><a href="/cgi/crossref-forward-links/89/13/917" rel="external-nw"
                              id="cb-crossref-citing-articles">Citing articles via CrossRef</a></li>
                        <li><a href="/scopus-links/jnci/89/13/917?access_num=/jnci/89/13/917"
                              rel="external-nw"
                              id="cb-scopus-citing-articles">Citing articles via Scopus</a></li>
                        <li><a href="/external-ref?access_num=%2Fjnci%2F89%2F13%2F917&amp;link_type=ISI_CITING&amp;accnum_type=native"
                              rel="external-nw"
                              id="cb-isi-citing-articles">Citing articles via Web of Science</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-gs">
                     <h4 class="cb-section-header"><span>Google Scholar</span></h4>
                     <ol>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ATrock%20author%3AB.J.%22"
                              class="cb-art-gs-auth author-link">Articles by  Trock, B. J.</a></li>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3AClarke%20author%3AR.%22"
                              class="cb-art-gs-auth author-link">Articles by  Clarke, R.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/89/13/917.abstract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-pm">
                     <h4 class="cb-section-header"><span>PubMed</span></h4>
                     <ol>
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="/external-ref?access_num=9214671&amp;link_type=PUBMED"
                              class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Trock%20BJ&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Trock, B. J.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Leonessa%20F&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Leonessa, F.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Clarke%20R&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Clarke, R.</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-rel">
                     <h4 class="cb-section-header"><span>Related Content</span></h4>
                     <ol>
                        <li><a href="/content/89/13/917.full?related-urls=yes&amp;legid=jnci;89/13/917#related-urls"
                              id="cb-related-urls">Load related web page information</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-soc">
                     <h4 class="cb-section-header"><span>Share</span></h4>
                     <ol>
                        <li><a href="/email?gca=jnci%3B89%2F13%2F917&amp;current-view-path=/content/89/13/917.full">
                              Email this article</a></li>
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/89/13/917&amp;title=Multidrug%20Resistance%20in%20Breast%20Cancer%3A%20a%20Meta-analysis%20of%20MDR1%2Fgp170%20Expression%20and%20Its%20Possible%20Functional%20Significance+--+Trock%20et%20al.%2089%20%2813%29%3A%20917+--+jnci&amp;doi=10.1093/jnci/89.13.917&amp;link_type=CITEULIKE"><img src="/shared/img/common/social-bookmarking/citeulike.gif"
                                            alt="Add to CiteULike"
                                            title="CiteULike" /></a><span class="soc-bm-link-text">CiteULike</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/89/13/917&amp;title=Multidrug%20Resistance%20in%20Breast%20Cancer%3A%20a%20Meta-analysis%20of%20MDR1%2Fgp170%20Expression%20and%20Its%20Possible%20Functional%20Significance+--+Trock%20et%20al.%2089%20%2813%29%3A%20917+--+jnci&amp;doi=10.1093/jnci/89.13.917&amp;link_type=DEL_ICIO_US"><img src="/shared/img/common/social-bookmarking/delicious.gif"
                                            alt="Add to Delicious"
                                            title="Delicious" /></a><span class="soc-bm-link-text">Delicious</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-facebook"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/short/89/13/917&amp;title=Multidrug%20Resistance%20in%20Breast%20Cancer%3A%20a%20Meta-analysis%20of%20MDR1%2Fgp170%20Expression%20and%20Its%20Possible%20Functional%20Significance+--+Trock%20et%20al.%2089%20%2813%29%3A%20917+--+jnci&amp;doi=10.1093/jnci/89.13.917&amp;link_type=FACEBOOK"
                                       class="sb-facebook"
                                       rel="external-nw"><img src="/shared/img/common/social-bookmarking/facebook.gif" alt="Add to Facebook"
                                            title="Facebook" /></a><span class="soc-bm-link-text">Facebook</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-googleplus"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/89/13/917&amp;title=Multidrug%20Resistance%20in%20Breast%20Cancer%3A%20a%20Meta-analysis%20of%20MDR1%2Fgp170%20Expression%20and%20Its%20Possible%20Functional%20Significance+--+Trock%20et%20al.%2089%20%2813%29%3A%20917+--+jnci&amp;doi=10.1093/jnci/89.13.917&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="/shared/img/common/social-bookmarking/googleplus.jpg" alt="Add to Google+"
                                            title="Google+" /></a><span class="soc-bm-link-text">Google+</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/89/13/917&amp;title=Multidrug%20Resistance%20in%20Breast%20Cancer%3A%20a%20Meta-analysis%20of%20MDR1%2Fgp170%20Expression%20and%20Its%20Possible%20Functional%20Significance+--+Trock%20et%20al.%2089%20%2813%29%3A%20917+--+jnci&amp;doi=10.1093/jnci/89.13.917&amp;link_type=MENDELEY"><img src="/shared/img/common/social-bookmarking/mendeley.gif" alt="Add to Mendeley"
                                            title="Mendeley" /></a><span class="soc-bm-link-text">Mendeley</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/89/13/917&amp;title=Multidrug%20Resistance%20in%20Breast%20Cancer%3A%20a%20Meta-analysis%20of%20MDR1%2Fgp170%20Expression%20and%20Its%20Possible%20Functional%20Significance+--+Trock%20et%20al.%2089%20%2813%29%3A%20917+--+jnci&amp;doi=10.1093/jnci/89.13.917&amp;link_type=TWITTER"><img src="/shared/img/common/social-bookmarking/twitter.gif" alt="Add to Twitter"
                                            title="Twitter" /></a><span class="soc-bm-link-text">Twitter</span></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#abstract-1">Abstract</a></li>
                        <li><a href="#sec-1">Materials and Methods</a></li>
                        <li><a href="#sec-7">Results</a></li>
                        <li><a href="#sec-12">Discussion</a></li>
                        <li><a href="#sec-22">Conclusions</a></li>
                        <li><a href="#fn-group-1">Footnotes</a></li>
                        <li><a href="#ref-list-1">References</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            
         </div>
         <div id="col-3">
            
            <div id="col-3-qs" class="sidebar-qs">
               
               
               <form class="searchbox" action="/search" method="get">
                  <p>Search this journal:</p>
                  <div>
                     	
                     	
                     	<input value="" type="text" name="fulltext" id="header-qs-input" />
                     <input type="hidden" name="submit" value="yes" />
                     
                     <input class="inline_button" type="image" alt="Go" src="/publisher/img/buttons/go.gif" />
                     
                     <div class="adv-search-link"><a href="/search">Advanced »</a></div>
                     
                     
                  </div>
               </form>
               
            </div>
            <div class="cb-contents">
               
               <div id="sidebar-current-issue" class="content-box">
                  	
                  <h3 class="cb-contents-header">Current Issue</h3>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           	      <a href="/content/current"><span>
                                 		  <span class="current-issue-date">
                                    October 2015
                                    </span><span class="toc-citation-volume">
                                    
                                    107
                                    </span><span class="toc-citation-issue">(10)</span>
                                 		  
                                 		</span></a>
                           	    
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           <a href="/content/current"><img src="/content/107/10.cover.gif" alt="JNCI J Natl Cancer Inst" id="cover" /></a>
                           
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section sidebar-etoc-link">
                     	  
                     <ol>
                        <li><a href="/cgi/alerts/etoc">Alert me to new issues</a></li>
                     </ol>
                     	
                  </div>
                  
               </div>
               
            </div>
            
            <div id="second">
               
               <div class="ad_hidden" id="oas_right1">
                  <iframe id="id_advertframe_right1"
                          src="/resource/htmlfiles/advert.html?p=Right1&amp;u=jnci.oxfordjournals.org/content/89/13/917.full"
                          width="0"
                          height="0"
                          frameborder="0"
                          scrolling="no"
                          class="resize_ad"></iframe>
                  
               </div>
               
               <div class="features">
                  
                  <div class="feature separator_after first">
                     
                     <h2 id="the_journal" title="The Journal"><span>The Journal</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/about.html" rel=""
                              title="About this journal">About this journal</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/contact_us.html" rel=""
                              title="Contact Us">Contact Us</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/rights_permissions.html"
                              rel=""
                              title="Rights &amp; Permissions">Rights &amp; Permissions</a>
                           
                        </li>
                        <li>
                           <a href="HTTP://www.oxfordjournals.org/access_purchase/dispatch_dates.html#JNCI.JP"
                              rel=""
                              title="Dispatch date of next issue">Dispatch date of next issue</a>
                           
                        </li>
                        <li>
                           <a href="http://publicationethics.org/" rel=""
                              title="This journal is a member of the Committee on Publication Ethics (COPE)">This journal is a member of the Committee on Publication Ethics (COPE)</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/mobile_faqs.html" rel=""
                              title="We are mobile – find out more">We are mobile – find out more</a>
                           
                        </li>
                        <li>
                           <a href="http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;t732=469986&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102"
                              rel=""
                              title="Journals Career Network">Journals Career Network</a>
                           
                        </li>
                     </ul>
                     
                     <p>
                        <a href="http://www.oxfordjournals.org/our_journals/jnci/episodes_2012.html">
                           <img alt="Podcast Logo" style="float:left"
                                src="http://www.oxfordjournals.org/podcasts/podcast_icon_35x35.gif" />JNCI Podcast</a>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Connect with us!</h3>
                     <a href="https://twitter.com/JNCI_Now">
                        <img class="small_margin" alt="Connect with us on Twitter!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/connect_twitter.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     <a href="https://www.facebook.com/thejnci">
                        <img class="small_margin" alt="Connect with us on Facebook!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/facebook.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     
                     <p>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Editor-in-Chief</h3>
                     
                     <p>Carmen J. Allegra</p>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/editorial_board.html"
                              rel=""
                              title="View full editorial board">View full editorial board</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Impact factor: 12.583</h3>
                     
                     <h3 class="five_year">5-Yr impact factor: 13.584</h3>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h3>For the Media</h3>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/press_room.html" rel=""
                              title="JNCI PRESS ROOM">JNCI PRESS ROOM</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="for_authors" title="For Authors"><span>For Authors</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/for_authors/index.html"
                              rel=""
                              title="Instructions to authors">Instructions to authors</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/self-archiving_policyb.html"
                              rel=""
                              title="Self Archiving/Public Access Policy">Self Archiving/Public Access Policy</a>
                           
                        </li>
                     </ul>
                     <a href="http://www.oxfordjournals.org/oxfordopen/ ">
                        <img alt="Open access options for authors - visit Oxford Open"
                             src="http://www.oxfordjournals.org/resource/image/promos/oxford_open_small.gif" />
                        </a>
                     <a href="http://www.oxfordjournals.org/oxfordopen/funder_policies/">
                        <img alt="RCUK Wellcome Trust Open Access"
                             src="http://www.oxfordjournals.org/resource/image/wellcome-trust-180x100.jpg" />
                        </a>
                     
                     <p>Open access options for authors - visit <a href="http://www.oxfordjournals.org/oxfordopen/">Oxford Open</a>
                        
                     </p>
                     <a href="http://publicaccess.nih.gov/submit_process_journals.htm">
                        <img alt="PMC Logo" src="http://www.oxfordjournals.org/resource/image/pmc-logo.gif" />
                        </a>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://publicaccess.nih.gov/submit_process_journals.htm" rel=""
                              title="This journal enables compliance with the NIH Public Access Policy">This journal enables compliance with the NIH Public Access Policy</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="alerting_services" title="Alerting Services"><span>Alerting Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email table of contents">Email table of contents</a>
                           
                        </li>
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email Advance Access">Email Advance Access</a>
                           
                        </li>
                        <li>
                           <a href="http://jnci.oxfordjournals.org/help/citetrack/index.dtl" rel=""
                              title="CiteTrack">CiteTrack</a>
                           
                        </li>
                        <li>
                           <a href="/rss" rel="" title="XML RSS feed">XML RSS feed</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="corporate_services" title="Corporate Services"><span>Corporate Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/advertising.html" rel=""
                              title="Advertising sales">Advertising sales</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/reprints.html" rel=""
                              title="Reprints">Reprints</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/classifiedadinprint.html"
                              rel=""
                              title="Classified Advertising">Classified Advertising</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
               </div>
               <script type="text/javascript">var taxonomies = ["MED00300"];</script>
               </div>
            
            <div class="most-links-box js-marker">
               
               <div class="most-header">
                  
                  <h3>Most</h3>
                  
               </div>
               
               <ul>
                  <li class="most-cur-sel">
                     <h4>Most Read</h4>
                     	  
                     <div class="most-list">
                        	    
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/6/443?rss=1&amp;ssource=mfr">Breast Density and Cancer Risk: What Is the Relationship?</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/9/713?rss=1&amp;ssource=mfr">The Female Prostate</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/91/14/1194?rss=1&amp;ssource=mfr">Tobacco Smoke Carcinogens and Lung Cancer</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/107/6/djv048?rss=1&amp;ssource=mfr">Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity,
                                 Poverty, and State</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/105/23/1799?rss=1&amp;ssource=mfr">Elevated Plasma Vitamin B12 Levels as a Marker for Cancer: A Population-Based Cohort Study</a></li>
                        </ol>
                        	    <a href="http://jnci.oxfordjournals.org/reports/mfr1.dtl" class="view-all">» View all Most Read articles</a>
                        	  
                     </div>
                     	
                  </li>
                  <li>
                     <h4>Most Cited</h4>
                     	
                     <div class="most-list">
                        	  
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/3/205?rss=1&amp;ssource=mfc">New Guidelines to Evaluate the Response to Treatment in Solid Tumors</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/18/1371?rss=1&amp;ssource=mfc">Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/85/5/365?rss=1&amp;ssource=mfc">The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International
                                 Clinical Trials in Oncology</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/13/1107?rss=1&amp;ssource=mfc">New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/1/4?rss=1&amp;ssource=mfc">What Is the Evidence That Tumors Are Angiogenesis Dependent?</a></li>
                        </ol>
                        	  <a href="http://jnci.oxfordjournals.org/reports/mfc1.dtl" class="view-all">» View all Most Cited articles</a>
                        	
                     </div>
                     
                  </li>
               </ul>
               
            </div>
            
            
            
         </div>
         
         
         
         <div id="oas_bottom" class="ad_hidden">
            <iframe id="id_advertframe_bottom"
                    src="/resource/htmlfiles/advert.html?p=Bottom&amp;u=jnci.oxfordjournals.org/content/89/13/917.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         
         
         
         
         <div id="secondary_footer">
            
            <div id="issn">Online ISSN 1460-2105 - Print ISSN 0027-8874</div>
            
            
            <div id="copyright"><a href="http://www.oxfordjournals.org/our_journals/terms.html">Copyright ©</a> 
               <span>2015</span> Oxford University Press
               
            </div>
            
         </div>
         
         <div id="primary_footer">
            
            <div id="site_logo">
               <strong><span>Oxford Journals</span></strong>
               <em><span>Oxford University Press</span></em>
               
            </div>
            
            
            <div id="third_nav">
               
               <ul>
                  <li><a href="http://www.oxfordjournals.org/site_map.html">Site Map</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/privacy_policy.html">Privacy Policy</a></li>
                  <li><a href="http://global.oup.com/cookiepolicy/?siteid=journals">Cookie Policy</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/legal_notices.html">Legal Notices</a></li>
                  <li><a href="http://www.oxfordjournals.org/faq/">Frequently Asked Questions</a></li>
               </ul>
               
            </div>
            
            
            <div id="other_oup_sites">
               
               <form action="http://www.oxfordjournals.org/service/redirect">
                  <div>
                     <label for="site_list">Other Oxford University Press sites:</label>
                     <select name="url" id="site_list">
                        <option value="http://www.oup.com">Oxford University Press</option>
                        <option value="http://www.oxfordjournals.org/china/">Oxford Journals China</option>
                        <option value="http://www.oxfordjournals.org/japan/">Oxford Journals Japan</option>
                        <option value="http://www.oup.com/uk/academic">Academic &amp; Professional books</option>
                        <option value="http://www.oup.com/oxed">Children's &amp; Schools Books</option>
                        <option value="http://www.oup.com/uk/dictionaries">Dictionaries &amp; Reference</option>
                        <option value="http://www.oup.co.uk/newdnb/">Dictionary of National Biography</option>
                        <option value="http://www.oup.com/uk/digital_reference">Digital Reference</option>
                        <option value="http://www.oup.com/elt/">English Language Teaching</option>
                        <option value="http://www.oup.com/uk/textbooks">Higher Education Textbooks</option>
                        <option value="http://www.oup.co.uk/ieu/">International Education Unit</option>
                        <option value="http://www.oup.com/uk/law">Law</option>
                        <option value="http://www.oup.com/uk/medicine">Medicine</option>
                        <option value="http://www.oup.com/uk/music">Music</option>
                        <option value="http://www.oup.com/online">Online Products &amp; Publishing</option>
                        <option value="http://oxfordbibliographiesonline.com">Oxford Bibliographies Online</option>
                        <option value="http://oxforddictionaries.com">Oxford Dictionaries Online</option>
                        <option value="http://www.oed.com">Oxford English Dictionary</option>
                        <option value="http://www.oxfordlanguagedictionaries.com">Oxford Language Dictionaries Online</option>
                        <option value="http://www.oxfordscholarship.com">Oxford Scholarship Online</option>
                        <option value="http://www.oup.com/uk/reference">Reference</option>
                        <option value="http://www.oup.com/uk/rights">Rights and Permissions</option>
                        <option value="http://www.oup.com/uk/booksellers">Resources for Retailers &amp; Wholesalers</option>
                        <option value="http://www.oup.com/uk/corporate">Resources for the Healthcare Industry</option>
                        <option value="http://www.oup.com/vsi">Very Short Introductions</option>
                        <option value="http://www.oup.com/worldsclassics">World's Classics</option></select>
                     
                     <input type="image" src="/resource/image/buttons/go.gif" alt="Go"
                            class="inline_button" />
                     
                  </div>
               </form>
               
            </div>
            
         </div>
         <script type="text/javascript"
                 src="http://gab.cookie.oup.com/aws-cookie/oup.cookiepolicy.pack.js"
                 defer="defer"></script>
         
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jquery-ui.min.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jcarousellite.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/pf_oiunderbarinit.js"
                 type="text/javascript"></script>
         <script defer="defer" src="/resource/js/underbar_local.js" type="text/javascript"></script>
         <script defer="defer" type="text/javascript">
    function fnc_onDomLoaded() {
        var query_context = getQueryContext();
        PF_initOIUnderbar(query_context,":QS:default","","JRN"); 
        PF_insertOIUnderbar(0);
    };
    if (window.addEventListener) { 
        window.addEventListener('load', fnc_onDomLoaded, false); 
    } else if (window.attachEvent) { 
        window.attachEvent('onload', fnc_onDomLoaded); 
    } 
</script>
         <noscript><img src="//ouptag.scholarlyiq.com/ntpagetag.gif?js=0" height="1" width="1"
                 border="0"
                 hspace="0"
                 vspace="0"
                 alt="" /></noscript><script type="text/javascript" src="//ouptag.scholarlyiq.com/ntpagetag.js"></script><script type="text/javascript">
        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script type="text/javascript">
        try {
        var pageTracker = _gat._getTracker("UA-189672-16");
        pageTracker._setDomainName(".oxfordjournals.org");
        pageTracker._trackPageview();
        } catch(err) {}
        </script></div>
   </body>
</html>